{
  "meta": {
    "id": "test6",
    "title": "Heamatology",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A 16-year-old male presents with jaundice and anemia. His blood smear shows spherical red blood cells, and laboratory tests reveal an increase in mean corpuscular hemoglobin concentration (MCHC). Which of the following is the most likely cause of his anemia?",
      "options": [
        {
          "label": "A",
          "text": "Iron deficiency anemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Megaloblastic anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anemia of chronic disease \u200b\u200b\u200b",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hereditary spherocytosis",
          "correct": true
        }
      ],
      "correct_answer": "D. Hereditary spherocytosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. \u00a0Hereditary spherocytosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Iron deficiency anemia: It is characterized by a decrease in the amount of hemoglobin in red blood cells, leading to a decreased MCHC .</li><li>\u2022 Option A. Iron deficiency anemia:</li><li>\u2022 decrease in the amount of hemoglobin</li><li>\u2022 decreased MCHC</li><li>\u2022 Option B. Megaloblastic anemia: It can be associated with vitamin B12 or folate deficiency and ha s macrocytosis . This condition is associated with a normal or decreased MCHC.</li><li>\u2022 Option B. Megaloblastic anemia:</li><li>\u2022 vitamin B12 or folate deficiency</li><li>\u2022 s macrocytosis</li><li>\u2022 normal or decreased MCHC.</li><li>\u2022 Option C. Anemia of chronic disease: The anomie is often normocytic and normochromic , with a normal MCH</li><li>\u2022 Option C. Anemia of chronic disease:</li><li>\u2022 normocytic and normochromic</li><li>\u2022 normal MCH</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hereditary spherocytosis often presents with an elevated MCHC due to the spherical shape of red blood cells , which concentrates the haemoglobin content</li><li>\u27a4 Hereditary spherocytosis</li><li>\u27a4 elevated MCHC</li><li>\u27a4 spherical shape of red blood cells</li><li>\u27a4 haemoglobin content</li><li>\u27a4 Ref : Robbins 10 th / 639</li><li>\u27a4 Ref : Robbins 10 th / 639</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d5c7e20d",
      "audio": ""
    },
    {
      "text": "The best method for estimation of hemoglobin concentration in blood is:",
      "options": [
        {
          "label": "A",
          "text": "Acid hematin method",
          "correct": false
        },
        {
          "label": "B",
          "text": "Alkali hematin method",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cyanmethemoglobin method",
          "correct": true
        },
        {
          "label": "D",
          "text": "Any of the above \u200b\u200b\u200b\u200b\u200b\u200b",
          "correct": false
        }
      ],
      "correct_answer": "C. Cyanmethemoglobin method",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/25/picture37.jpg"
      ],
      "explanation": "<p><strong>Ans. C. \u00a0Cyanmethemoglobin method</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. The acid hematin method involves converting hemoglobin to acid hematin using an acidic solution . This method is less frequently used due to its lower specificity and sensitivity compared to other methods.</li><li>\u2022 Option A. The acid hematin</li><li>\u2022 hemoglobin to acid hematin</li><li>\u2022 acidic solution</li><li>\u2022 less frequently</li><li>\u2022 lower specificity and sensitivity</li><li>\u2022 Option B. Similar to the acid hematin method, the alkali hematin method involves the conversion of hemoglobin to alkali hematin using an alkaline solution . It is also not commonly used in clinical practice because it can be less accurate and is affected by turbidity caused by the presence of other substances in the blood.</li><li>\u2022 Option B. Similar to the acid hematin</li><li>\u2022 alkali hematin</li><li>\u2022 conversion of hemoglobin to alkali hematin</li><li>\u2022 alkaline solution</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "668e52e6",
      "audio": ""
    },
    {
      "text": "Reticulocytes are BEST stained with:",
      "options": [
        {
          "label": "A",
          "text": "Methyl violet",
          "correct": false
        },
        {
          "label": "B",
          "text": "Brilliant Cresyl blue",
          "correct": false
        },
        {
          "label": "C",
          "text": "New methylene blue",
          "correct": true
        },
        {
          "label": "D",
          "text": "Indigo carmine",
          "correct": false
        }
      ],
      "correct_answer": "C. New methylene blue",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. New methylene blue</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Methyl violet is a basic dye that can be used to stain acidic components of cells like nucleic acids, but it is not the best choice for staining reticulocytes. It is commonly used in Gram staining.</li><li>\u2022 Option A. Methyl violet</li><li>\u2022 basic dye</li><li>\u2022 acidic components</li><li>\u2022 nucleic acids,</li><li>\u2022 Option B. Brilliant Cresyl blue is used to stain reticulocytes by binding to the residual ribosomal RNA . It is a vital stain, but it is not the optimal dye for reticulocyte staining as it may not be as sensitive as new methylene blue .</li><li>\u2022 Option B. Brilliant Cresyl</li><li>\u2022 stain reticulocytes</li><li>\u2022 residual ribosomal RNA</li><li>\u2022 not the optimal dye for reticulocyte staining</li><li>\u2022 not be as sensitive as new methylene blue</li><li>\u2022 Option D. Indigo carmine is not used for staining blood cells ; it is a dye more commonly used in medical procedures to highlight structures and assess the function of certain organs, such as during kidney surgery.</li><li>\u2022 Option D. Indigo carmine</li><li>\u2022 staining blood cells</li><li>\u2022 dye</li><li>\u2022 highlight structures</li><li>\u2022 assess the function</li><li>\u2022 kidney surgery.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Reticulocytes are stained in living state in vitro so staining with dyes like brilliant cresyl blue and new methylene blue (Best stain) is referred to as supravital staining.</li><li>\u27a4 Reticulocytes</li><li>\u27a4 in living state</li><li>\u27a4 new methylene blue (Best stain)</li><li>\u27a4 supravital staining.</li><li>\u27a4 Ref : Robbins 10 th 637</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th 637</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "26d51dbe",
      "audio": ""
    },
    {
      "text": "A 20-year-old female presents with the following laboratory values: hemoglobin 9gm%, MCV is 55%, RBC is 4.5 million/mm3. There is no history of blood transfusion. What is the most likely diagnosis out of the following?",
      "options": [
        {
          "label": "A",
          "text": "Thalassemia major",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thalassemia minor",
          "correct": true
        },
        {
          "label": "C",
          "text": "Iron deficiency anemia \u200b",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anemia of chronic disease",
          "correct": false
        }
      ],
      "correct_answer": "B. Thalassemia minor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Thalassemia minor</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Patients with thalassemia major typically present with severe anemia requiring regular blood transfusions. The degree of anemia in the vignette is not consistent with thalassemia major.</li><li>\u2022 Option A. Patients with thalassemia</li><li>\u2022 major</li><li>\u2022 severe anemia</li><li>\u2022 blood transfusions.</li><li>\u2022 vignette</li><li>\u2022 Option C. Iron deficiency anemia typically presents with microcytic and hypochromic anemia . The Mentzer index is generally greater than 13 , which is not the case here.</li><li>\u2022 Option C. Iron deficiency anemia</li><li>\u2022 microcytic and hypochromic anemia</li><li>\u2022 Mentzer index</li><li>\u2022 greater than 13</li><li>\u2022 Option D. Anemia of chronic disease usually presents with normocytic or sometimes microcytic anemia , but it is often characterized by a normal or increased storage iron level , which can be evaluated by serum ferritin.</li><li>\u2022 Option D. Anemia of chronic disease</li><li>\u2022 normocytic or sometimes microcytic anemia</li><li>\u2022 normal or increased storage iron level</li><li>\u2022 serum ferritin.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When presented with mild to moderate microcytic anemia and an MCV/RBC count that yields a Mentzer index of less than 13, thalassemia minor is a likely diagnosis.</li><li>\u27a4 mild to moderate microcytic anemia</li><li>\u27a4 MCV/RBC count</li><li>\u27a4 Mentzer index of less than 13, thalassemia minor</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fa347cfb",
      "audio": ""
    },
    {
      "text": "A 13-yr-girl with fatigue and weakness was found to be having reduced hemoglobin. Her MCV 70fl, MCH 22pg and RDW was 28. What is her most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Iron deficiency anemia \u200b\u200b\u200b\u200b\u200b",
          "correct": true
        },
        {
          "label": "B",
          "text": "Thalassemia minor \u200b\u200b\u200b",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sideroblastic anemia \u200b\u200b\u200b\u200b\u200b",
          "correct": false
        },
        {
          "label": "D",
          "text": "Thalassemia major \u200b\u200b\u200b\u200b\u200b\u200b",
          "correct": false
        }
      ],
      "correct_answer": "A. Iron deficiency anemia \u200b\u200b\u200b\u200b\u200b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Iron deficiency anemia:</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Thalassemia minor often presents with microcytosis and a low MCH , but RDW is typically normal because the red blood cells are uniformly small .</li><li>\u2022 Option B. Thalassemia minor</li><li>\u2022 microcytosis and a low MCH</li><li>\u2022 RDW</li><li>\u2022 normal</li><li>\u2022 red blood cells are uniformly small</li><li>\u2022 Option C. Sideroblastic anemia can also present with microcytosis, but it is usually associated with ringed sideroblasts in the bone marrow and may show elevated iron indices.</li><li>\u2022 Option C. Sideroblastic anemia</li><li>\u2022 microcytosis,</li><li>\u2022 ringed sideroblasts</li><li>\u2022 bone marrow</li><li>\u2022 elevated iron indices.</li><li>\u2022 Option D. Thalassemia major presents with severe microcytic anemia , usually early in life , and patients are typically symptomatic with a history of blood transfusions.</li><li>\u2022 Option D. Thalassemia major presents</li><li>\u2022 severe microcytic anemia</li><li>\u2022 early in life</li><li>\u2022 history of blood transfusions.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 An elevated RDW in the context of microcytic, hypochromic anemia is suggestive of iron deficiency anemia , which can be distinguished from thalassemia minor by the increased RDW.</li><li>\u27a4 elevated RDW</li><li>\u27a4 microcytic, hypochromic anemia</li><li>\u27a4 iron deficiency anemia</li><li>\u27a4 thalassemia minor by the increased RDW.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "eb821597",
      "audio": ""
    },
    {
      "text": "A 68-year-old male with a history of progressive fatigue and a recent diagnosis of alcoholism presents for evaluation. His complete blood count shows a macrocytic anemia and the bone marrow biopsy reveals the presence of ringed sideroblasts. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Iron deficiency anemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Myelodysplastic syndrome \u200b\u200b\u200b\u200b\u200b",
          "correct": true
        },
        {
          "label": "C",
          "text": "Thalassemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anemia of chronic disease",
          "correct": false
        }
      ],
      "correct_answer": "B. Myelodysplastic syndrome \u200b\u200b\u200b\u200b\u200b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Myelodysplastic syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Iron deficiency anemia is characterized by microcytic, hypochromic red cells without the presence of ringed sideroblasts in the bone marrow.</li><li>\u2022 Option A. Iron deficiency anemia</li><li>\u2022 microcytic, hypochromic red cells</li><li>\u2022 Option C. Thalassemia syndromes are hereditary hemoglobinopathies leading to ineffective erythropoiesis and anemia , but they do not typically present with ringed sideroblasts.</li><li>\u2022 Option C. Thalassemia syndromes</li><li>\u2022 hereditary hemoglobinopathies</li><li>\u2022 ineffective erythropoiesis and anemia</li><li>\u2022 Option D. Anemia of chronic disease can cause a microcytic anemia , but it is usually normocytic and does not present with ringed sideroblasts.</li><li>\u2022 Option D. Anemia of chronic disease</li><li>\u2022 microcytic anemia</li><li>\u2022 normocytic</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Myelodysplastic syndrome (MDS) is associated with ineffective hematopoiesis and the presence of ringed sideroblasts</li><li>\u27a4 Myelodysplastic syndrome (MDS)</li><li>\u27a4 ineffective hematopoiesis</li><li>\u27a4 ringed sideroblasts</li><li>\u27a4 Ref : Robbins 10 th /620</li><li>\u27a4 Ref : Robbins 10 th /620</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3d8a7048",
      "audio": ""
    },
    {
      "text": "A 30 years old female undergoes blood investigations which reveal RBC count 4.5 million, MCV 55fl and TLC 8000/mm3. There is no history of blood transfusion. What is the likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Iron deficiency anemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thalassemia major",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thalassemia minor",
          "correct": true
        },
        {
          "label": "D",
          "text": "Megaloblastic anemia \u200b\u200b\u200b\u200b\u200b\u200b",
          "correct": false
        }
      ],
      "correct_answer": "C. Thalassemia minor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Thalassemia minor</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Iron deficiency anemia (IDA) is characterized by microcytic, hypochromic red cells , often with a high RDW and low serum ferritin levels .</li><li>\u2022 Option A. Iron deficiency anemia</li><li>\u2022 microcytic, hypochromic red cells</li><li>\u2022 high RDW and low serum ferritin levels</li><li>\u2022 Option B. Thalassemia major presents with severe microcytic anemia usually requiring blood transfusions for survival , often diagnosed in childhood.</li><li>\u2022 Option B. Thalassemia major presents</li><li>\u2022 severe microcytic anemia</li><li>\u2022 blood transfusions for survival</li><li>\u2022 Option D. Megaloblastic anemia Megaloblastic anemia is characterized by macrocytosis with an MCV typically greater than 100 fL due to impaired DNA synthesis .</li><li>\u2022 Option D. Megaloblastic anemia Megaloblastic</li><li>\u2022 macrocytosis</li><li>\u2022 MCV</li><li>\u2022 100 fL due to impaired DNA synthesis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In a patient with microcytic anemia and an MCV of 55 fL, a normal TLC, and no history of transfusion, thalassemia minor is likely, particularly when using indices such as the Mentzer index (MCV/RBC count), which is less than 13 in thalassemia minor.</li><li>\u27a4 microcytic anemia</li><li>\u27a4 an MCV of 55 fL, a normal TLC,</li><li>\u27a4 no history of transfusion, thalassemia minor</li><li>\u27a4 Mentzer index (MCV/RBC count),</li><li>\u27a4 less than 13</li><li>\u27a4 Ref: Robbins 10 th 644</li><li>\u27a4 Ref: Robbins 10 th 644</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d787262f",
      "audio": ""
    },
    {
      "text": "The pathogenesis of hypochromic anemia in lead poisoning is due to:",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of enzymes involved in heme biosynthesis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Binding of lead to transferrin, inhibiting the trans\u00adport of iron",
          "correct": false
        },
        {
          "label": "C",
          "text": "Binding of lead to cell membrane of erythroid pre\u00adcursors.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Binding of lead to ferritin inhibiting their break\u00addown into hemosiderin",
          "correct": false
        }
      ],
      "correct_answer": "A. Inhibition of enzymes involved in heme biosynthesis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Inhibition of enzymes involved in heme bio\u00adsynthesis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Lead does not bind to transferrin directly</li><li>\u2022 Option B. Lead</li><li>\u2022 Option C. While lead can affect cell membrane s, the primary mechanism of hypochromic anemia in lead poisoning is related to its impact on enzymes involved in heme biosynthesis, not direct binding to cell membranes.</li><li>\u2022 Option C. While lead can affect</li><li>\u2022 cell membrane</li><li>\u2022 hypochromic anemia</li><li>\u2022 enzymes involved in heme biosynthesis,</li><li>\u2022 Option D. Lead does not directly bind to ferritin to inhibit their breakdown. The primary effect is on heme synthesis enzymes.</li><li>\u2022 Option D. Lead does not directly</li><li>\u2022 ferritin to inhibit their breakdown.</li><li>\u2022 heme synthesis enzymes.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The primary pathogenesis of hypochromic anemia in lead poisoning involves the inhibition of enzymes necessary for heme biosynthesis , such as aminolevulinic acid dehydratase (ALAD) and ferrochelatase, leading to reduced heme and hemoglobin production.</li><li>\u27a4 hypochromic anemia in lead poisoning</li><li>\u27a4 inhibition of enzymes necessary</li><li>\u27a4 heme biosynthesis</li><li>\u27a4 aminolevulinic acid dehydratase (ALAD) and ferrochelatase,</li><li>\u27a4 heme and hemoglobin production.</li><li>\u27a4 Ref : Robbins 10 th / 411, Tejinder Singh 1st/147</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 411, Tejinder Singh 1st/147</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "871b1073",
      "audio": ""
    },
    {
      "text": "A patient presented with fatigue and dyspnea. His peripheral blood smear demonstrated microcytic hypochromic red blood cells and pencil cells. The likely diagnosis in him is:",
      "options": [
        {
          "label": "A",
          "text": "B12 deficiency",
          "correct": false
        },
        {
          "label": "B",
          "text": "Iron deficiency anemia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Thalassemia minor",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sickle cell anemia",
          "correct": false
        }
      ],
      "correct_answer": "B. Iron deficiency anemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Iron deficiency anemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Vitamin B12 deficiency typically causes macrocytic anemia , not microcytic, and would not present with pencil cells on the blood smear.</li><li>\u2022 Option A. Vitamin B12 deficiency</li><li>\u2022 macrocytic anemia</li><li>\u2022 Option C. Thalassemia minor often presents with microcytosis, but red cells are usually target cells rather than pencil cells, and other hematologic indices such as hemoglobin A2 levels can help in the diagnosis.</li><li>\u2022 Option C. Thalassemia minor</li><li>\u2022 microcytosis, but red cells are usually target cells</li><li>\u2022 hemoglobin A2 levels</li><li>\u2022 Option D. Sickle cell anemia usually presents with normocytic anemia and sickled red cells on the blood smear, not pencil cells, and are associated with hemoglobin Son electrophoresis.</li><li>\u2022 Option D. Sickle cell anemia</li><li>\u2022 normocytic anemia and sickled red cells</li><li>\u2022 hemoglobin Son electrophoresis.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Iron deficiency anemia is characterized by microcytic, hypochromic red blood cells with the presence of pencil cells on the peripheral blood smear . Iron deficiency anemia is a common cause of anemia worldwide and should be considered in patients presenting with symptoms of anemia and microcytosis.</li><li>\u27a4 microcytic, hypochromic red blood cells</li><li>\u27a4 peripheral blood smear</li><li>\u27a4 Iron deficiency anemia</li><li>\u27a4 common</li><li>\u27a4 anemia worldwide</li><li>\u27a4 anemia and microcytosis.</li><li>\u27a4 Ref : Robbins 10th/e p658</li><li>\u27a4 Ref : Robbins 10th/e p658</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c7f76c91",
      "audio": ""
    },
    {
      "text": "A 50-year-old male is evaluated for anemia. Laboratory findings reveal increased serum ferritin, decreased total iron-binding capacity (TIBC), increased serum iron, and elevated transferrin saturation. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Anemia of chronic disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sideroblastic anemia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Iron deficiency anemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Thalassemia minor",
          "correct": false
        }
      ],
      "correct_answer": "B. Sideroblastic anemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Anemia of chronic disease - Typically presents with normal to increased serum ferritin , normal to decreased serum iron, and low transferrin saturation due to the sequestration of iron in macrophages .</li><li>\u2022 Option A. Anemia of chronic disease</li><li>\u2022 normal to increased serum ferritin</li><li>\u2022 normal to decreased serum iron, and low transferrin saturation</li><li>\u2022 sequestration of iron in macrophages</li><li>\u2022 Option C. Iron deficiency anemia - Manifests with decreased serum ferritin, increased TIBC, decreased serum iron, and low transferrin saturation due to a lack of iron stores.</li><li>\u2022 Option C. Iron deficiency anemia</li><li>\u2022 decreased serum ferritin, increased TIBC, decreased serum iron, and low</li><li>\u2022 transferrin saturation</li><li>\u2022 lack of iron stores.</li><li>\u2022 Option D. Thalassemia minor - This condition usually presents with normal iron studies and is characterized by microcytic red blood cells without an increase in iron parameters.</li><li>\u2022 Option D. Thalassemia minor</li><li>\u2022 normal iron studies</li><li>\u2022 microcytic red blood cells</li><li>\u2022 increase in iron parameters.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Sideroblastic anemia is indicated by increased serum ferritin , decreased TIBC, increased serum iron, and elevated transferrin saturation , reflecting a defect in the incorporation of iron into hemoglobin within the erythroid precursors in the bone marrow .</li><li>\u27a4 Sideroblastic anemia</li><li>\u27a4 increased serum ferritin</li><li>\u27a4 decreased TIBC, increased serum iron, and elevated transferrin saturation</li><li>\u27a4 iron into hemoglobin</li><li>\u27a4 erythroid precursors in the bone marrow</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a118bcfd",
      "audio": ""
    },
    {
      "text": "In a patient with raised LDH, elevated bilirubin and hemoglobinuria. Peripheral smear shows schistocytes. What would the likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Red cell enzyme defect \u200b\u200b\u200b\u200b\u200b",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hypersplenism",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mechanical heart valves \u200b\u200b\u200b\u200b\u200b",
          "correct": true
        },
        {
          "label": "D",
          "text": "Thyroid dysfunction",
          "correct": false
        }
      ],
      "correct_answer": "C. Mechanical heart valves \u200b\u200b\u200b\u200b\u200b",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/25/picture38.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Mechanical heart valves</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Red cell enzyme defects typically do not cause microangiopathic hemolytic anemia with schistocytes.</li><li>\u2022 Option A. Red cell enzyme</li><li>\u2022 do not</li><li>\u2022 microangiopathic hemolytic anemia with schistocytes.</li><li>\u2022 Option B. Hypersplenism is associated with the sequestration and destruction of blood cells in the spleen but is not typically associated with the specific findings mentioned in the question.</li><li>\u2022 Option B. Hypersplenism is associated</li><li>\u2022 sequestration and destruction of blood cells</li><li>\u2022 Option D. Thyroid dysfunction is not known to cause microangiopathic hemolytic anemia with schistocytes.</li><li>\u2022 Option D. Thyroid dysfunction</li><li>\u2022 not known</li><li>\u2022 microangiopathic hemolytic anemia with schistocytes.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The correct diagnosis in a patient with elevated LDH, hyperbilirubinemia, hemoglobinuria, and schistocytes on the peripheral blood smear is mechanical heart valve -related hemolysis.</li><li>\u27a4 elevated LDH, hyperbilirubinemia, hemoglobinuria, and schistocytes on the peripheral blood smear</li><li>\u27a4 mechanical heart valve</li><li>\u27a4 hemolysis.</li><li>\u27a4 Ref : Robbins 10th/e p650</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10th/e p650</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7441baaf",
      "audio": ""
    },
    {
      "text": "In a patient diagnosed with iron deficiency anemia, the values of all of the following increase except",
      "options": [
        {
          "label": "A",
          "text": "Total iron binding capacity",
          "correct": false
        },
        {
          "label": "B",
          "text": "RBC protoporphyrin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Transferrin saturation",
          "correct": true
        },
        {
          "label": "D",
          "text": "Transferrin receptor",
          "correct": false
        }
      ],
      "correct_answer": "C. Transferrin saturation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. \u00a0Transferrin saturation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Total iron binding capacity (TIBC): TIBC increases in iron deficiency anemia . It represents the maximum amount of iron that can be bound to transferrin.</li><li>\u2022 Option A. Total iron binding capacity (TIBC):</li><li>\u2022 increases</li><li>\u2022 iron deficiency anemia</li><li>\u2022 iron</li><li>\u2022 bound to transferrin.</li><li>\u2022 Option B. RBC protoporphyrin: RBC protoporphyrin increases in iron deficiency anemia . It reflects decreased availability of iron for heme synthesis .</li><li>\u2022 Option B. RBC protoporphyrin:</li><li>\u2022 increases in iron deficiency anemia</li><li>\u2022 decreased</li><li>\u2022 iron for heme synthesis</li><li>\u2022 Option D. Transferrin receptor: Transferrin receptor levels increase in iron deficiency anemia . It is a marker of increased demand for iron by erythroid precursors .</li><li>\u2022 Option D. Transferrin receptor:</li><li>\u2022 increase in iron deficiency anemia</li><li>\u2022 increased</li><li>\u2022 iron by erythroid precursors</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Transferrin saturation decreases in iron deficiency anemia , reflecting a reduced percentage of transferrin loaded with iron due to diminished iron stores , whereas total iron binding capacity, RBC protoporphyrin, and transferrin receptor levels increase in response to this condition.</li><li>\u27a4 Transferrin saturation decreases</li><li>\u27a4 iron deficiency anemia</li><li>\u27a4 reduced</li><li>\u27a4 transferrin</li><li>\u27a4 iron due to diminished iron stores</li><li>\u27a4 total iron binding capacity, RBC protoporphyrin, and transferrin receptor levels increase</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e62cd893",
      "audio": ""
    },
    {
      "text": "A 12-year-old with history of recurrent infection and bleeding gums. On investigations the patient had pancytopenia and the peripheral smear showed macrocytes. The bone marrow biopsy showed no megakaryocytes and filled with fat globules. What is your diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Myelodysplasia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Aplastic anemia \u200b\u200b\u200b\u200b\u200b\u200b",
          "correct": true
        },
        {
          "label": "C",
          "text": "ITP",
          "correct": false
        },
        {
          "label": "D",
          "text": "PNH",
          "correct": false
        }
      ],
      "correct_answer": "B. Aplastic anemia \u200b\u200b\u200b\u200b\u200b\u200b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. \u00a0Aplastic anemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The given clinical presentation of a 12-year-old with recurrent infections, bleeding gums, pancytopenia, macrocytes on peripheral smear, absence of megakaryocytes in bone marrow, and the presence of fat globules in the bone marrow biopsy is suggestive of aplastic anemia. Aplastic anemia is characterized by a deficiency of all blood cell types (pancytopenia) due to bone marrow failure . The absence of megakaryocytes in the bone marrow biopsy indicates a lack of platelet precursors, which can lead to bleeding manifestations . The presence of fat globules suggests replacement of hematopoietic cells by adipose tissue in the bone marrow.</li><li>\u2022 12-year-old</li><li>\u2022 recurrent infections, bleeding gums, pancytopenia, macrocytes on peripheral</li><li>\u2022 smear, absence of megakaryocytes in bone marrow,</li><li>\u2022 presence of fat globules</li><li>\u2022 aplastic anemia.</li><li>\u2022 Aplastic anemia</li><li>\u2022 deficiency of all blood cell types (pancytopenia)</li><li>\u2022 bone marrow failure</li><li>\u2022 absence of megakaryocytes</li><li>\u2022 lack of platelet precursors,</li><li>\u2022 bleeding manifestations</li><li>\u2022 fat globules</li><li>\u2022 hematopoietic cells by adipose tissue</li><li>\u2022 EXPLANATION:</li><li>\u2022 EXPLANATION:</li><li>\u2022 Option A. Myelodysplastic syndromes : may also present with cytopenias and dysplastic changes in the bone marrow, but the absence of megakaryocytes and the presence of fat globules are not typical features.</li><li>\u2022 Option A. Myelodysplastic syndromes :</li><li>\u2022 cytopenias and dysplastic</li><li>\u2022 absence of megakaryocytes</li><li>\u2022 presence of fat globules are not typical features.</li><li>\u2022 Option C. ITP: is characterized by isolated thrombocytopenia without affecting other cell lines. It does not typically present with pancytopenia or the absence of megakaryocytes in the bone marrow.</li><li>\u2022 Option C. ITP:</li><li>\u2022 isolated thrombocytopenia</li><li>\u2022 Option D. PNH: is characterized by hemolysis, often presenting with hemoglobinuria. However, it is not typically associated with pancytopenia and fat globules in the bone marrow.</li><li>\u2022 Option D. PNH:</li><li>\u2022 hemolysis,</li><li>\u2022 hemoglobinuria.</li><li>\u2022 not typically</li><li>\u2022 pancytopenia and fat globules in the bone</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The clinical presentation of recurrent infections, bleeding gums, pancytopenia, macrocytes on peripheral smear, absence of megakaryocytes in bone marrow , and presence of fat globules in bone marrow biopsy is indicative of aplastic anemia . This diagnosis is supported by the bone marrow biopsy findings showing a lack of megakaryocytes, indicative of platelet precursor deficiency, and fat globules suggesting the replacement of hematopoietic cells by adipose tissue .</li><li>\u27a4 recurrent infections, bleeding gums, pancytopenia, macrocytes on peripheral smear, absence of megakaryocytes in bone marrow</li><li>\u27a4 presence of fat globules</li><li>\u27a4 aplastic anemia</li><li>\u27a4 bone marrow biopsy</li><li>\u27a4 lack of megakaryocytes, indicative of platelet precursor deficiency,</li><li>\u27a4 fat globules</li><li>\u27a4 hematopoietic cells by adipose tissue</li><li>\u27a4 Ref : Robbins 10th/458</li><li>\u27a4 Ref : Robbins 10th/458</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "96a4b6a1",
      "audio": ""
    },
    {
      "text": "An elderly female with mediastinal mass undergoes a microscopic examination showing red cell aplasia. What is the likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Bronchogenic cancer",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thymoma",
          "correct": true
        },
        {
          "label": "C",
          "text": "Non-Hodgkin lymphoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Squamous cell carcinoma",
          "correct": false
        }
      ],
      "correct_answer": "B. Thymoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. \u00a0Thymoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Bronchogenic cancer often presents as a mediastinal mass , especially in smokers . However, it is not commonly associated with red cell aplasia, but rather with other paraneoplastic syndromes such as hypercalcemia (due to production of PTH-related protein) or the secretion of ADH or ACTH.</li><li>\u2022 Option A. Bronchogenic cancer</li><li>\u2022 mediastinal mass</li><li>\u2022 smokers</li><li>\u2022 paraneoplastic syndromes such as hypercalcemia (due to production of PTH-related protein) or the secretion of ADH or ACTH.</li><li>\u2022 Option C. Non-Hodgkin lymphoma can present as a mediastinal mass . It may cause bone marrow involvement leading to various cytopenias but is not specifically associated with pure red cell aplasia .</li><li>\u2022 Option C. Non-Hodgkin lymphoma</li><li>\u2022 mediastinal mass</li><li>\u2022 bone marrow</li><li>\u2022 cytopenias</li><li>\u2022 not</li><li>\u2022 pure red cell aplasia</li><li>\u2022 Option D. Squamous cell carcinoma typically arises from the epithelial cells of the skin or mucous membranes and is not commonly found within the mediastinum. It is associated with paraneoplastic syndromes , but not typically with red cell aplasia.</li><li>\u2022 Option D. Squamous cell carcinoma</li><li>\u2022 epithelial cells of the skin or mucous membranes</li><li>\u2022 paraneoplastic syndromes</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Thymoma is the likely diagnosis in an elderly patient with a mediastinal mass and red cell aplasia, as thymomas are associated with this condition and other paraneoplastic syndromes such as myasthenia gravis, hypogammaglobulinemia, and multi-organ autoimmunity.</li><li>\u27a4 Thymoma</li><li>\u27a4 mediastinal mass and red cell aplasia, as thymomas</li><li>\u27a4 paraneoplastic syndromes</li><li>\u27a4 myasthenia gravis, hypogammaglobulinemia, and multi-organ autoimmunity.</li><li>\u27a4 Ref : Robbins 10th/e p493</li><li>\u27a4 Ref : Robbins 10th/e p493</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4bf00069",
      "audio": ""
    },
    {
      "text": "A patient has been eating junk food regularly for few months and avoids fruits and vegetables. His hemoglobin is 9 g/dl and MCV is >125 fl. What is the deficiency she would likely be having?",
      "options": [
        {
          "label": "A",
          "text": "Cyanocobalamin deficiency",
          "correct": false
        },
        {
          "label": "B",
          "text": "Folate deficiency",
          "correct": true
        },
        {
          "label": "C",
          "text": "Sideroblastic anemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acute blood loss",
          "correct": false
        }
      ],
      "correct_answer": "B. Folate deficiency",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. \u00a0Folate deficiency</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Cyanocobalamin (Vitamin B12) deficiency typically develops over years due to the substantial stores in the liver . While it can cause megaloblastic anemia with a high MCV, the patient's short history of symptoms makes this less likely.</li><li>\u2022 Option A. Cyanocobalamin (Vitamin B12)</li><li>\u2022 deficiency</li><li>\u2022 over years due to the substantial stores in the liver</li><li>\u2022 megaloblastic anemia</li><li>\u2022 high MCV,</li><li>\u2022 Option C. Sideroblastic anemia is characterized by the presence of ringed sideroblasts in the bone marrow and can be associated with certain drugs and toxins, genetic disorders , or may be idiopathic . It doesn't typically relate directly to dietary habits and usually shows a normal or increased MCV but not typically in the megaloblastic range (>100 fL).</li><li>\u2022 Option C. Sideroblastic anemia</li><li>\u2022 ringed sideroblasts</li><li>\u2022 drugs and toxins, genetic disorders</li><li>\u2022 idiopathic</li><li>\u2022 Option D. Acute blood loss would cause anemia with a low or normal MCV (microcytic or normocytic), not the high MCV (>100 fL) that is typical of megaloblastic anemias. Plus, there is no history suggestive of blood loss.</li><li>\u2022 Option D. Acute blood loss would cause anemia</li><li>\u2022 low or normal MCV (microcytic or normocytic),</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Folate deficiency is the likely cause of megaloblastic anemia with a high MCV in a patient with a diet lacking in fruits and vegetables and a relatively quick onset of symptoms , as folate stores are depleted much more rapidly than vitamin B12 stores .</li><li>\u27a4 Folate deficiency</li><li>\u27a4 megaloblastic anemia</li><li>\u27a4 high MCV</li><li>\u27a4 fruits and vegetables and a relatively quick onset of symptoms</li><li>\u27a4 folate stores are depleted much more rapidly than vitamin B12 stores</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cdd95845",
      "audio": ""
    },
    {
      "text": "A 30-year-old female presents with fatigue, pallor, and a smooth tongue. She reports a vegetarian diet with minimal animal product intake. Laboratory tests show a high mean corpuscular volume (MCV) and hypersegmented neutrophils. A peripheral blood smear likely would reveal which of the following?",
      "options": [
        {
          "label": "A",
          "text": "Hereditary spherocytosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Iron deficiency anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sickle cell anemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Megaloblastic anemia",
          "correct": true
        }
      ],
      "correct_answer": "D. Megaloblastic anemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Megaloblastic anemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hereditary spherocytosis is characterized by the presence of spherocytes , which are small, dense red blood cells without the central pallor, not macropolycytes .</li><li>\u2022 Option A. Hereditary spherocytosis</li><li>\u2022 presence of spherocytes</li><li>\u2022 small, dense red blood cells without the central pallor, not macropolycytes</li><li>\u2022 Option B. Iron deficiency anemia typically shows microcytic, hypochromic red blood cells due to decreased hemoglobin content, not macropolycytes.</li><li>\u2022 Option B. Iron deficiency anemia</li><li>\u2022 microcytic, hypochromic red blood cells</li><li>\u2022 decreased hemoglobin</li><li>\u2022 Option C. Sickle cell anemia is identified by the presence of sickle-shaped cells due to abnormal hemoglobin , which does not include macropolycytes.</li><li>\u2022 Option C. Sickle cell anemia</li><li>\u2022 sickle-shaped cells due to abnormal hemoglobin</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Macropolycytes in a peripheral blood smear are a feature of megaloblastic anemia , which is often due to vitamin B12 or folate deficiency and is characterized by macrocytosis and hypersegmented neutrophils.</li><li>\u27a4 Macropolycytes</li><li>\u27a4 megaloblastic anemia</li><li>\u27a4 due to vitamin B12 or folate deficiency</li><li>\u27a4 macrocytosis and hypersegmented neutrophils.</li><li>\u27a4 Ref : Robbins 10 th / 652</li><li>\u27a4 Ref : Robbins 10 th / 652</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ef0b9be1",
      "audio": ""
    },
    {
      "text": "All are laboratory finding in iron deficiency anemia except:",
      "options": [
        {
          "label": "A",
          "text": "Decreased serum iron",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increased total iron binding capacity",
          "correct": false
        },
        {
          "label": "C",
          "text": "Decreased serum ferritin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increased mean corpuscular volume",
          "correct": true
        }
      ],
      "correct_answer": "D. Increased mean corpuscular volume",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Increased mean corpuscular volume</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Decreased serum iron: In iron deficiency anemia, there is a decrease in serum iron levels because there is insufficient iron available for hemoglobin synthesis .</li><li>\u2022 Option A. Decreased serum iron:</li><li>\u2022 decrease in serum iron levels</li><li>\u2022 insufficient iron</li><li>\u2022 hemoglobin synthesis</li><li>\u2022 Option B. Increased total iron binding capacity (TIBC): TIBC increases in iron deficiency anemia. It represents the maximum amount of iron that can be bound to transferrin .</li><li>\u2022 Option B. Increased total iron binding capacity (TIBC):</li><li>\u2022 maximum amount of iron</li><li>\u2022 transferrin</li><li>\u2022 Option C. Decreased serum ferritin: Serum ferritin levels decrease in iron deficiency anemia . Ferritin is an indicator of iron stores, and low levels suggest depleted iron stores.</li><li>\u2022 Option C. Decreased serum ferritin:</li><li>\u2022 iron deficiency anemia</li><li>\u2022 iron stores, and low levels</li><li>\u2022 depleted iron stores.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Increased mean corpuscular volume (MCV) is not a finding in iron deficiency anemia ; rather, this condition is characterized by a decreased MCV due to microcytic, hypochromic red blood cells resulting from insufficient iron for hemoglobin synthesis.</li><li>\u27a4 Increased mean corpuscular volume (MCV)</li><li>\u27a4 not</li><li>\u27a4 iron deficiency anemia</li><li>\u27a4 decreased MCV due to microcytic, hypochromic red blood cells</li><li>\u27a4 insufficient iron for hemoglobin synthesis.</li><li>\u27a4 Ref : Robbins 10 th / 652</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 652</li><li>\u27a4 Robbins 10 th / 658</li><li>\u27a4 Robbins 10 th / 658</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d26efac7",
      "audio": ""
    },
    {
      "text": "A 25-year-old male is undergoing workup for fatigue and joint pain. His serum ferritin levels are markedly elevated, and a liver biopsy shows iron deposition. Which of the following most directly regulates iron uptake in the gut?",
      "options": [
        {
          "label": "A",
          "text": "Mucosal cell iron stores",
          "correct": true
        },
        {
          "label": "B",
          "text": "Route of administration",
          "correct": false
        },
        {
          "label": "C",
          "text": "Preparation administered",
          "correct": false
        },
        {
          "label": "D",
          "text": "Age of the patient",
          "correct": false
        }
      ],
      "correct_answer": "A. Mucosal cell iron stores",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Mucosal cell iron stores</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. The route of administration, such as oral or parenteral , can influence the rate of iron absorption but does not directly regulate iron uptake at the molecular level .</li><li>\u2022 Option B. The route of administration,</li><li>\u2022 oral or parenteral</li><li>\u2022 iron absorption</li><li>\u2022 iron uptake at the molecular level</li><li>\u2022 Option C. The preparation administered , for example, ferrous sulfate versus ferric gluconate , can affect the efficiency of absorption but , like the route, does not regulate the iron uptake process per se.</li><li>\u2022 Option C. The preparation administered</li><li>\u2022 ferrous sulfate versus ferric gluconate</li><li>\u2022 efficiency of absorption but</li><li>\u2022 does not regulate the iron uptake process</li><li>\u2022 Option D. The age of the patient can affect the demand for iron , especially during growth spurts or aging , but it is not a direct regulator of iron uptake in the gut.</li><li>\u2022 Option D. The age of the patient</li><li>\u2022 demand for iron</li><li>\u2022 growth spurts or aging</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mucosal cell iron stores , through their regulation of hepcidin synthesis, play a direct role in regulating iron uptake across the gut mucosa , which is crucial for maintaining systemic iron homeostasis .</li><li>\u27a4 Mucosal cell iron stores</li><li>\u27a4 hepcidin synthesis,</li><li>\u27a4 regulating iron uptake</li><li>\u27a4 gut mucosa</li><li>\u27a4 systemic iron homeostasis</li><li>\u27a4 Ref : Robbins 10 th / 658</li><li>\u27a4 Ref</li><li>\u27a4 Robbins 10 th / 658</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bbf85a59",
      "audio": ""
    },
    {
      "text": "A 45-year-old male with a history of hereditary hemochromatosis is being evaluated for his condition. Which of the following is considered the most important but nonspecific regulator of iron metabolism?",
      "options": [
        {
          "label": "A",
          "text": "Hepcidin",
          "correct": true
        },
        {
          "label": "B",
          "text": "DMT1",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ferroportin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ferritin",
          "correct": false
        }
      ],
      "correct_answer": "A. Hepcidin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Hepcidin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. DMT1 (Divalent metal transporter 1) is a specific transporter that moves ferrous iron across the apical membrane of enterocytes. While important for iron uptake, it has a more focused role.</li><li>\u2022 Option B. DMT1</li><li>\u2022 Option C. Ferroportin is the protein responsible for exporting iron from cells into the plasma. It has a specific function and is regulated by hepcidin.</li><li>\u2022 Option C. Ferroportin</li><li>\u2022 Option D. Ferritin is the primary intracellular iron storage protein and is a marker of iron stores but does not regulate iron metabolism directly.</li><li>\u2022 Option D. Ferritin</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hepcidin is the most important but nonspecific regulator of iron metabolism since it not only controls iron homeostasis but also has broader effects including antimicrobial activity and is influenced by various physiological and pathological conditions.</li><li>\u27a4 Ref: Robbins 10th/ 652</li><li>\u27a4 Ref: Robbins 10th/ 652</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "96787206",
      "audio": ""
    },
    {
      "text": "A 30-year-old male presents with dark urine in the morning and has been found to have hemolytic anemia on laboratory evaluation. A diagnostic test reveals increased sensitivity of his red blood cells to lysis in acidified serum. Which of the following underlying defects is most consistent with these findings?",
      "options": [
        {
          "label": "A",
          "text": "Spectrin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Defect in complement activating proteins",
          "correct": false
        },
        {
          "label": "C",
          "text": "Defective GPI anchor",
          "correct": true
        },
        {
          "label": "D",
          "text": "Mannose-binding residue effect",
          "correct": false
        }
      ],
      "correct_answer": "C. Defective GPI anchor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. \u00a0Defective GPI anchor</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Spectrin is a cytoskeletal protein that helps maintain the red blood cell's shape . Defects in spectrin can cause hereditary spherocytosis but are not associated with increased red cell lysis in acidified serum.</li><li>\u2022 Option A. Spectrin is a cytoskeletal protein</li><li>\u2022 red blood cell's shape</li><li>\u2022 hereditary spherocytosis</li><li>\u2022 Option B. A defect in complement activating proteins may lead to conditions such as hereditary angioedema , but they do not result in the increased red cell lysis characteristic of the Ham test.</li><li>\u2022 Option B. A defect in complement</li><li>\u2022 hereditary angioedema</li><li>\u2022 Option D. The Mannose-binding lectin pathway is involved in innate immunity and can lead to opsonization and phagocytosis of pathogens, but defects here do not lead to the clinical picture described.</li><li>\u2022 Option D. The Mannose-binding lectin</li><li>\u2022 innate immunity</li><li>\u2022 opsonization and phagocytosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A defective GPI anchor is implicated in paroxysmal nocturnal hemoglobinuria (PNH), a condition that can be diagnosed with the Ham test , indicating increased red blood cell lysis in acidified serum due to increased complement sensitivity.</li><li>\u27a4 defective GPI anchor</li><li>\u27a4 paroxysmal nocturnal hemoglobinuria (PNH),</li><li>\u27a4 Ham test</li><li>\u27a4 increased red blood cell lysis</li><li>\u27a4 increased complement sensitivity.</li><li>\u27a4 Ref : Robbins 10 th / 645</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 645</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f3530ee9",
      "audio": ""
    },
    {
      "text": "A 52-year-old man presents with acrocyanosis and hemolysis after exposure to cold temperatures. His direct Coombs' test is positive with cold sub type of antibodies. Which of the following antibodies is most likely responsible for his condition?",
      "options": [
        {
          "label": "A",
          "text": "Anti IgM",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anti IgG",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anti IgA",
          "correct": false
        },
        {
          "label": "D",
          "text": "Donath-Landsteiner antibody",
          "correct": true
        }
      ],
      "correct_answer": "D. Donath-Landsteiner antibody",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Donath-Landsteiner antibody</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Anti-IgM would imply an antibody against IgM itself, which is not the cause of cold hemagglutinin disease . Cold agglutinins are typically IgM antibodies that can agglutinate and lyse red blood cells at cold temperatures.</li><li>\u2022 Option A.  Anti-IgM would imply</li><li>\u2022 antibody against IgM</li><li>\u2022 not</li><li>\u2022 cold hemagglutinin disease</li><li>\u2022 Option B.  Anti-IgG suggests an antibody against IgG , which is not typically involved in cold hemagglutinin disease . IgG antibodies can, however, cause warm autoimmune hemolytic anemia .</li><li>\u2022 Option B.  Anti-IgG suggests</li><li>\u2022 antibody against IgG</li><li>\u2022 not</li><li>\u2022 cold hemagglutinin disease</li><li>\u2022 warm autoimmune hemolytic anemia</li><li>\u2022 Option C.  Anti-IgA indicates an antibody against IgA and is not associated with cold hemagglutinin disease.</li><li>\u2022 Option C.  Anti-IgA indicates</li><li>\u2022 antibody against IgA</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Donath-Landsteiner antibody is the cause of paroxysmal cold hemoglobinuria , a rare type of cold hemagglutinin disease , which can present with symptoms like acrocyanosis and hemolysis after cold exposure .</li><li>\u27a4 Donath-Landsteiner antibody</li><li>\u27a4 paroxysmal cold hemoglobinuria</li><li>\u27a4 cold hemagglutinin disease</li><li>\u27a4 acrocyanosis and hemolysis after cold exposure</li><li>\u27a4 Ref : Robbins 10 th / 648</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 648</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "410b2e92",
      "audio": ""
    },
    {
      "text": "Microspherocytes in peripheral blood smear are seen in:",
      "options": [
        {
          "label": "A",
          "text": "Congenital spherocytosis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Autoimmune acquired hemolytic anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thalassemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": false
        }
      ],
      "correct_answer": "A. Congenital spherocytosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Congenital spherocytosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. In autoimmune hemolytic anemia , spherocytes can also be present due to the partial phagocytosis of the red blood cell membrane by macrophages in response to antibody binding .</li><li>\u2022 Option B. In autoimmune</li><li>\u2022 hemolytic anemia</li><li>\u2022 spherocytes</li><li>\u2022 partial phagocytosis of the red blood cell membrane</li><li>\u2022 macrophages</li><li>\u2022 antibody binding</li><li>\u2022 Option C. Thalassemia typically presents with target cells and microcytes on blood smear, not specifically spherocytes. It involves a defect in hemoglobin production .</li><li>\u2022 Option C. Thalassemia typically</li><li>\u2022 target cells and microcytes</li><li>\u2022 defect in hemoglobin production</li><li>\u2022 Option D. While spherocytes can be seen in autoimmune hemolytic anemia , they are not a feature of thalassemia. Hence, the presence of spherocytes is not common to all the conditions listed.</li><li>\u2022 Option D. While spherocytes</li><li>\u2022 autoimmune hemolytic anemia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Congenital spherocytosis is the condition most consistently associated with the presence of small, round red blood cells without central pallor (spherocytes) on a peripheral blood smear .</li><li>\u27a4 Congenital spherocytosis</li><li>\u27a4 small, round red blood cells without central pallor (spherocytes) on a peripheral blood smear</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d238115c",
      "audio": ""
    },
    {
      "text": "A patient presents with signs of anemia and a history of taking a medication known to cause hemolysis. Blood tests reveal anemia, and a direct antiglobulin test (DAT) is performed. Which of the following conditions is least likely to be associated with a positive direct Coombs test?",
      "options": [
        {
          "label": "A",
          "text": "Drug induced AIHA",
          "correct": false
        },
        {
          "label": "B",
          "text": "Aplastic anemia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Hemolytic anemia due to transfusion",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hemolytic disease of newborn",
          "correct": false
        }
      ],
      "correct_answer": "B. Aplastic anemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Aplastic anemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Drug-induced AIHA can lead to the production of antibodies against red blood cells (RBCs) or induce the RBCs to adsorb plasma proteins, in either case leading to a positive Coombs test.</li><li>\u2022 Option A. Drug-induced AIHA</li><li>\u2022 antibodies against red blood cells (RBCs)</li><li>\u2022 RBCs to adsorb plasma proteins,</li><li>\u2022 Option C. Hemolytic anemia due to a transfusion reaction can occur if the transfused blood is not compatible with the patient's blood type , leading to antibody-mediated destruction of RBCs and a positive Coombs test .</li><li>\u2022 Option C. Hemolytic anemia</li><li>\u2022 transfusion reaction</li><li>\u2022 not compatible</li><li>\u2022 patient's blood type</li><li>\u2022 antibody-mediated destruction of RBCs</li><li>\u2022 positive Coombs test</li><li>\u2022 Option D. Hemolytic disease of the newborn, such as Rh or ABO incompatibility, involves maternal antibodies targeting fetal RBCs , which would yield a positive Coombs test.</li><li>\u2022 Option D. Hemolytic disease</li><li>\u2022 Rh or ABO incompatibility,</li><li>\u2022 maternal antibodies</li><li>\u2022 fetal RBCs</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A positive direct Coombs test indicates the presence of antibodies bound to RBCs , which is seen in conditions like drug-induced AIHA, hemolytic transfusion reactions, and hemolytic disease of the newborn, but not in aplastic anemia.</li><li>\u27a4 positive direct Coombs test</li><li>\u27a4 presence of antibodies</li><li>\u27a4 RBCs</li><li>\u27a4 drug-induced AIHA, hemolytic transfusion reactions, and hemolytic disease of the newborn,</li><li>\u27a4 not in aplastic anemia.</li><li>\u27a4 Ref : Robbins 10 th / 655</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 655</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1742a56c",
      "audio": ""
    },
    {
      "text": "A 26-year\u2011old female presents with pallor with a hemoglobin of 9.5 g/dL, PCV 30 mm Hg and RBC count of 2 million per cubic millimeters. What is the likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Sideroblastic anemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Iron deficiency anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thalassemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Folic acid deficiency",
          "correct": true
        }
      ],
      "correct_answer": "D. Folic acid deficiency",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/10/whatsapp-image-2024-09-10-at-114902-am.jpeg"
      ],
      "explanation": "<p><strong>Ans. D. Folic acid deficiency</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Sideroblastic anemia usually results in a microcytic anemia due to ineffective iron utilization , making it an unlikely cause of macrocytic anemia.</li><li>\u2022 Option A. Sideroblastic anemia</li><li>\u2022 microcytic anemia</li><li>\u2022 ineffective iron utilization</li><li>\u2022 Option B. Iron deficiency anemia typically presents with microcytic, hypochromic anemia due to the reduced hemoglobin content within RBC s, not macrocytic anemia.</li><li>\u2022 Option B. Iron deficiency anemia</li><li>\u2022 microcytic, hypochromic anemia</li><li>\u2022 reduced</li><li>\u2022 RBC</li><li>\u2022 Option C. Thalassemia is another cause of microcytic anemia , associated with genetic mutations leading to abnormal hemoglobin production . It does not cause macrocytic anemia.</li><li>\u2022 Option C. Thalassemia is another</li><li>\u2022 microcytic anemia</li><li>\u2022 genetic mutations</li><li>\u2022 abnormal hemoglobin production</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Upon finding an MCV of 150 fL , which indicates macrocytic anemia, folic acid deficiency becomes the most likely diagnosis among the options provided because it, along with vitamin B12 deficiency, can cause macrocytosis .</li><li>\u27a4 MCV of 150 fL</li><li>\u27a4 macrocytic anemia, folic acid deficiency</li><li>\u27a4 vitamin B12 deficiency, can cause macrocytosis</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5227981a",
      "audio": ""
    },
    {
      "text": "A patient presents with anemia and jaundice. The osmotic fragility test is normal, but the patient has an enlarged spleen. which of the following is not an intrinsic cause of of hemolytic anemia?",
      "options": [
        {
          "label": "A",
          "text": "G6PD deficiency",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hereditary spherocytosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypersplenism",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pyruvate kinase deficiency",
          "correct": false
        }
      ],
      "correct_answer": "C. Hypersplenism",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Hypersplenism</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. G6PD deficiency is an intrinsic cause of hemolytic anemia due to a defect in the red blood cell enzyme G6PD, which is necessary to protect the cell from oxidative damage.</li><li>\u2022 Option A. G6PD deficiency</li><li>\u2022 intrinsic</li><li>\u2022 hemolytic anemia</li><li>\u2022 red blood cell enzyme G6PD,</li><li>\u2022 protect the cell</li><li>\u2022 oxidative damage.</li><li>\u2022 Option B. Hereditary spherocytosis is an intrinsic cause of hemolytic anemia characterized by a defect in the red blood cell membrane proteins that provide structural support , resulting in spherical red blood cells that are prone to destruction .</li><li>\u2022 Option B. Hereditary</li><li>\u2022 spherocytosis</li><li>\u2022 intrinsic cause of hemolytic anemia</li><li>\u2022 red blood cell membrane proteins</li><li>\u2022 structural support</li><li>\u2022 spherical red blood cells</li><li>\u2022 prone to destruction</li><li>\u2022 Option D. Pyruvate kinase deficiency is an intrinsic cause of hemolytic anemia due to a defect in the enzyme pyruvate kinase , which is involved in the glycolytic pathway of red blood cells , leading to a lack of ATP and subsequent cell death .</li><li>\u2022 Option D. Pyruvate kinase</li><li>\u2022 deficiency</li><li>\u2022 hemolytic anemia</li><li>\u2022 enzyme pyruvate kinase</li><li>\u2022 glycolytic pathway of red blood cells</li><li>\u2022 lack of ATP</li><li>\u2022 subsequent cell death</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hypersplenism is an extracorpuscular cause of hemolytic anemia and not an intrinsic defect of the red blood cell itself , which distinguishes it from conditions such as G6PD deficiency, hereditary spherocytosis, and pyruvate kinase deficiency that are intrinsic to the red cells.</li><li>\u27a4 Hypersplenism</li><li>\u27a4 extracorpuscular</li><li>\u27a4 hemolytic anemia</li><li>\u27a4 not an intrinsic defect of the red blood cell itself</li><li>\u27a4 G6PD deficiency, hereditary spherocytosis, and pyruvate kinase deficiency</li><li>\u27a4 intrinsic to the red cells.</li><li>\u27a4 Ref: Robbins 9/e 631</li><li>\u27a4 Ref: Robbins 9/e 631</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2685937d",
      "audio": ""
    },
    {
      "text": "A 52-year-old male presents with fatigue, light-headedness, and a beefy-red tongue. Laboratory tests show macrocytosis and hypersegmented neutrophils. Which of the following laboratory findings is inconsistent with untreated megaloblastic anemia?",
      "options": [
        {
          "label": "A",
          "text": "Increased reticulocyte count",
          "correct": true
        },
        {
          "label": "B",
          "text": "Raised Bilirubin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mild splenomegaly",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nucleated RBC",
          "correct": false
        }
      ],
      "correct_answer": "A. Increased reticulocyte count",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Increased reticulocyte count</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Raised bilirubin levels can be seen in megaloblastic anemia due to increased destruction of defective erythroid precursor cells in the bone marrow, which release bilirubin into the blood.</li><li>\u2022 Option B. Raised bilirubin</li><li>\u2022 megaloblastic anemia</li><li>\u2022 increased destruction of defective erythroid precursor</li><li>\u2022 cells in the bone marrow,</li><li>\u2022 bilirubin</li><li>\u2022 Option C. Mild splenomegaly may be observed in megaloblastic anemia as the spleen works to filter the abnormal cells from the bloodstream.</li><li>\u2022 Option C. Mild splenomegaly</li><li>\u2022 megaloblastic anemia</li><li>\u2022 filter the abnormal cells</li><li>\u2022 bloodstream.</li><li>\u2022 Option D. The presence of nucleated RBCs in the peripheral blood smear is a sign of severe anemia , including megaloblastic anemia , where immature and abnormal erythroid precursor cells are released into the bloodstream.</li><li>\u2022 Option D. The presence</li><li>\u2022 nucleated RBCs</li><li>\u2022 severe anemia</li><li>\u2022 megaloblastic anemia</li><li>\u2022 immature and abnormal erythroid precursor cells</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 in untreated megaloblastic anemia , the reticulocyte count is low due to impaired DNA synthesis and ineffective erythropoiesis. An increased reticulocyte count after initiating treatment with vitamin B12 and folate supplementation indicates a positive response to therapy.</li><li>\u27a4 untreated megaloblastic anemia</li><li>\u27a4 reticulocyte count is low due to impaired DNA synthesis</li><li>\u27a4 ineffective erythropoiesis.</li><li>\u27a4 increased reticulocyte count</li><li>\u27a4 vitamin B12 and folate supplementation</li><li>\u27a4 Ref : Robbins 10 th / 645, Wintrobe\u2019s 12th/1151-3</li><li>\u27a4 Ref : Robbins 10 th / 645, Wintrobe\u2019s 12th/1151-3</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1c45e129",
      "audio": ""
    },
    {
      "text": "A 40-year-old male presents with fatigue, pallor, and glossitis. Laboratory findings show macrocytic anemia. He reports frequently consuming raw fish. Which organism is most likely responsible for his anemia?",
      "options": [
        {
          "label": "A",
          "text": "Ancylostoma duodenale",
          "correct": false
        },
        {
          "label": "B",
          "text": "Diphyllobothrium latum",
          "correct": true
        },
        {
          "label": "C",
          "text": "Giardia lamblia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Taenia solium",
          "correct": false
        }
      ],
      "correct_answer": "B. Diphyllobothrium latum",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.\u00a0Diphyllobothrium latum</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Ancylostoma duodenale: Ancylostoma duodenale, or hookworm, causes iron deficiency anemia by chronic blood loss in the intestines where the worms attach to the mucosa and feed on blood , leading to microcytic hypochromic anemia.</li><li>\u2022 Option A. Ancylostoma duodenale:</li><li>\u2022 hookworm, causes iron deficiency anemia</li><li>\u2022 chronic blood loss in the intestines</li><li>\u2022 mucosa and feed on blood</li><li>\u2022 microcytic hypochromic anemia.</li><li>\u2022 Option C. Giardia lamblia: Giardiasis, caused by Giardia lamblia, typically leads to malabsorption and diarrhea but does not directly cause anemia . It is not known to cause megaloblastic anemia.</li><li>\u2022 Option C. Giardia lamblia:</li><li>\u2022 malabsorption and diarrhea</li><li>\u2022 does not directly</li><li>\u2022 cause anemia</li><li>\u2022 Option D: Taenia solium: Taenia solium, or pork tapeworm , usually causes intestinal disturbances or systemic issues when in its larval form but does not cause megaloblastic anemia.</li><li>\u2022 Option D:</li><li>\u2022 Taenia solium:</li><li>\u2022 pork tapeworm</li><li>\u2022 intestinal disturbances or systemic issues</li><li>\u2022 larval form</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The correct answer is Option B: Diphyllobothrium latum or fish tapeworm causes megaloblastic anemia due to vitamin B12 deficiency ,</li><li>\u27a4 Option B: Diphyllobothrium latum or fish tapeworm causes megaloblastic anemia due to vitamin B12 deficiency</li><li>\u27a4 Ref : Robbins 10 th / 651</li><li>\u27a4 Ref : Robbins 10 th / 651</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "106e0299",
      "audio": ""
    },
    {
      "text": "A 52-year-old male with a history of strict vegetarianism presents with weakness and paresthesias. A CBC shows macrocytosis, and his serum vitamin B12 level is low. Which of the following is most consistent with the pathophysiology of his condition?",
      "options": [
        {
          "label": "A",
          "text": "Microcytic hypochromic anemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sickled red cells",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anemia occurs after 3-4 years of poor absorption",
          "correct": true
        },
        {
          "label": "D",
          "text": "Development of polycythemia",
          "correct": false
        }
      ],
      "correct_answer": "C. Anemia occurs after 3-4 years of poor absorption",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Anemia occurs after 3-4 years of poor absorption</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Microcytic hypochromic anemia is typically associated with iron deficiency, thalassemia, or other disorders of hemoglobin synthesis, not with vitamin B12 deficiency .</li><li>\u2022 Option A.</li><li>\u2022 Microcytic hypochromic anemia</li><li>\u2022 iron deficiency, thalassemia,</li><li>\u2022 hemoglobin synthesis,</li><li>\u2022 vitamin B12 deficiency</li><li>\u2022 Option B. Sickled red cells are characteristic of sickle cell anemia , a genetic disorder caused by a mutation in the hemoglobin gene , not related to vitamin B12 absorption.</li><li>\u2022 Option B.</li><li>\u2022 Sickled red cells</li><li>\u2022 sickle cell anemia</li><li>\u2022 genetic disorder</li><li>\u2022 mutation in the hemoglobin gene</li><li>\u2022 Option D. Polycythemia refers to an increased concentration of hemoglobin in the blood , typically not related to vitamin B12 deficiency. Instead, vitamin B12 deficiency would lead to a decrease in red cell production due to maturation failure .</li><li>\u2022 Option D.</li><li>\u2022 Polycythemia</li><li>\u2022 increased concentration of hemoglobin in the blood</li><li>\u2022 vitamin B12 deficiency</li><li>\u2022 decrease in red cell production</li><li>\u2022 maturation failure</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When considering a diagnosis of megaloblastic anemia due to vitamin B12 deficiency, significant hepatic stores of vitamin B12 can delay the onset of anemia for several years in patients with poor dietary intake .</li><li>\u27a4 megaloblastic anemia due to vitamin B12 deficiency,</li><li>\u27a4 hepatic stores of vitamin B12</li><li>\u27a4 delay the onset of anemia for several years</li><li>\u27a4 poor dietary intake</li><li>\u27a4 Ref : Robbins 10 th / 651-2</li><li>\u27a4 Ref : Robbins 10 th / 651-2</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ae174892",
      "audio": ""
    },
    {
      "text": "A 32-year-old female presents with fatigue, weakness, and shortness of breath. Laboratory investigations reveal macrocytic anemia, and the FIGLU test is conducted to assess the etiology. FIGLU test is done for:",
      "options": [
        {
          "label": "A",
          "text": "Cyanocobalamin deficiency",
          "correct": false
        },
        {
          "label": "B",
          "text": "Folic acid deficiency",
          "correct": true
        },
        {
          "label": "C",
          "text": "Thiamine deficiency",
          "correct": false
        },
        {
          "label": "D",
          "text": "Riboflavin deficiency",
          "correct": false
        }
      ],
      "correct_answer": "B. Folic acid deficiency",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Folic acid deficiency</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Vitamin B12 deficiency can lead to macrocytic anemia and is usually confirmed by low serum levels of B12 or elevated serum methylmalonic acid and homocysteine levels , not typically with a FIGLU test.</li><li>\u2022 Option A. Vitamin B12</li><li>\u2022 macrocytic anemia</li><li>\u2022 low serum levels of B12 or elevated serum methylmalonic acid and homocysteine levels</li><li>\u2022 Option C. Deficiency of thiamine leads to conditions like beriberi or Wernicke-Korsakoff syndrome , not typically associated with macrocytic anemia or a positive FIGLU test.</li><li>\u2022 Option C. Deficiency</li><li>\u2022 thiamine</li><li>\u2022 beriberi or Wernicke-Korsakoff syndrome</li><li>\u2022 Option D. Riboflavin deficiency is associated with symptoms such as angular stomatitis and glossitis, but not usually with macrocytic anemia, and it does not cause elevated FIGLU levels.</li><li>\u2022 Option D. Riboflavin</li><li>\u2022 angular stomatitis and glossitis,</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In patients with unexplained macrocytic anemia, a positive FIGLU test in the urine indicates a deficiency in folate . FIGLU is a biomarker for intracellular levels of folate .</li><li>\u27a4 unexplained macrocytic anemia,</li><li>\u27a4 positive FIGLU test</li><li>\u27a4 deficiency in folate</li><li>\u27a4 biomarker</li><li>\u27a4 for</li><li>\u27a4 intracellular levels of folate</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "723579de",
      "audio": ""
    },
    {
      "text": "Hypersegmented neutrophils are present in which of the following anemia?",
      "options": [
        {
          "label": "A",
          "text": "Hemolytic \u200b\u200b\u200b\u200b\u200b",
          "correct": false
        },
        {
          "label": "B",
          "text": "Iron deficiency",
          "correct": false
        },
        {
          "label": "C",
          "text": "Megaloblastic \u200b\u200b\u200b\u200b\u200b\u200b",
          "correct": true
        },
        {
          "label": "D",
          "text": "Aplastic",
          "correct": false
        }
      ],
      "correct_answer": "C. Megaloblastic \u200b\u200b\u200b\u200b\u200b\u200b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Megaloblastic</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hemolytic anemias are characterized by the premature destruction of red blood cells, but they do not typically cause hypersegmentation of neutrophils .</li><li>\u2022 Option A. Hemolytic</li><li>\u2022 anemias</li><li>\u2022 hypersegmentation of neutrophils</li><li>\u2022 Option B. Iron deficiency anemia is characterized by microcytic and hypochromic red blood cells , and it does not usually result in hypersegmentation of neutrophils.</li><li>\u2022 Option B. Iron deficiency anemia</li><li>\u2022 microcytic and hypochromic red blood cells</li><li>\u2022 Option D. Aplastic anemia is characterized by a reduction in the number of all blood cell types (red blood cells, white blood cells, and platelets) due to bone marrow failure . It does not cause hypersegmentation of neutrophils.</li><li>\u2022 Option D. Aplastic anemia</li><li>\u2022 reduction in the number of all blood cell types (red blood cells, white blood cells, and platelets)</li><li>\u2022 bone marrow failure</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hypersegmented neutrophils are indicative of megaloblastic anemia , a condition arising from impaired DNA synthesis which leads to abnormally large red blood cells and distinctive changes in neutrophils . This finding is not typical of hemolytic, iron deficiency, or aplastic anemias.</li><li>\u27a4 Hypersegmented neutrophils</li><li>\u27a4 megaloblastic anemia</li><li>\u27a4 impaired DNA synthesis</li><li>\u27a4 large red blood cells</li><li>\u27a4 distinctive changes in neutrophils</li><li>\u27a4 Ref : Robbins 10 th / 652</li><li>\u27a4 Ref : Robbins 10 th / 652</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "399f9992",
      "audio": ""
    },
    {
      "text": "A 24-year-old woman presents with mild anemia noted on routine screening. She reports a family history of anemia but has no significant personal medical history. She denies any symptoms of anemia. A hemoglobin electrophoresis is performed, showing an increased HbA2 level. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Beta thalassemia trait",
          "correct": true
        },
        {
          "label": "B",
          "text": "Sickle cell anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hereditory spherocytosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "G6 PD deficiency",
          "correct": false
        }
      ],
      "correct_answer": "A. Beta thalassemia trait",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Beta thalassemia trait</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Sickle cell anemia is characterized by a mutation in the beta-globin gene that leads to the production of hemoglobin S. Hemoglobin electrophoresis in sickle cell anemia typically shows a predominance of HbS and possibly elevated HbF but not HbA2.</li><li>\u2022 Option B. Sickle cell anemia</li><li>\u2022 Option C. Hereditary spherocytosis is a disorder of the red blood cell membrane leading to spherical erythrocytes and hemolytic anemia. It does not involve abnormalities in hemoglobin synthesis or elevated HbA2 levels.</li><li>\u2022 Option C. Hereditary spherocytosis</li><li>\u2022 Option D. G6PD deficiency is an X-linked enzymatic defect leading to hemolytic anemia under conditions of oxidative stress. It is not associated with an increase in HbA2 on electrophoresis.</li><li>\u2022 Option D. G6PD deficiency</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When a hemoglobin electrophoresis reveals increased HbA2 levels, it is indicative of beta thalassemia trait, reflecting an imbalance in globin chain production.</li><li>\u27a4 Ref : Robbins 10 th / 641</li><li>\u27a4 Ref : Robbins 10 th / 641</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6f11e4ce",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT a clinical presentation feature of paroxysmal nocturnal hemoglobinuria?",
      "options": [
        {
          "label": "A",
          "text": "Thrombosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Leukemia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Aplastic anemia \u200b\u200b\u200b\u200b\u200b",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hemolysis \u200b\u200b\u200b\u200b\u200b",
          "correct": false
        }
      ],
      "correct_answer": "B. Leukemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Leukemi</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Thrombosis, particularly in unusual sites such as the hepatic or cerebral veins , is a well-recognized complication of paroxysmal nocturnal hemoglobinuria (PNH) due to the increased propensity for red blood cells to activate the complement system and the coagulation cascade .</li><li>\u2022 Option A. Thrombosis,</li><li>\u2022 hepatic or cerebral veins</li><li>\u2022 of paroxysmal nocturnal hemoglobinuria (PNH)</li><li>\u2022 increased propensity for red blood cells</li><li>\u2022 complement system and the coagulation cascade</li><li>\u2022 Option C. Aplastic anemia can be a presenting feature of PNH due to the associated bone marrow failure that can occur with the disease process.</li><li>\u2022 Option C. Aplastic anemia</li><li>\u2022 PNH due to the associated bone marrow failure</li><li>\u2022 Option D. Intravascular hemolysis is a hallmark of PNH , caused by the increased sensitivity of red blood cells to complement due to a deficiency in GPI-anchored proteins that normally protect the cell membrane from complement activation .</li><li>\u2022 Option D. Intravascular hemolysis</li><li>\u2022 hallmark of PNH</li><li>\u2022 increased sensitivity of red blood cells to complement due to a deficiency in GPI-anchored proteins</li><li>\u2022 cell membrane from complement activation</li><li>\u2022 ducational Objective:</li><li>\u2022 ducational Objective:</li><li>\u2022 PNH is characterized by hemolytic anemia, pancytopenia, and thrombosis , but leukemia is not a feature of PNH but may be a secondary complication of the disease.</li><li>\u2022 PNH</li><li>\u2022 hemolytic anemia, pancytopenia, and thrombosis</li><li>\u2022 leukemia is not a feature of PNH</li><li>\u2022 secondary complication</li><li>\u2022 Ref : Robbins 10th/e p648</li><li>\u2022 Ref : Robbins 10th/e p648</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fcc1a4ed",
      "audio": ""
    },
    {
      "text": "A 55-year-old male presents with fatigue, weakness, and pallor. Laboratory investigations reveal a microcytic, hypochromic anemia. Peripheral blood smear shows microcytic red blood cells, and bone marrow biopsy confirms the presence of ringed sideroblasts. The patient does not have a history of significant alcohol consumption. Which of the following treatments is most likely to improve the anemia in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Iron \u200b\u200b\u200b\u200b\u200b\u200b",
          "correct": false
        },
        {
          "label": "B",
          "text": "B1",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pyridoxine",
          "correct": true
        },
        {
          "label": "D",
          "text": "B12",
          "correct": false
        }
      ],
      "correct_answer": "C. Pyridoxine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Pyridoxine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. iron supplementation is used for iron deficiency anemia, which typically does not feature ringed sideroblasts. In sideroblastic anemia , there is usually adequate or increased iron in the body , but it's not properly incorporated into hemoglobin.</li><li>\u2022 Option A. iron supplementation is used</li><li>\u2022 iron deficiency anemia,</li><li>\u2022 sideroblastic anemia</li><li>\u2022 adequate or increased iron in the body</li><li>\u2022 Option B.Thiamine deficiency does not typically cause sideroblastic anemia , so supplementation would not address the underlying pathophysiology in this case.</li><li>\u2022 Option B.Thiamine deficiency</li><li>\u2022 does not</li><li>\u2022 sideroblastic anemia</li><li>\u2022 would not address</li><li>\u2022 pathophysiology</li><li>\u2022 Option D. Vitamin B12 deficiency causes megaloblastic anemia , not typically sideroblastic anemia, so this would not be the treatment of choice for a patient with ringed sideroblasts .</li><li>\u2022 Option D. Vitamin B12 deficiency</li><li>\u2022 megaloblastic anemia</li><li>\u2022 sideroblastic anemia,</li><li>\u2022 not be the</li><li>\u2022 treatment of choice</li><li>\u2022 ringed sideroblasts</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Sideroblastic anemia can be responsive to pyridoxine supplementation, especially when ringed sideroblasts are observed on bone marrow biopsy and the patient does not have a history of conditions that could cause secondary sideroblastic anemia , such as alcoholism or lead poisoning.</li><li>\u27a4 Sideroblastic anemia</li><li>\u27a4 pyridoxine supplementation,</li><li>\u27a4 ringed sideroblasts</li><li>\u27a4 bone marrow biopsy</li><li>\u27a4 does not</li><li>\u27a4 cause secondary sideroblastic anemia</li><li>\u27a4 alcoholism or lead poisoning.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "502b542c",
      "audio": ""
    },
    {
      "text": "A 58-year-old man with a history of rheumatoid arthritis presents with fatigue and exertional dyspnea. Laboratory tests show a mild anemia with a hemoglobin of 10 g/dL. Further workup reveals the following: serum ferritin is elevated, total iron-binding capacity (TIBC) is decreased, serum iron is reduced, and transferrin saturation percentage is decreased. Which laboratory finding is most characteristic of the anemia of chronic disease?",
      "options": [
        {
          "label": "A",
          "text": "TIBC \u2191",
          "correct": false
        },
        {
          "label": "B",
          "text": "S. Iron \u2191",
          "correct": false
        },
        {
          "label": "C",
          "text": "BM iron \u2193",
          "correct": false
        },
        {
          "label": "D",
          "text": "S. ferritin \u2191",
          "correct": true
        }
      ],
      "correct_answer": "D. S. ferritin \u2191",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. S. ferritin \u2191</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. TIBC is typically increased due to the body's attempt to increase iron binding capacity in response to low iron stores , which is not the case in anemia of chronic disease.</li><li>\u2022 Option A. TIBC is typically</li><li>\u2022 increased</li><li>\u2022 increase iron binding capacity</li><li>\u2022 low iron stores</li><li>\u2022 Option B. Anemia of chronic disease typically presents with decreased serum iron due to sequestration of iron within macrophages and hepatocytes .</li><li>\u2022 Option B. Anemia of chronic disease</li><li>\u2022 decreased serum iron due to sequestration of iron</li><li>\u2022 macrophages and hepatocytes</li><li>\u2022 Option C. In anemia of chronic disease , bone marrow iron stores are usually normal or increased , not decreased.</li><li>\u2022 Option C. In anemia of chronic disease</li><li>\u2022 iron stores</li><li>\u2022 normal or increased</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The most characteristic laboratory finding in anemia of chronic disease is increased serum ferritin, reflecting sequestered iron stores that are not available for effective erythropoiesis despite the body having adequate or increased total iron.</li><li>\u27a4 anemia of chronic disease</li><li>\u27a4 increased serum ferritin,</li><li>\u27a4 sequestered iron stores</li><li>\u27a4 effective erythropoiesis despite the body</li><li>\u27a4 adequate or increased total iron.</li><li>\u27a4 Robbins 10 th / 659</li><li>\u27a4 Robbins 10 th / 659</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "99f3c466",
      "audio": ""
    },
    {
      "text": "Hypochromic microcytic blood picture is seen in all of the following conditions except",
      "options": [
        {
          "label": "A",
          "text": "Iron deficiency anemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lead poisoning",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rheumatoid arthritis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Sideroblastic anemia",
          "correct": false
        }
      ],
      "correct_answer": "C. Rheumatoid arthritis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Iron deficiency anemia classically presents with a hypochromic microcytic blood picture due to a deficiency in iron , leading to reduced hemoglobin synthesis and, consequently, smaller red blood cells with less hemoglobin .</li><li>\u2022 Option A. Iron deficiency anemia</li><li>\u2022 hypochromic microcytic</li><li>\u2022 deficiency in iron</li><li>\u2022 reduced hemoglobin synthesis</li><li>\u2022 smaller red blood cells with less hemoglobin</li><li>\u2022 Option B. Lead poisoning causes hypochromic microcytic anemia by interfering with several enzymatic steps in the heme synthesis pathway, leading to inadequate production of hemoglobin and microcytosis.</li><li>\u2022 Option B. Lead poisoning causes</li><li>\u2022 hypochromic microcytic anemia</li><li>\u2022 enzymatic steps</li><li>\u2022 heme synthesis pathway,</li><li>\u2022 inadequate</li><li>\u2022 hemoglobin and microcytosis.</li><li>\u2022 Option D. Sideroblastic anemia is characterized by the presence of ring sideroblasts in the bone marrow and can present with a hypochromic microcytic blood picture due to ineffective iron utilization and heme synthesis.</li><li>\u2022 Option D. Sideroblastic anemia</li><li>\u2022 presence of ring sideroblasts</li><li>\u2022 hypochromic microcytic</li><li>\u2022 ineffective iron utilization and heme synthesis.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Rheumatoid arthritis is least likely to be associated with a hypochromic microcytic blood picture among the options provided, as it is more typically linked to normocytic or mildly microcytic anemia of chronic disease .</li><li>\u27a4 Rheumatoid arthritis</li><li>\u27a4 hypochromic microcytic</li><li>\u27a4 normocytic or mildly microcytic anemia of chronic disease</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e73125f9",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman with a history of rheumatoid arthritis presents with fatigue and pallor. Her blood tests show mild anemia. Additional laboratory tests are ordered to determine the cause of her anemia. Which of the following laboratory findings is most consistent with a diagnosis of anemia of chronic disease?",
      "options": [
        {
          "label": "A",
          "text": "Serum ferritin is decreased",
          "correct": false
        },
        {
          "label": "B",
          "text": "Reduced hepcidin levels",
          "correct": false
        },
        {
          "label": "C",
          "text": "Transferrin saturation is decreased",
          "correct": true
        },
        {
          "label": "D",
          "text": "Total iron binding capacity is increased \u200b\u200b\u200b\u200b\u200b",
          "correct": false
        }
      ],
      "correct_answer": "C. Transferrin saturation is decreased",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Transferrin saturation is decreased</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  In iron deficiency anemia , serum ferritin, which reflects body iron stores, is decreased.</li><li>\u2022 Option A.  In iron deficiency anemia</li><li>\u2022 serum ferritin,</li><li>\u2022 iron stores, is decreased.</li><li>\u2022 Option B. Hepcidin levels are typically increased in anemia of chronic disease because it is an inflammatory marker that blocks the release of iron from body stores, contributing to the anemia.</li><li>\u2022 Option B. Hepcidin</li><li>\u2022 increased in anemia of chronic disease</li><li>\u2022 blocks the release of iron</li><li>\u2022 Option D. In anemia of chronic disease, TIBC is usually normal or decreased , not increased , because the body's iron is sequestered due to inflammation and is not readily available for erythropoiesis.</li><li>\u2022 Option D. In anemia</li><li>\u2022 TIBC</li><li>\u2022 normal or decreased</li><li>\u2022 not increased</li><li>\u2022 body's iron is sequestered</li><li>\u2022 inflammation</li><li>\u2022 not readily available for erythropoiesis.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In anemia of chronic disease , transferrin saturation is decreased due to limited iron utilization, despite adequate or increased iron stores reflected by normal or increased serum ferritin levels.</li><li>\u27a4 anemia of chronic disease</li><li>\u27a4 transferrin saturation</li><li>\u27a4 decreased due to limited iron utilization,</li><li>\u27a4 adequate or increased iron</li><li>\u27a4 stores</li><li>\u27a4 normal or increased serum ferritin levels.</li><li>\u27a4 Ref : Robbins 10th/e p658</li><li>\u27a4 Ref : Robbins 10th/e p658</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9a22a8e9",
      "audio": ""
    },
    {
      "text": "Which of the following test best differentiates cobalamin and folate deficiency?",
      "options": [
        {
          "label": "A",
          "text": "Plasma homocysteine levels",
          "correct": false
        },
        {
          "label": "B",
          "text": "Peripheral smear showing megaloblasts",
          "correct": false
        },
        {
          "label": "C",
          "text": "High value of mean cell volume",
          "correct": false
        },
        {
          "label": "D",
          "text": "Serum methylmalonic acid levels",
          "correct": true
        }
      ],
      "correct_answer": "D. Serum methylmalonic acid levels",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Serum methylmalonic acid levels</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Plasma homocysteine levels are elevated in both cobalamin (vitamin B12) and folate deficiencies, as both vitamins are involved in the metabolism of homocysteine . Therefore, it does not differentiate between the two.</li><li>\u2022 Option A. Plasma homocysteine levels</li><li>\u2022 elevated</li><li>\u2022 cobalamin (vitamin B12) and folate deficiencies,</li><li>\u2022 metabolism of homocysteine</li><li>\u2022 Option B. Peripheral smear showing megaloblasts is a feature common to both cobalamin and folate deficiencies , as both lead to impaired DNA synthesis and resultant megaloblastic anemia.</li><li>\u2022 Option B. Peripheral smear</li><li>\u2022 megaloblasts</li><li>\u2022 cobalamin and folate deficiencies</li><li>\u2022 impaired DNA synthesis and resultant megaloblastic anemia.</li><li>\u2022 Option C. A high mean cell volume (MCV) is indicative of macrocytic anemia , which can result from either cobalamin or folate deficiency . This finding is not specific to either condition.</li><li>\u2022 Option C. A high mean cell volume</li><li>\u2022 macrocytic anemia</li><li>\u2022 either cobalamin or folate deficiency</li><li>\u2022 not specific</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Serum methylmalonic acid levels is one of diagnostic test that differentiates between cobalamin and folate deficiencies, since it is increased in cobalamin deficiency but remains normal in folate deficiency.</li><li>\u27a4 Serum methylmalonic acid</li><li>\u27a4 diagnostic test</li><li>\u27a4 cobalamin and folate deficiencies,</li><li>\u27a4 increased in cobalamin deficiency</li><li>\u27a4 normal in folate deficiency.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "813d0f92",
      "audio": ""
    },
    {
      "text": "A 16-year-old male presents with jaundice and anemia. A blood smear shows numerous spherocytes, and a family history reveals a similar condition in his mother. Which of the following proteins, if defective, is most likely to be the cause of his hereditary spherocytosis?",
      "options": [
        {
          "label": "A",
          "text": "Ankyrin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Palladin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glycophorin C",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anion transport protein",
          "correct": false
        }
      ],
      "correct_answer": "A. Ankyrin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Ankyrin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Ankyrin is a key protein in the RBC membrane that links the integral membrane proteins to the underlying spectrin-actin cytoskeleton. Mutations in ankyrin are the most common cause of hereditary spherocytosis.</li><li>\u2022 Other Option:</li><li>\u2022 Other Option:</li><li>\u2022 Option B : Palladin is not commonly associated with the RBC membrane or hereditary spherocytosis. This protein is involved in cytoskeletal organization and cell morphology, mainly in non-erythroid cells.</li><li>\u2022 Option B</li><li>\u2022 Option C : Glycophorin C is another membrane protein of the RBC; however, deficiencies in glycophorin C are more commonly associated with hereditary elliptocytosis, not hereditary spherocytosis.</li><li>\u2022 Option C</li><li>\u2022 Option D : The anion transport protein, also known as band 3, is an integral membrane protein of the RBC. Defects in band 3 are a well-established cause of hereditary spherocytosis.</li><li>\u2022 Option D</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ankyrin is the most commonly mutated protein in hereditary spherocytosis. It plays a crucial role in linking the RBC membrane proteins to the spectrin-actin cytoskeleton, maintaining the biconcave shape of RBCs. Defects in ankyrin result in loss of membrane stability, leading to the formation of spherocytes and increased RBC destruction.</li><li>\u27a4 (Ref: Robbins 10th/ 635)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8359ed57",
      "audio": ""
    },
    {
      "text": "An Rh -ve woman became pregnant with Rh +ve fetus. Within few days after birth, the infant developed jaundice, ascites, hepatomegaly and edema. The likely substance(s) deposited in skin and sclera in jaundice is/are given below. Which is the best possible answer?",
      "options": [
        {
          "label": "A",
          "text": "Biliverdin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Conjugated and unconjugated bilirubin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Unconjugated bilirubin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Conjugated bilirubin",
          "correct": false
        }
      ],
      "correct_answer": "B. Conjugated and unconjugated bilirubin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Conjugated and unconjugated bilirubin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Biliverdin is a green tetrapyrrolic bile pigment , and it is an intermediate product in the breakdown of heme . It is subsequently reduced to bilirubin in the liver. Biliverdin itself does not contribute to the yellow discoloration seen in jaundice.</li><li>\u2022 Option A. Biliverdin is a green tetrapyrrolic</li><li>\u2022 bile pigment</li><li>\u2022 intermediate product</li><li>\u2022 heme</li><li>\u2022 reduced to bilirubin</li><li>\u2022 Biliverdin</li><li>\u2022 does not</li><li>\u2022 yellow discoloration</li><li>\u2022 Option C. Unconjugated bilirubin is the form that is i nitially produced during the breakdown of hemoglobin . While it does accumulate in conditions of increased hemolysis , it is not water-soluble and requires conjugation by the liver to become water-soluble .</li><li>\u2022 Option C. Unconjugated bilirubin</li><li>\u2022 nitially produced</li><li>\u2022 breakdown of hemoglobin</li><li>\u2022 accumulate</li><li>\u2022 increased hemolysis</li><li>\u2022 not water-soluble</li><li>\u2022 conjugation by the liver to become water-soluble</li><li>\u2022 Option D. Conjugated bilirubin is water-soluble and can be excreted into the bile and urine. High levels of conjugated bilirubin can indicate liver dysfunction or biliary obstruction , but on its own does not typically cause the systemic findings seen in erythroblastosis fetalis.</li><li>\u2022 Option D. Conjugated bilirubin</li><li>\u2022 water-soluble</li><li>\u2022 excreted into the bile and urine. High levels of conjugated bilirubin</li><li>\u2022 liver dysfunction or biliary obstruction</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Both conjugated and unconjugated bilirubin can deposit in the skin and sclera in newborns with erythroblastosis fetalis, contributing to the yellow discoloration observed in jaundice.</li><li>\u27a4 conjugated and unconjugated bilirubin</li><li>\u27a4 skin and sclera</li><li>\u27a4 erythroblastosis fetalis,</li><li>\u27a4 yellow discoloration</li><li>\u27a4 jaundice.</li><li>\u27a4 Ref : Robbins 10 th / 857</li><li>\u27a4 Ref : Robbins 10 th / 857</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c251b9af",
      "audio": ""
    },
    {
      "text": "A 40-year-old patient presents with fatigue, episodes of dark urine, especially in the morning, and a recent history of thrombosis. Lab tests show hemolytic anemia and cytopenias. Which of the following findings is least likely to be associated with the likely diagnosis of paroxysmal nocturnal hemoglobinuria (PNH)?",
      "options": [
        {
          "label": "A",
          "text": "LDH levels are raised",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increased hemosiderin in urine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Decreased leukocyte alkaline phosphatase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increased platelets",
          "correct": true
        }
      ],
      "correct_answer": "D. Increased platelets",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D.\u00a0 Increased platelets</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. LDH levels are raised: True as LDH (lactate dehydrogenase) levels are often elevated in PNH due to intravascular hemolysis .</li><li>\u2022 Option A. LDH levels are raised:</li><li>\u2022 True</li><li>\u2022 LDH (lactate dehydrogenase)</li><li>\u2022 elevated in PNH</li><li>\u2022 intravascular hemolysis</li><li>\u2022 Option B. Increased hemosiderin in urine: True ; Hemolysis in PNH can result in the release of free hemoglobin , which is filtered by the kidneys , leading to hemosiderinuria.</li><li>\u2022 Option B. Increased hemosiderin in urine:</li><li>\u2022 True</li><li>\u2022 PNH</li><li>\u2022 free hemoglobin</li><li>\u2022 kidneys</li><li>\u2022 hemosiderinuria.</li><li>\u2022 Option C. Decreased leukocyte alkaline phosphatase: True; PNH cells are deficient in GPI-linked proteins, including alkaline phosphatase . Therefore, leukocyte alkaline phosphatase is decreased in PNH .</li><li>\u2022 Option C. Decreased leukocyte alkaline phosphatase:</li><li>\u2022 True; PNH cells</li><li>\u2022 GPI-linked proteins,</li><li>\u2022 alkaline phosphatase</li><li>\u2022 leukocyte alkaline phosphatase</li><li>\u2022 decreased in PNH</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Thrombocytopenia , not thrombocytosis, is a common feature of PNH due to increased platelet consumption and intravascular thrombosis , leading to a decreased platelet count .</li><li>\u27a4 Thrombocytopenia</li><li>\u27a4 common feature of PNH</li><li>\u27a4 increased platelet consumption and intravascular thrombosis</li><li>\u27a4 decreased platelet count</li><li>\u27a4 Ref : Robbins 10 th / 645</li><li>\u27a4 Ref : Robbins 10 th / 645</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "634747e1",
      "audio": ""
    },
    {
      "text": "A patient presents with fatigue, pallor, and dark urine. Laboratory tests reveal anemia with increased bilirubin levels. Which of the following laboratory findings is inconsistent with a diagnosis of hemolytic anemia?",
      "options": [
        {
          "label": "A",
          "text": "Yellowing of eyes and sclera",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increased LDH",
          "correct": false
        },
        {
          "label": "C",
          "text": "Decrease in haptoglobin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Low reticulocyte count",
          "correct": true
        }
      ],
      "correct_answer": "D. Low reticulocyte count",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Low reticulocyte count</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Yellowing of eyes and sclera is due to hyperbilirubinemia , which is commonly seen in hemolytic anemia as a result of increased breakdown of red blood cells .</li><li>\u2022 Option A. Yellowing of eyes</li><li>\u2022 and sclera</li><li>\u2022 hyperbilirubinemia</li><li>\u2022 hemolytic anemia</li><li>\u2022 increased breakdown of red blood cells</li><li>\u2022 Option B. Increased lactate dehydrogenase (LDH) is often observed in hemolytic anemia because this intracellular enzyme is released into the blood when red cells are destroyed .</li><li>\u2022 Option B. Increased lactate</li><li>\u2022 dehydrogenase</li><li>\u2022 hemolytic anemia</li><li>\u2022 intracellular enzyme</li><li>\u2022 red cells are destroyed</li><li>\u2022 Option C. A decrease in haptoglobin is expected in hemolytic anemia. Haptoglobin binds free hemoglobin released from lysed red blood cells , and its levels drop as it is consumed in this process.</li><li>\u2022 Option C. A decrease in haptoglobin</li><li>\u2022 Haptoglobin binds free hemoglobin</li><li>\u2022 lysed red blood cells</li><li>\u2022 levels drop</li><li>\u2022 consumed</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hemolytic anemia is typically characterized by an increased reticulocyte count as the bone marrow compensates for the loss of red blood cells . A low reticulocyte count suggests an inadequate bone marrow response .</li><li>\u27a4 Hemolytic anemia</li><li>\u27a4 increased reticulocyte count</li><li>\u27a4 bone marrow compensates</li><li>\u27a4 red blood cells</li><li>\u27a4 low reticulocyte count</li><li>\u27a4 inadequate bone marrow response</li><li>\u27a4 Ref: Robbins 10 th / 634</li><li>\u27a4 Ref:</li><li>\u27a4 Robbins 10 th / 634</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "007ea9eb",
      "audio": ""
    },
    {
      "text": "A 25-year-old female presented with fatiguability and dyspnea on exertion. She was found to be having a hemoglobin of 6 g/dL. What will be most likely finding in her peripheral blood smear?",
      "options": [
        {
          "label": "A",
          "text": "Macrocytic hypochromic red cells",
          "correct": false
        },
        {
          "label": "B",
          "text": "Target cells",
          "correct": false
        },
        {
          "label": "C",
          "text": "Reduced poikilocytosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Microcytic and hypochromic red cell",
          "correct": true
        }
      ],
      "correct_answer": "D. Microcytic and hypochromic red cell",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Microcytic and hypochromic red cells</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Macrocytosis (larger than normal red cells) typically indicates a deficiency in vitamin B12 or folate , not iron. While hypochromia refers to red cells with reduced hemoglobin content, it is not typically associated with macrocytosis.</li><li>\u2022 Option A. Macrocytosis</li><li>\u2022 (larger than normal red cells)</li><li>\u2022 vitamin B12 or folate</li><li>\u2022 Option B. Target cells can be seen in various hemoglobinopathies, liver disease, and post-splenectomy, but they are not characteristic of iron deficiency anemia.</li><li>\u2022 Option B. Target cells</li><li>\u2022 hemoglobinopathies, liver disease, and post-splenectomy,</li><li>\u2022 Option C. Poikilocytosis refers to abnormally shaped red blood cells and is a nonspecific finding. The term \"reduced poikilocytosis\" is not typically used to describe findings in anemia.</li><li>\u2022 Option C. Poikilocytosis</li><li>\u2022 abnormally shaped red blood cells</li><li>\u2022 nonspecific finding.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When evaluating a patient with anemia, particularly in the setting of fatigue and dyspnea on exertion with a significantly low hemoglobin level , finding microcytic and hypochromic red cells on the peripheral blood smear strongly suggests iron deficiency anemia .</li><li>\u27a4 fatigue and dyspnea on exertion</li><li>\u27a4 low hemoglobin level</li><li>\u27a4 microcytic and hypochromic red cells</li><li>\u27a4 iron deficiency anemia</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "01e7fb4e",
      "audio": ""
    },
    {
      "text": "A young child presents with the sudden onset of hemoglobinuria following a viral infection. He was noted to have red urine after playing outside in the cold weather. A specific antibody test is positive when his blood is cooled and then warmed. Which of the following antibodies is most likely responsible for this patient\u2019s condition?",
      "options": [
        {
          "label": "A",
          "text": "Warm agglutination",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cold agglutination",
          "correct": true
        },
        {
          "label": "C",
          "text": "Paroxysmal nocturnal hemoglobinuria",
          "correct": false
        },
        {
          "label": "D",
          "text": "Immune thrombocytopeniax`",
          "correct": false
        }
      ],
      "correct_answer": "B. Cold agglutination",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Cold agglutination</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Warm agglutinins are antibodies , typically IgG , that react with red blood cell antigens at body temperature and are often involved in autoimmune hemolytic anemia , not typically causing hemoglobinuria upon cold exposure.</li><li>\u2022 Option A. Warm agglutinins are antibodies</li><li>\u2022 IgG</li><li>\u2022 red blood cell antigens at body temperature</li><li>\u2022 autoimmune hemolytic anemia</li><li>\u2022 Option C. PNH is a condition caused by a mutation leading to a deficiency of GPI-anchored proteins on the cell surface , which makes red blood cells sensitive to complement-mediated lysis ; it does not involve the Donath-Landsteiner antibody.</li><li>\u2022 Option C. PNH is a condition caused</li><li>\u2022 deficiency of GPI-anchored proteins on the cell surface</li><li>\u2022 red blood cells sensitive to complement-mediated lysis</li><li>\u2022 Option D. Immune thrombocytopenia is characterized by antibodies, usually IgG , that target platelets for destruction by the spleen, which is unrelated to hemoglobinuria upon cold exposure .</li><li>\u2022 Option D. Immune thrombocytopenia</li><li>\u2022 antibodies, usually IgG</li><li>\u2022 platelets</li><li>\u2022 spleen,</li><li>\u2022 unrelated to hemoglobinuria upon cold exposure</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Donath-Landsteiner antibody , a cold agglutinin with anti-P specificity , is responsible for hemoglobinuria in patients with paroxysmal cold hemoglobinuria, a condition that is triggered by cold temperatures .</li><li>\u27a4 Donath-Landsteiner antibody</li><li>\u27a4 cold agglutinin</li><li>\u27a4 anti-P specificity</li><li>\u27a4 hemoglobinuria</li><li>\u27a4 paroxysmal cold hemoglobinuria,</li><li>\u27a4 cold temperatures</li><li>\u27a4 Ref : Robbins 10 th / 660</li><li>\u27a4 Ref : Robbins 10 th / 660</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "119af16f",
      "audio": ""
    },
    {
      "text": "A 30-year-old African American male presents to the emergency room with jaundice and dark urine after taking a sulfa drug for a urinary tract infection. He has a past medical history of a similar episode after eating fava beans. His labs reveal hemolytic anemia. Which of the following is NOT a consequence of the enzyme deficiency this patient most likely has?",
      "options": [
        {
          "label": "A",
          "text": "Decrease in reduced glutathione",
          "correct": false
        },
        {
          "label": "B",
          "text": "Decrease in NADPH",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased in lipid peroxidation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Decreased RBC membrane damage \u200b\u200b\u200b",
          "correct": true
        }
      ],
      "correct_answer": "D. Decreased RBC membrane damage \u200b\u200b\u200b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Decreased RBC membrane damage</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. In G6PD deficiency , there is a decrease in reduced glutathione due to insufficient NADPH , leading to decreased ability to neutralize oxidative stress in red blood cells.</li><li>\u2022 Option A. In G6PD deficiency</li><li>\u2022 decrease in reduced glutathione</li><li>\u2022 insufficient NADPH</li><li>\u2022 decreased ability to neutralize oxidative stress</li><li>\u2022 Option B. G6PD deficiency results in a decrease in NADPH production , a critical factor in maintaining the reduced state of glutathione.</li><li>\u2022 Option B. G6PD deficiency</li><li>\u2022 decrease in NADPH production</li><li>\u2022 reduced state of glutathione.</li><li>\u2022 Option C. Without enough reduced glutathione , red blood cells are more susceptible to oxidative stress , leading to increased lipid peroxidation and membrane damage .</li><li>\u2022 Option C. Without enough</li><li>\u2022 reduced glutathione</li><li>\u2022 more susceptible to oxidative stress</li><li>\u2022 lipid peroxidation and membrane damage</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Decreased red blood cell membrane damage is not associated with G6PD deficiency.</li><li>\u27a4 Decreased red blood cell membrane</li><li>\u27a4 not</li><li>\u27a4 G6PD deficiency.</li><li>\u27a4 Ref : Robbins 10th/e p640</li><li>\u27a4 Ref : Robbins 10th/e p640</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0c130e54",
      "audio": ""
    },
    {
      "text": "A 60-year-old woman with a prosthetic heart valve presents with anemia and schistocytes on peripheral smear. Which of the following conditions is least likely to be associated with microangiopathic hemolytic anemia (MAHA)?",
      "options": [
        {
          "label": "A",
          "text": "Antiphospholipid antibody syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thrombotic thrombocytopenic purpura",
          "correct": false
        },
        {
          "label": "C",
          "text": "Microscopic polyangiitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Metallic cardiac valves",
          "correct": true
        }
      ],
      "correct_answer": "D. Metallic cardiac valves",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Metallic cardiac valves</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Antiphospholipid antibody syndrome is characterized by the presence of autoantibodies that increase the risk of thrombosis , which can lead to MAHA due to mechanical damage to red cells as they pass through the narrowed, thrombosed vessels .</li><li>\u2022 Option A. Antiphospholipid antibody</li><li>\u2022 autoantibodies</li><li>\u2022 thrombosis</li><li>\u2022 MAHA</li><li>\u2022 mechanical damage</li><li>\u2022 red cells</li><li>\u2022 thrombosed vessels</li><li>\u2022 Option B. Thrombotic thrombocytopenic purpura (TTP) is a well-known cause of MAHA and is due to the formation of microthrombi that shear red blood cells as they traverse the microcirculation.</li><li>\u2022 Option B. Thrombotic thrombocytopenic</li><li>\u2022 MAHA</li><li>\u2022 microthrombi</li><li>\u2022 shear red blood cells</li><li>\u2022 traverse the microcirculation.</li><li>\u2022 Option C. Microscopic polyangiitis is a type of small vessel vasculitis and can be associated with MAHA due to the damage to red cells caused by the inflammation of blood vessels.</li><li>\u2022 Option C. Microscopic polyangiitis</li><li>\u2022 small vessel vasculitis</li><li>\u2022 MAHA</li><li>\u2022 red cells</li><li>\u2022 inflammation of blood vessels.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Metallic cardiac valves are associated with macroangiopathic hemolytic anemia due to physical destruction of red blood cells rather than microangiopathic hemolytic anemia, which is characterized by red cell fragmentation in the microcirculation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2039e21f",
      "audio": ""
    },
    {
      "text": "A patient presents with an acute hemolytic episode after taking an antimalarial drug. His urine is dark brown, almost black. Laboratory findings are suggestive of intravascular hemolysis. A deficiency in which of the following enzymes is most likely responsible for this patient\u2019s condition?",
      "options": [
        {
          "label": "A",
          "text": "Controlling reduction stress on RBC",
          "correct": false
        },
        {
          "label": "B",
          "text": "Controlling oxidative stress on RBC",
          "correct": true
        },
        {
          "label": "C",
          "text": "Maintaining flexibility of cell membrane",
          "correct": false
        },
        {
          "label": "D",
          "text": "Component of electron transport chain",
          "correct": false
        }
      ],
      "correct_answer": "B. Controlling oxidative stress on RBC",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Controlling oxidative stress on RBC</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Controlling reduction stress on RBC refers to the balance of redox states within the cell. While redox balance is crucial, there is no specific enzyme known as the \u2018reduction stress controller\u2019 in RBCs.</li><li>\u2022 Option A. Controlling reduction stress</li><li>\u2022 RBC</li><li>\u2022 redox states</li><li>\u2022 Option C. Maintaining flexibility of cell membrane is related to the cytoskeletal proteins of the RBC , such as spectrin , and does not involve G6PD.</li><li>\u2022 Option C. Maintaining flexibility</li><li>\u2022 cell membrane</li><li>\u2022 cytoskeletal proteins of the RBC</li><li>\u2022 spectrin</li><li>\u2022 Option D. Components of the electron transport chain are involved in energy production in the mitochondria , which RBCs lack ; hence, it does not relate to the integrity of RBCs .</li><li>\u2022 Option D. Components of the electron</li><li>\u2022 energy production in the mitochondria</li><li>\u2022 RBCs lack</li><li>\u2022 integrity of RBCs</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The role of G6PD is in maintaining the redox balance to protect RBCs from oxidative stress , where its deficiency can lead to hemolytic anemia upon exposure to certain oxidative drugs or foods .</li><li>\u27a4 G6PD</li><li>\u27a4 redox balance</li><li>\u27a4 RBCs from oxidative stress</li><li>\u27a4 hemolytic anemia upon exposure to certain oxidative drugs or foods</li><li>\u27a4 Ref : Robbins 10 th /640</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th /640</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bb5faefc",
      "audio": ""
    },
    {
      "text": "A patient presents with acrocyanosis and hemolytic anemia after exposure to cold weather. Laboratory tests reveal agglutination of red blood cells at temperatures between 4 to 6\u00b0C. Which type of immunoglobulin is most likely responsible for this agglutination?",
      "options": [
        {
          "label": "A",
          "text": "IgG",
          "correct": false
        },
        {
          "label": "B",
          "text": "IgM",
          "correct": true
        },
        {
          "label": "C",
          "text": "IgA",
          "correct": false
        },
        {
          "label": "D",
          "text": "IgD",
          "correct": false
        }
      ],
      "correct_answer": "B. IgM",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. IgM</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. IgG antibodies are generally involved in warm autoimmune hemolytic anemias and do not typically cause agglutination at low temperatures.</li><li>\u2022 Option A. IgG antibodies</li><li>\u2022 warm autoimmune hemolytic anemias</li><li>\u2022 Option C. IgA antibodies are mainly secretory antibodies and do not usually cause agglutination of red blood cells in cold environments.</li><li>\u2022 Option C. IgA antibodies</li><li>\u2022 secretory antibodies</li><li>\u2022 Option D. IgD antibodies are found in very low concentrations in serum and are not associated with cold agglutination of red blood cells.</li><li>\u2022 Option D. IgD antibodies</li><li>\u2022 very low concentrations in serum</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 IgM antibodies , known as cold agglutinins , can cause agglutination of red blood cells at low temperatures , as seen in cold agglutinin disease .</li><li>\u27a4 IgM antibodies</li><li>\u27a4 cold agglutinins</li><li>\u27a4 agglutination of red blood cells</li><li>\u27a4 low temperatures</li><li>\u27a4 cold agglutinin disease</li><li>\u27a4 Ref : Robbins 10 th / 648</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 648</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "45491b77",
      "audio": ""
    },
    {
      "text": "A child presents with acute renal failure, thrombocytopenia, and a microangiopathic hemolytic anemia after a diarrheal illness. A peripheral blood smear shows fragmented red cells, including helmet cells. Which condition is most consistent with these findings?",
      "options": [
        {
          "label": "A",
          "text": "Hemolytic uremic syndrome",
          "correct": true
        },
        {
          "label": "B",
          "text": "Polysplenia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Spherocytosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acanthocytosis",
          "correct": false
        }
      ],
      "correct_answer": "A. Hemolytic uremic syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Hemolytic uremic syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Polysplenia is a condition where multiple small spleens are present and is typically associated with congenital abnormalities ; it does not characteristically present with schistocytes or helmet cells.</li><li>\u2022 Option B. Polysplenia</li><li>\u2022 multiple small spleens</li><li>\u2022 congenital abnormalities</li><li>\u2022 Option C. Spherocytosis is a disorder causing spherically shaped red blood cells due to a defect in the RBC membrane, not typically associated with schistocytes or helmet cells.</li><li>\u2022 Option C. Spherocytosis</li><li>\u2022 spherically shaped red blood cells</li><li>\u2022 RBC membrane,</li><li>\u2022 Option D. Acanthocytosis refers to spur cells with spiculated membranes , which are seen in liver disease and abetalipoproteinemia, among others, and does not present with helmet cells.</li><li>\u2022 Option D. Acanthocytosis</li><li>\u2022 spur cells with spiculated membranes</li><li>\u2022 liver disease and abetalipoproteinemia,</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Helmet cells on a blood smear are characteristic of microangiopathic hemolytic anemias , such as those seen in hemolytic uremic syndrome (HUS), which can present with renal failure and thrombocytopenia following gastroenteritis .</li><li>\u27a4 Helmet cells</li><li>\u27a4 microangiopathic hemolytic anemias</li><li>\u27a4 hemolytic uremic syndrome (HUS),</li><li>\u27a4 renal failure and thrombocytopenia</li><li>\u27a4 gastroenteritis</li><li>\u27a4 Ref : Robbins 10 th / 662</li><li>\u27a4 Ref : Robbins 10 th / 662</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "61c5b80a",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman presents with fatigue, pallor, and shortness of breath on exertion. Her blood tests show a low hemoglobin concentration and a mean corpuscular volume (MCV) within the low-normal range. To further evaluate her anemia, which of the following mean corpuscular hemoglobin concentration (MCHC) values would suggest a diagnosis of iron deficiency anemia?",
      "options": [
        {
          "label": "A",
          "text": "<32",
          "correct": false
        },
        {
          "label": "B",
          "text": "<34",
          "correct": true
        },
        {
          "label": "C",
          "text": "<28",
          "correct": false
        },
        {
          "label": "D",
          "text": "<30",
          "correct": false
        }
      ],
      "correct_answer": "B. <34",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.<34</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 At all ages the normal MCHC should be 34; values below that indicate that red cells are hypochromic , which occurs in iron deficiency anaemia.</li><li>\u2022 At all ages the normal MCHC should be 34;</li><li>\u2022 below</li><li>\u2022 hypochromic</li><li>\u2022 iron deficiency anaemia.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When evaluating for iron deficiency anemia , an MCHC value below 34 g/dL is indicative of hypochromic red blood cells , which is a typical laboratory finding in this condition.</li><li>\u27a4 iron deficiency anemia</li><li>\u27a4 MCHC value below 34 g/dL</li><li>\u27a4 hypochromic red blood cells</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "92beced3",
      "audio": ""
    },
    {
      "text": "A 30-year-old male presents with jaundice and anemia. His peripheral blood smear shows numerous small, dense, and spherically shaped red blood cells. He reports a family history of similar symptoms. A defect in which of the following is the most likely cause of his anemia?",
      "options": [
        {
          "label": "A",
          "text": "Autoimmune hemolytic anemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hereditary spherocytosis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Microangiopathic haemolytic anemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Thermal injury causing anemia \u200b\u200b\u200b\u200b",
          "correct": false
        }
      ],
      "correct_answer": "B. Hereditary spherocytosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. \u00a0Hereditary spherocytosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Autoimmune hemolytic anemia is caused by antibodies targeting and destroying red blood cells , not by an intrinsic defect in the red blood cell membrane.</li><li>\u2022 Option A.</li><li>\u2022 Autoimmune hemolytic anemia</li><li>\u2022 antibodies</li><li>\u2022 destroying red blood cells</li><li>\u2022 Option C. Leading to red blood cell fragmentation Microangiopathic hemolytic anemia is caused by red blood cells being damaged as they pass through narrowed or damaged small blood vessels , not by an intrinsic membrane defect.</li><li>\u2022 Option C. Leading to red blood cell fragmentation Microangiopathic hemolytic anemia</li><li>\u2022 narrowed or damaged small blood vessels</li><li>\u2022 Option D. Thermal injury causes anemia due to direct heat damage to the red blood cells or indirect effects following burn injury , not due to intrinsic membrane defects .</li><li>\u2022 Option D. Thermal injury causes anemia</li><li>\u2022 direct heat damage to the red blood cells</li><li>\u2022 burn injury</li><li>\u2022 intrinsic membrane defects</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hereditary spherocytosis and other disorders such as hereditary elliptocytosis and abetalipoproteinemia involve intrinsic red cell membrane defects , leading to characteristic morphological changes in red blood cells and associated clinical symptoms.</li><li>\u27a4 Hereditary spherocytosis</li><li>\u27a4 hereditary elliptocytosis and abetalipoproteinemia</li><li>\u27a4 intrinsic red cell membrane defects</li><li>\u27a4 morphological changes in red blood cells</li><li>\u27a4 Ref : Robbins 10 th / 632</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 632</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8a38bcc1",
      "audio": ""
    },
    {
      "text": "A 6-years-old child belonging to Punjabi family with past history of blood transfusions presented with hemoglobin 3.5 g/dl, MCV \u2013 30 fl, MCHC \u2013 20. Peripheral smear findings of microcytic hypochromic anemia with target cell and reduced osmotic fragility. What is the he probable diagnosis of patient?",
      "options": [
        {
          "label": "A",
          "text": "Alpha thalassemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Beta thalassemia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Sickle cell anemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "G6PD deficiency",
          "correct": false
        }
      ],
      "correct_answer": "B. Beta thalassemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Beta thalassemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Alpha thalassemia typically presents with microcytic anemia and can be severe depending on the number of gene deletions but is less common in the Punjabi population.</li><li>\u2022 Option A. Alpha thalassemia</li><li>\u2022 microcytic anemia</li><li>\u2022 severe</li><li>\u2022 number of gene deletions</li><li>\u2022 Option C. Sickle cell anemia usually presents with normocytic anemia and not typically microcytic anemia. It can have target cells but is most commonly associated with the African population.</li><li>\u2022 Option C. Sickle cell anemia</li><li>\u2022 normocytic anemia</li><li>\u2022 African population.</li><li>\u2022 Option D. G6PD deficiency can lead to hemolytic anemia, often episodic and related to oxidative stress, but it typically does not cause a microcytic hypochromic anemia or a reduced MCV and MCHC.</li><li>\u2022 Option D. G6PD deficiency</li><li>\u2022 hemolytic anemia,</li><li>\u2022 oxidative stress,</li><li>\u2022 does not cause a microcytic hypochromic anemia or a reduced</li><li>\u2022 MCV and MCHC.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The  presentation of s evere microcytic hypochromic anemia with target cells , a history of multiple blood transfusions, and reduced osmotic fragility in a child from an ethnicity with a high prevalence of thalassemia strongly suggests beta thalassemia major as the most likely diagnosis.</li><li>\u27a4 evere microcytic hypochromic anemia with target cells</li><li>\u27a4 multiple blood transfusions,</li><li>\u27a4 reduced</li><li>\u27a4 osmotic fragility</li><li>\u27a4 ethnicity with a high prevalence of thalassemia</li><li>\u27a4 beta thalassemia major</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8008edf7",
      "audio": ""
    },
    {
      "text": "NESTROF test is a screening test for which of the following conditions?",
      "options": [
        {
          "label": "A",
          "text": "\u03b2- thalassemia",
          "correct": true
        },
        {
          "label": "B",
          "text": "Hereditary spherocytosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Autoimmune haemolytic anaemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Megaloblastic anaemia",
          "correct": false
        }
      ],
      "correct_answer": "A. \u03b2- thalassemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.\u00a0 \u03b2</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 \u03b2-thalassemia - NESTROFT is used to screen for beta-thalassemia because red blood cells in this condition exhibit increased fragility in hypotonic solutions due to their membrane characteristics.</li><li>\u2022 \u03b2-thalassemia</li><li>\u2022 NESTROFT is</li><li>\u2022 screen for beta-thalassemia</li><li>\u2022 increased fragility</li><li>\u2022 in hypotonic solutions</li><li>\u2022 membrane characteristics.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 NESTROFT is a screening test for beta-thalassemia, which is based on the increased osmotic fragility of red blood cells in this condition.</li><li>\u27a4 NESTROFT</li><li>\u27a4 beta-thalassemia,</li><li>\u27a4 increased osmotic fragility</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9f8385bd",
      "audio": ""
    },
    {
      "text": "Which of the following is the cause of alpha thalassemia?",
      "options": [
        {
          "label": "A",
          "text": "Deletion of alpha genes",
          "correct": true
        },
        {
          "label": "B",
          "text": "Deletion of beta genes",
          "correct": false
        },
        {
          "label": "C",
          "text": "Excess of alpha genes",
          "correct": false
        },
        {
          "label": "D",
          "text": "Single amino acid substitution in alpha chain",
          "correct": false
        }
      ],
      "correct_answer": "A. Deletion of alpha genes",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Deletion of alpha genes</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A:</li><li>\u2022 Option A:</li><li>\u2022 Deletion of alpha genes is the primary cause of alpha thalassemia. The number of deleted genes can affect the severity of the disease ; the loss of two genes causes mild disease, while the loss of all four genes leads to hydrops fetalis .</li><li>\u2022 Deletion of alpha genes</li><li>\u2022 alpha thalassemia.</li><li>\u2022 severity of the disease</li><li>\u2022 loss of two genes</li><li>\u2022 loss of all four genes leads to hydrops fetalis</li><li>\u2022 Option B. Deletion of beta genes leads to beta thalassemia. This condition results from mutations in the beta-globin gene on chromosome 11 , not the alpha-globin gene on chromosome 16.</li><li>\u2022 Option B. Deletion of beta</li><li>\u2022 beta thalassemia.</li><li>\u2022 mutations in the beta-globin gene</li><li>\u2022 chromosome 11</li><li>\u2022 Option C. Excess of alpha genes does not cause alpha thalassemia. Typically, an imbalance between alpha and beta chains due to a relative lack of alpha genes is what causes thalassemias.</li><li>\u2022 Option C. Excess of alpha</li><li>\u2022 does not cause alpha thalassemia.</li><li>\u2022 imbalance between alpha and beta chains</li><li>\u2022 alpha genes</li><li>\u2022 thalassemias.</li><li>\u2022 Option D. Single amino acid substitution in the alpha chain is commonly associated with hemoglobin variants like Hemoglobin C or S, but not with thalassemia , which is a quantitative problem with globin chain production.</li><li>\u2022 Option D. Single amino</li><li>\u2022 alpha chain</li><li>\u2022 Hemoglobin C or S,</li><li>\u2022 not with thalassemia</li><li>\u2022 quantitative problem with globin chain production.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Alpha thalassemia is most commonly caused by the deletion of alpha genes on chromosome 16 , which leads to a quantitative reduction in the production of alpha-globin chains.</li><li>\u27a4 Alpha thalassemia</li><li>\u27a4 deletion of alpha genes on chromosome 16</li><li>\u27a4 quantitative reduction</li><li>\u27a4 alpha-globin chains.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5a2d72b2",
      "audio": ""
    },
    {
      "text": "HbH is formed due to which of the following?",
      "options": [
        {
          "label": "A",
          "text": "Deletion of 4 alpha chains",
          "correct": false
        },
        {
          "label": "B",
          "text": "Deletion of 3 alpha chains",
          "correct": true
        },
        {
          "label": "C",
          "text": "Deletion of 2 alpha chains",
          "correct": false
        },
        {
          "label": "D",
          "text": "Deletion of 1 alpha chain",
          "correct": false
        }
      ],
      "correct_answer": "B. Deletion of 3 alpha chains",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Deletion of 3 alpha chains</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Deletion of all 4 alpha chains typically results in hydrops fetalis and is usually incompatible with life ; hence it does not lead to the formation of HbH.</li><li>\u2022 Option A. Deletion</li><li>\u2022 of all 4 alpha chains</li><li>\u2022 hydrops fetalis</li><li>\u2022 incompatible with life</li><li>\u2022 Option D. Deletion of 1 alpha chain usually causes no significant clinical symptoms and is known as silent carrier state ; it does not lead to HbH formation.</li><li>\u2022 Option D. Deletion</li><li>\u2022 of 1</li><li>\u2022 alpha chain</li><li>\u2022 silent carrier state</li><li>\u2022 Option C: Deletion of 2 alpha chains often causes a milder form of alpha thalassemia, known as alpha thalassemia trait or alpha thalassemia minor , not typically associated with the formation of HbH.</li><li>\u2022 Option C: Deletion of 2</li><li>\u2022 alpha chains</li><li>\u2022 alpha thalassemia,</li><li>\u2022 alpha thalassemia trait or alpha thalassemia minor</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 HbH disease is caused by the deletion of three alpha-globin genes , which leads to an excess of beta-globin chains that form the abnormal hemoglobin H (beta4).</li><li>\u27a4 HbH disease</li><li>\u27a4 deletion of three alpha-globin genes</li><li>\u27a4 excess of beta-globin chains</li><li>\u27a4 abnormal hemoglobin H (beta4).</li><li>\u27a4 Ref : Robbins 10 th / 645</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 645</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "65fb0fb8",
      "audio": ""
    },
    {
      "text": "What is affected in sickled hemoglobin; HbS?",
      "options": [
        {
          "label": "A",
          "text": "Stability",
          "correct": false
        },
        {
          "label": "B",
          "text": "Function",
          "correct": false
        },
        {
          "label": "C",
          "text": "Affinity",
          "correct": false
        },
        {
          "label": "D",
          "text": "Solubility",
          "correct": true
        }
      ],
      "correct_answer": "D. Solubility",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Solubility</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Stability refers to the hemoglobin molecule's resistance to denaturation and degradation . While HbS can be less stable under deoxygenating conditions, this is not the primary issue.</li><li>\u2022 Option A. Stability</li><li>\u2022 hemoglobin molecule's resistance to denaturation and degradation</li><li>\u2022 Option B. Function pertains to the ability of hemoglobin to carry oxygen . HbS can still carry oxygen , but the sickling process can hinder its release to tissues.</li><li>\u2022 Option B. Function pertains</li><li>\u2022 ability</li><li>\u2022 carry oxygen</li><li>\u2022 carry oxygen</li><li>\u2022 Option C. Affinity refers to the hemoglobin's ability to bind oxygen . HbS has a slightly different oxygen affinity compared to normal hemoglobin, but again, this is not the main problem.</li><li>\u2022 Option C. Affinity refers</li><li>\u2022 hemoglobin's ability</li><li>\u2022 bind oxygen</li><li>\u2022 HbS</li><li>\u2022 slightly different oxygen</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Sickle cell hemoglobin (HbS) is primarily characterized by reduced solubility under deoxygenated conditions, leading to polymerization and sickling of red blood cells. This results in vaso-occlusive crises and chronic hemolytic anemia.</li><li>\u27a4 Sickle cell hemoglobin (HbS)</li><li>\u27a4 reduced solubility</li><li>\u27a4 deoxygenated</li><li>\u27a4 polymerization and sickling</li><li>\u27a4 vaso-occlusive crises and chronic hemolytic anemia.</li><li>\u27a4 Ref : Robbins 10 th / 638</li><li>\u27a4 Ref : Robbins 10 th / 638</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "63a26d90",
      "audio": ""
    },
    {
      "text": "Which of the following manifestations is common to sickle cell anemia and thalassemia major?",
      "options": [
        {
          "label": "A",
          "text": "Autosplenectomy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bone marrow expansion in the calvarium",
          "correct": true
        },
        {
          "label": "C",
          "text": "Effective erythropoeisis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Predisposition to *Hemophilus influenzae *infections",
          "correct": false
        }
      ],
      "correct_answer": "B. Bone marrow expansion in the calvarium",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Bone marrow expansion in the calvarium</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A . Autosplenectomy is the process of spleen shrinkage and fibrosis due to chronic damage, commonly seen in sickle cell anemia as a result of repeated vaso-occlusive episodes but is not a typical feature of thalassemia major.</li><li>\u2022 Option A</li><li>\u2022 Option C . Effective erythropoiesis refers to the production of functional red blood cells that successfully mature and enter circulation. This is not characteristic of either condition, as both sickle cell anemia and thalassemia major are marked by ineffective erythropoiesis resulting in inadequate functional red cell production.</li><li>\u2022 Option C</li><li>\u2022 Option D . Predisposition to Hemophilus influenzae infections is more commonly associated with asplenic or hyposplenic individuals, but it is not directly related to the bone marrow changes seen on skull x-rays.</li><li>\u2022 Option D</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Both sickle cell anemia and thalassemia major can lead to bone marrow expansion in the calvarium as a compensatory response to increased erythropoietic demand due to chronic hemolytic anemia.</li><li>\u27a4 Ref : Robbins 10th/ 640</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dd4b5341",
      "audio": ""
    },
    {
      "text": "One of the common variants of sickle cell anemia frequently marked by lesser degree of haemolytic anemia and greater propensity for the development of retinopathy and aseptic necrosis of bones is:",
      "options": [
        {
          "label": "A",
          "text": "Sickle cell trait",
          "correct": false
        },
        {
          "label": "B",
          "text": "Haemoglobin SC disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sickle thalassaemia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Sickle \u2013Hb E disease",
          "correct": false
        }
      ],
      "correct_answer": "C. Sickle thalassaemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Sickle thalassaemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Sickle cell trait , the heterozygous form of sickle cell disease, usually causes no symptoms or a very mild clinical course and does not typically lead to complications like retinopathy or aseptic necrosis of bones.</li><li>\u2022 Option A. Sickle cell trait</li><li>\u2022 Option B. Hemoglobin SC disease is a compound heterozygous condition with one sickle cell gene and one gene for hemoglobin C. It can present with a clinical picture similar to sickle cell disease but usually with a milder course.</li><li>\u2022 Option B. Hemoglobin</li><li>\u2022 Option D. Sickle-Hb E disease involves coinheritance of the sickle cell gene and hemoglobin E gene. It usually presents with milder symptoms compared to sickle cell anemia but can have clinical variability.</li><li>\u2022 Option D. Sickle-Hb E disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Sickle thalassemia often presents with less severe hemolytic anemia compared to sickle cell anemia but has a greater propensity for complications such as retinopathy and aseptic necrosis of bones.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b627b1fb",
      "audio": ""
    },
    {
      "text": "All are seen in Thalasemia major except:",
      "options": [
        {
          "label": "A",
          "text": "Transfusion dependency",
          "correct": false
        },
        {
          "label": "B",
          "text": "Splenoheptatomegaly",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ineffective erythropoiesis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Macrocytic anaemia",
          "correct": true
        }
      ],
      "correct_answer": "D. Macrocytic anaemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Macrocytic anaemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Transfusion dependency is a characteristic of thalassemia major, as patients often require regular blood transfusions to manage severe anemia due to ineffective erythropoiesis.</li><li>\u2022 Option A. Transfusion dependency</li><li>\u2022 thalassemia major,</li><li>\u2022 blood transfusions</li><li>\u2022 ineffective erythropoiesis.</li><li>\u2022 Option B. Splenohepatomegaly in thalassemia major results from extramedullary hematopoiesis, where the spleen and liver try to compensate for the anemia by producing blood cells, and from iron overload due to repeated transfusions.</li><li>\u2022 Option B. Splenohepatomegaly</li><li>\u2022 extramedullary hematopoiesis,</li><li>\u2022 blood cells, and from iron overload due to repeated transfusions.</li><li>\u2022 Option C. Ineffective erythropoiesis refers to the bone marrow's inability to produce mature and functional red blood cells , a hallmark of thalassemia major due to mutations affecting hemoglobin production.</li><li>\u2022 Option C. Ineffective erythropoiesis</li><li>\u2022 inability to produce mature and functional red blood cells</li><li>\u2022 hallmark of thalassemia major</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Thalassemia major typically presents with transfusion dependency, splenohepatomegaly, and ineffective erythropoiesis but not with macrocytic anemia , which is more consistent with deficiencies in vitamin B12 or folate.</li><li>\u27a4 Thalassemia major</li><li>\u27a4 transfusion dependency, splenohepatomegaly, and ineffective erythropoiesis</li><li>\u27a4 macrocytic anemia</li><li>\u27a4 more consistent with deficiencies in vitamin B12 or folate.</li><li>\u27a4 Ref : Robbins 10 th / 638</li><li>\u27a4 Ref : Robbins 10 th / 638</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cd485cf8",
      "audio": ""
    },
    {
      "text": "Bone infarcts are seen in:",
      "options": [
        {
          "label": "A",
          "text": "Iron deficiency anemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thalassemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sickle cell anemia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hereditary spherocytosis",
          "correct": false
        }
      ],
      "correct_answer": "C. Sickle cell anemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Sickle cell anemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Iron deficiency anemia usually presents with symptoms related to a lack of hemoglobin and oxygen delivery, such as fatigue and pallor , not bone infarcts.</li><li>\u2022 Option A. Iron deficiency anemia</li><li>\u2022 lack of hemoglobin and oxygen delivery,</li><li>\u2022 fatigue and pallor</li><li>\u2022 Option B. Thalassemia can cause bone deformities due to marrow expansion but does not typically cause bone infarcts.</li><li>\u2022 Option B. Thalassemia can cause bone</li><li>\u2022 due to marrow expansion</li><li>\u2022 Option D. Hereditary spherocytosis typically involves hemolysis and anemia due to defects in the red blood cell membrane , but it does not usually result in bone infarcts.</li><li>\u2022 Option D. Hereditary spherocytosis</li><li>\u2022 hemolysis</li><li>\u2022 anemia</li><li>\u2022 red blood cell membrane</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Bone infarcts are a common complication in sickle cell anemia due to vaso-occlusive events caused by the abnormal, sickled red blood cells .</li><li>\u27a4 Bone infarcts</li><li>\u27a4 sickle cell anemia</li><li>\u27a4 vaso-occlusive events</li><li>\u27a4 abnormal, sickled red blood cells</li><li>\u27a4 (Ref: Robbins 10 th / 640)</li><li>\u27a4 (Ref: Robbins 10 th / 640)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "15da5b09",
      "audio": ""
    },
    {
      "text": "A 18-year-old Afro American boy presenting with a non healing ulcer of the foot, with recurrent pneumonia and chronic hemolytic anemia. The peripheral blood erythrocytes showed some peculiar appearance. Most likely cause is:",
      "options": [
        {
          "label": "A",
          "text": "Trinucleotide repeat",
          "correct": false
        },
        {
          "label": "B",
          "text": "Genomic imprinting \u200b\u200b\u200b\u200b\u200b\u200b",
          "correct": false
        },
        {
          "label": "C",
          "text": "Single amino acid base substitution",
          "correct": true
        },
        {
          "label": "D",
          "text": "Antibody to red cell membrane",
          "correct": false
        }
      ],
      "correct_answer": "C. Single amino acid base substitution",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Single amino acid base substitution</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Trinucleotide repeat expansions cause disorders such as Huntington's disease and some forms of muscular dystrophy , not sickle cell anemia.</li><li>\u2022 Option A. Trinucleotide repeat expansions</li><li>\u2022 Huntington's disease</li><li>\u2022 muscular dystrophy</li><li>\u2022 not sickle cell anemia.</li><li>\u2022 Option B. Genomic imprinting is a form of gene expression regulation that does not relate to the structural changes in hemoglobin seen in sickle cell anemia.</li><li>\u2022 Option B. Genomic imprinting is a form of gene expression regulation</li><li>\u2022 Option D. Antibody to red cell membrane would suggest an autoimmune hemolytic anemia rather than a genetically determined structural hemoglobinopathy.</li><li>\u2022 Option D. Antibody to red cell membrane would suggest</li><li>\u2022 autoimmune</li><li>\u2022 genetically</li><li>\u2022 structural hemoglobinopathy.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Sickle cell anemia is caused by a single amino acid substitution ( valine for glutamic acid) at the sixth position of the \u03b2-globin chain of hemoglobin, which results in the sickling of red cells and related complications.</li><li>\u27a4 Sickle cell anemia</li><li>\u27a4 single amino acid substitution</li><li>\u27a4 valine for glutamic acid)</li><li>\u27a4 sixth</li><li>\u27a4 \u03b2-globin chain</li><li>\u27a4 sickling of red cells</li><li>\u27a4 Ref : Robbins 10 th / 648</li><li>\u27a4 Ref : Robbins 10 th / 648</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "27e96dd2",
      "audio": ""
    },
    {
      "text": "A 56-year\u2011old female presents in the month of December with chronic fatigue and cyanosis of nose with blue lips. A peripheral blood smear showed the following image. What is the most likely cause of the findings seen?",
      "options": [
        {
          "label": "A",
          "text": "Clumps of RBCs due to IgM mediated cold autoim\u00admune haemolytic anemia",
          "correct": true
        },
        {
          "label": "B",
          "text": "Clumps of RBCs due to IgG mediated warm auto\u00adimmune haemolytic anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "RBC lysis due to hemoglobinopathy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Clumps of RBCs due to IgG mediated cold autoim\u00admune haemolytic anemia \u200b\u200b\u200b\u200b\u200b\u200b",
          "correct": false
        }
      ],
      "correct_answer": "A. Clumps of RBCs due to IgM mediated cold autoim\u00admune haemolytic anemia",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/26/picture1_67TV6O2.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Clumps of RBCs due to IgM mediated cold autoimmune haemolytic anemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Warm autoimmune hemolytic anemia (WAIHA) involves IgG antibodies that react with red blood cells at body temperature, leading to their destruction by the spleen . This would not typically be associated with cold exposure and is not consistent with the symptom of cyanosis, which is related to cold.</li><li>\u2022 Option B. Warm autoimmune</li><li>\u2022 IgG antibodies</li><li>\u2022 at body temperature,</li><li>\u2022 spleen</li><li>\u2022 Option C. Hemoglobinopathies, such as sickle cell disease , can cause hemolytic anemia , but the red blood cells do not clump in response to cold. Instead, hemoglobinopathies typically involve structural abnormalities of the hemoglobin molecule itself.</li><li>\u2022 Option C. Hemoglobinopathies,</li><li>\u2022 sickle cell disease</li><li>\u2022 hemolytic anemia</li><li>\u2022 red blood cells do not clump in</li><li>\u2022 response to cold.</li><li>\u2022 structural abnormalities of the hemoglobin molecule itself.</li><li>\u2022 Option D. Cold agglutinin disease can sometime s involve IgG antibodies , but it is more commonly associated with IgM antibodies. IgG-mediated hemolysis at cold temperatures is much less common and would not explain the typical clumping seen in CAHA.</li><li>\u2022 Option D. Cold agglutinin</li><li>\u2022 sometime</li><li>\u2022 IgG antibodies</li><li>\u2022 more commonly associated with IgM antibodies.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 It is important to recognize the clinical and laboratory findings consistent with cold autoimmune hemolytic anemia (CAHA), where IgM antibodies bind to red blood cells at low temperatures , causing them to agglutinate . This can lead to hemolytic anemia , resulting in symptoms such as chronic fatigue and cyanosis upon cold exposure.</li><li>\u27a4 cold autoimmune hemolytic anemia (CAHA),</li><li>\u27a4 IgM antibodies bind to red blood cells at low temperatures</li><li>\u27a4 to agglutinate</li><li>\u27a4 hemolytic anemia</li><li>\u27a4 chronic fatigue and cyanosis</li><li>\u27a4 Ref : Robbins 10 th / 643-4</li><li>\u27a4 Ref : Robbins 10 th / 643-4</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9e37c945",
      "audio": ""
    },
    {
      "text": "All of the following if present provide protection against malaria except:",
      "options": [
        {
          "label": "A",
          "text": "Duffy blood group",
          "correct": true
        },
        {
          "label": "B",
          "text": "Sickle cell anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thalassemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "G6PD deficiency",
          "correct": false
        }
      ],
      "correct_answer": "A. Duffy blood group",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Duffy blood group</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Sickle cell disease: P falciparum cannot multiply properly in the presence of HbS \u03b1 and \u03b2 thalassemia:</li><li>\u2022 Option B. Sickle cell disease:</li><li>\u2022 HbS \u03b1 and \u03b2 thalassemia:</li><li>\u2022 Option D. G6 PD deficiency: G6PD is required for respiration of plas\u00acmodium</li><li>\u2022 Option D. G6 PD deficiency:</li><li>\u2022 respiration of plas\u00acmodium</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The absence of the Duffy blood group, the trait for sickle cell disease, thalassemia traits, and G6PD deficiency are all known to confer some protection against malaria due to various mechanisms that interfere with the parasite's ability to infect or survive within red blood cells . However, the Duffy blood group's absence , while protective against Plasmodium vivax , does not provide protection against P. falciparum, the most common and virulent cause of malaria.</li><li>\u27a4 absence of the Duffy blood group, the trait for sickle cell disease, thalassemia traits, and G6PD deficiency</li><li>\u27a4 against malaria</li><li>\u27a4 parasite's ability to infect or survive within red blood cells</li><li>\u27a4 Duffy blood group's absence</li><li>\u27a4 against Plasmodium vivax</li><li>\u27a4 does not provide protection against P. falciparum, the most common and virulent cause of malaria.</li><li>\u27a4 Ref : Robbins 10 th / 403</li><li>\u27a4 Ref : Robbins 10 th / 403</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "623437c4",
      "audio": ""
    },
    {
      "text": "A 50-year-old male presents with fatigue and widespread purpura. Blood work reveals a marked decrease in platelets, with counts persistently below 20,000/\u00b5L. The patient's history includes recurrent epistaxis and one instance of hematuria. Bone marrow biopsy reveals a hypocellular marrow with a markedly reduced number of megakaryocytes. All of the following can cause megakaryocytic thrombocytopenia, except:",
      "options": [
        {
          "label": "A",
          "text": "Idiopathic thrombocytopenia purpura",
          "correct": false
        },
        {
          "label": "B",
          "text": "Systemic lupus erythematosus",
          "correct": false
        },
        {
          "label": "C",
          "text": "Aplastic anemia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Disseminated intravascular coagulation (DIC)",
          "correct": false
        }
      ],
      "correct_answer": "C. Aplastic anemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Aplastic anemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Idiopathic thrombocytopenic purpura [ITP]: ITP is characterized by autoimmune destruction of platelets . It typically presents with isolated thrombocytopenia and may show an increased number of megakaryocytes in the bone marrow due to compensatory production.</li><li>\u2022 Option A. Idiopathic thrombocytopenic purpura [ITP]:</li><li>\u2022 autoimmune destruction of platelets</li><li>\u2022 Option B. Systemic lupus erythematosus [SLE]: SLE can cause thrombocytopenia due to autoantibody-mediated platelet destruction . Megakaryocytes may be increased in the bone marrow as the body tries to compensate for the peripheral platelet destruction.</li><li>\u2022 Option B. Systemic lupus erythematosus [SLE]:</li><li>\u2022 cause thrombocytopenia</li><li>\u2022 autoantibody-mediated platelet destruction</li><li>\u2022 Option D. Disseminated intravascular coagulation [DIC]: DIC is a condition that leads to the systemic activation of the coagulation cascade , resulting in widespread microthrombi and secondary consumption of platelets and coagulation factors . This can also lead to a compensatory increase in megakaryocytes in the bone marrow.</li><li>\u2022 Option D. Disseminated intravascular coagulation [DIC]:</li><li>\u2022 leads to the systemic activation of the coagulation cascade</li><li>\u2022 widespread microthrombi</li><li>\u2022 secondary consumption of platelets</li><li>\u2022 coagulation factors</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In megakaryocytic thrombocytopenia , there is an increase in bone marrow megakaryocytes as a compensatory mechanism for peripheral platelet destruction , but in aplastic anemia, there is bone marrow failure and reduced megakaryocytes.</li><li>\u27a4 megakaryocytic thrombocytopenia</li><li>\u27a4 increase in bone marrow megakaryocytes</li><li>\u27a4 compensatory mechanism</li><li>\u27a4 peripheral platelet destruction</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5cce1c6d",
      "audio": ""
    },
    {
      "text": "All are true about thrombotic thrombocytopenic purpura except?",
      "options": [
        {
          "label": "A",
          "text": "Microangiopathic hemolytic anemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thrombocytopenia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Normal complement level",
          "correct": false
        },
        {
          "label": "D",
          "text": "Grossly abnormal coagulation tests",
          "correct": true
        }
      ],
      "correct_answer": "D. Grossly abnormal coagulation tests",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Grossly abnormal coagulation tests</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Microangiopathic hemolytic anemia: True . TTP is associated with the formation of microclots that damage red blood cells , leading to hemolysis.</li><li>\u2022 Option A. Microangiopathic hemolytic anemia:</li><li>\u2022 True</li><li>\u2022 TTP</li><li>\u2022 microclots that damage red blood cells</li><li>\u2022 hemolysis.</li><li>\u2022 Option B. Thrombocytopenia: True . TTP is characterized by low platelet counts due to the formation of platelet-rich microclots.</li><li>\u2022 Option B. Thrombocytopenia:</li><li>\u2022 True</li><li>\u2022 TTP</li><li>\u2022 low platelet counts</li><li>\u2022 platelet-rich microclots.</li><li>\u2022 Option C. Normal complement level: True . Unlike other conditions such as hemolytic uremic syndrome (HUS), TTP is not typically associated with complement activation, so complement levels are generally normal .</li><li>\u2022 Option C. Normal complement level:</li><li>\u2022 True</li><li>\u2022 hemolytic uremic syndrome (HUS), TTP is not</li><li>\u2022 complement activation,</li><li>\u2022 normal</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 TTP doesn't grossly affect the standard coagulation tests . So, the coagulation tests such as PT (prothrombin time) and APTT (activated partial thromboplastin time) are typically normal . Direct lines from Robbins\u2026 \u201cIf coagulation tests indicate a major consumption of procoagulants, the diagnosis of TTP is doubtful \u201d.</li><li>\u2022 TTP doesn't</li><li>\u2022 affect the standard coagulation tests</li><li>\u2022 coagulation tests</li><li>\u2022 PT</li><li>\u2022 APTT</li><li>\u2022 normal</li><li>\u2022 coagulation tests</li><li>\u2022 major consumption of procoagulants,</li><li>\u2022 TTP is doubtful</li><li>\u2022 Ref : Robbins 10 th / 665</li><li>\u2022 Ref</li><li>\u2022 : Robbins 10 th / 665</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b47ebf21",
      "audio": ""
    },
    {
      "text": "A newborn baby presented with profuse bleeding from the umbilical stump after birth. Rest of the examination and PT, APTT are within normal limits. Most likely diagnosis is which of the following?",
      "options": [
        {
          "label": "A",
          "text": "Factor X deficiency",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glanzmann\u2019s thrombasthenia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Von Willebrand disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Bernard Soulier disease",
          "correct": false
        }
      ],
      "correct_answer": "B. Glanzmann\u2019s thrombasthenia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Glanzmann\u2019s thrombasthenia > (d) Bernard Soulier disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Factor X deficiency: Factor X deficiency is a rare bleeding disorder where the clotting factor X is either deficient or not functioning properly . It typically presents with a prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), which are not normal in this case.</li><li>\u2022 Option A. Factor X deficiency:</li><li>\u2022 rare bleeding disorder</li><li>\u2022 clotting factor X</li><li>\u2022 deficient or not functioning properly</li><li>\u2022 prolonged prothrombin time</li><li>\u2022 activated partial thromboplastin time</li><li>\u2022 Option C. von Willebrand disease: Von Willebrand disease is the most common hereditary bleeding disorder and is caused by a qualitative or quantitative deficiency of von Willebrand factor (vWF). vWF is crucial for platelet adhesion; however, PT and aPTT can be normal in mild cases, but there's often an abnormal bleeding time or abnormal vWF assays.</li><li>\u2022 Option C. von Willebrand disease:</li><li>\u2022 most common hereditary bleeding disorder</li><li>\u2022 qualitative or quantitative deficiency of von Willebrand factor</li><li>\u2022 Option D. Bernard-Soulier disease: Bernard-Soulier syndrome is another rare platelet disorder , caused by a deficiency or dysfunction of the platelet glycoprotein Ib-IX-V complex , important for platelet adhesion to the vascular subendothelium. Similar to Glanzmann\u2019s thrombasthenia, PT and aPTT are normal, but the platelet function is impaired, leading to bleeding.</li><li>\u2022 Option D. Bernard-Soulier disease:</li><li>\u2022 rare platelet disorder</li><li>\u2022 deficiency or dysfunction of the platelet glycoprotein Ib-IX-V complex</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The presence of normal PT and aPTT despite bleeding symptoms points towards a platelet function disorder rather than a clotting factor deficiency . Glanzmann\u2019s thrombasthenia and Bernard-Soulier syndrome are both characterized by normal coagulation tests and abnormal platelet function ; however, Glanzmann\u2019s thrombasthenia is generally considered more likely when these two conditions are indistinguishable based on clinical and laboratory findings.</li><li>\u27a4 presence of normal PT</li><li>\u27a4 aPTT despite bleeding symptoms</li><li>\u27a4 platelet function disorder</li><li>\u27a4 clotting factor deficiency</li><li>\u27a4 Glanzmann\u2019s thrombasthenia</li><li>\u27a4 Bernard-Soulier syndrome</li><li>\u27a4 normal coagulation tests</li><li>\u27a4 abnormal platelet function</li><li>\u27a4 Ref : Wintrobe\u2019s 12th/1365-1370</li><li>\u27a4 Ref</li><li>\u27a4 : Wintrobe\u2019s 12th/1365-1370</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7b1e1a16",
      "audio": ""
    },
    {
      "text": "A 25 years old asymptomatic pregnant female underwent a pre-op coagulation test. Her bleeding time is 3 minutes, PT is 15/14sec, a PTT is 45/35 sec, platelet count is 2.5 lac/ mm 3 and factor VIII levels were 60IU/dL. What is her most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Factor IX deficiency",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lupus anticoagulant",
          "correct": false
        },
        {
          "label": "C",
          "text": "Factor VIII inhibitors",
          "correct": true
        },
        {
          "label": "D",
          "text": "VWD \u2013 Type III",
          "correct": false
        }
      ],
      "correct_answer": "C. Factor VIII inhibitors",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Factor VIII inhibitors</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Factor IX deficiency: Factor IX deficiency, also known as Hemophilia B or Christmas disease , is a bleeding disorder caused by a deficiency of clotting factor IX . It is an X-linked recessive disorder , making it much less likely in females . It presents with a prolonged aPTT but normal PT and bleeding time , which does not fully match the patient's profile since her PT and bleeding time are within normal limits.</li><li>\u2022 Option A. Factor IX deficiency:</li><li>\u2022 Hemophilia B</li><li>\u2022 Christmas disease</li><li>\u2022 bleeding disorder</li><li>\u2022 deficiency of clotting factor IX</li><li>\u2022 X-linked recessive disorder</li><li>\u2022 less likely in females</li><li>\u2022 prolonged aPTT</li><li>\u2022 normal PT</li><li>\u2022 bleeding time</li><li>\u2022 Option B. Lupus anticoagulant: The presence of lupus anticoagulant, an autoimmune inhibitor , is associated with prolonged aPTT and may also lead to a prolonged PT . It is part of the antiphospholipid syndrome and can cause both bleeding and thrombotic episodes. Patients often have thrombocytopenia, which is not the case here as the patient has a normal platelet count.</li><li>\u2022 Option B. Lupus anticoagulant:</li><li>\u2022 autoimmune inhibitor</li><li>\u2022 prolonged aPTT</li><li>\u2022 lead to a prolonged PT</li><li>\u2022 Option D. VWD \u2013 Type III: Von Willebrand Disease (VWD) Type III is the most severe form of VWD and is characterized by a markedly reduced or absent von Willebrand factor , leading to a significant bleeding tendency . Patients usually have a prolonged bleeding time and a decreased factor VIII activity, which is not consistent with this patient's normal bleeding time and near-normal factor VIII levels.</li><li>\u2022 Option D. VWD \u2013 Type III:</li><li>\u2022 most severe form of VWD</li><li>\u2022 markedly reduced</li><li>\u2022 absent von Willebrand factor</li><li>\u2022 bleeding tendency</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 This patient\u2019s normal bleeding time and PT but prolonged aPTT, along with the presence of normal factor VIII activity , suggest the presence of an inhibitor against factor VIII rather than a deficiency, which is consistent with acquired hemophilia .</li><li>\u27a4 normal bleeding time</li><li>\u27a4 PT but prolonged aPTT,</li><li>\u27a4 presence of normal factor VIII activity</li><li>\u27a4 presence of an inhibitor against factor VIII</li><li>\u27a4 acquired hemophilia</li><li>\u27a4 Ref : Robbins 10 th 672-3, Wintrobe 12th/1447-1453, Har\u00adrison 21 st /980</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th 672-3, Wintrobe 12th/1447-1453, Har\u00adrison 21 st /980</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9f4bd604",
      "audio": ""
    },
    {
      "text": "True about prothrombin time to:",
      "options": [
        {
          "label": "A",
          "text": "Immediate refrigeration to preserve factor viability",
          "correct": false
        },
        {
          "label": "B",
          "text": "Platelet-rich plasma is essential",
          "correct": false
        },
        {
          "label": "C",
          "text": "Done within 2 hours",
          "correct": true
        },
        {
          "label": "D",
          "text": "Activated with kaolin",
          "correct": false
        }
      ],
      "correct_answer": "C. Done within 2 hours",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture1_R5zNr7B.jpg"
      ],
      "explanation": "<p><strong>Ans. C) Done within 2 hours</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Immediate refrigeration to preserve factor viability: While it's true that certain coagulation factors are temperature sensitive , prothrombin time (PT) testing typically requires the sample to be kept at room temperature to prevent the cold activation of factors and potential precipitation of fibrinogen. Immediate refrigeration is not required for PT.</li><li>\u2022 Option A. Immediate refrigeration to preserve factor viability:</li><li>\u2022 coagulation factors</li><li>\u2022 temperature sensitive</li><li>\u2022 prothrombin time</li><li>\u2022 testing</li><li>\u2022 kept at room temperature</li><li>\u2022 prevent the cold activation of factors</li><li>\u2022 Option B. Platelet-rich plasma is essential: PT is actually performed on platelet-poor plasma , not platelet-rich plasma. The presence of platelets can affect the test results by providing phospholipid surfaces that could artificially shorten the clotting time.</li><li>\u2022 Option B. Platelet-rich plasma is essential:</li><li>\u2022 PT</li><li>\u2022 performed</li><li>\u2022 platelet-poor plasma</li><li>\u2022 Option D. Activated with kaolin: PT is not activated with kaolin . Instead, thromboplastin (a combination of tissue factor and phospholipids) is used to activate the extrinsic pathway of coagulation . Kaolin is used as an activator in the activated partial thromboplastin time (aPTT) test, which evaluates the intrinsic pathway.</li><li>\u2022 Option D. Activated with kaolin:</li><li>\u2022 PT</li><li>\u2022 not activated with kaolin</li><li>\u2022 thromboplastin</li><li>\u2022 activate the extrinsic pathway of coagulation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The PT test must be done on platelet-poor plasma and usually within 2 hours of sample collection to ensure accurate results , using thromboplastin for activation.</li><li>\u27a4 PT test</li><li>\u27a4 done on platelet-poor plasma</li><li>\u27a4 within 2 hours of sample collection</li><li>\u27a4 accurate results</li><li>\u27a4 thromboplastin for activation.</li><li>\u27a4 Ref : Dacie and Lewis practical hematology 10th/392, 398</li><li>\u27a4 Ref</li><li>\u27a4 : Dacie and Lewis practical hematology 10th/392, 398</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8418ebf2",
      "audio": ""
    },
    {
      "text": "Patient with bleeding due to platelet function defects has which of the following features?",
      "options": [
        {
          "label": "A",
          "text": "Normal platelet count and normal bleeding time",
          "correct": false
        },
        {
          "label": "B",
          "text": "Normal platelet count and increased bleeding time",
          "correct": true
        },
        {
          "label": "C",
          "text": "Decreased platelet count and increased bleeding time",
          "correct": false
        },
        {
          "label": "D",
          "text": "Normal platelet count and decreased bleeding time",
          "correct": false
        }
      ],
      "correct_answer": "B. Normal platelet count and increased bleeding time",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Normal platelet count and increased</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Normal platelet count and normal bleeding time: This option would suggest no defect in platelet function or number , which would not typically be associated with a bleeding disorder.</li><li>\u2022 Option A. Normal platelet count and normal bleeding time:</li><li>\u2022 no defect in platelet function</li><li>\u2022 number</li><li>\u2022 Option C. Decreased platelet count and increased bleeding time: This suggests a quantitative defect of platelets , such as thrombocytopenia , rather than a functional defect. Although patients with thrombocytopenia will also have an increased bleeding time, the platelet count in functional defects remains normal.</li><li>\u2022 Option C. Decreased platelet count and increased bleeding time:</li><li>\u2022 quantitative defect of platelets</li><li>\u2022 thrombocytopenia</li><li>\u2022 Option D. Normal platelet count and decreased bleeding time: A decreased bleeding time indicates an efficient clotting process , which would not align with platelet function defects.</li><li>\u2022 Option D. Normal platelet count and decreased bleeding time:</li><li>\u2022 decreased bleeding time</li><li>\u2022 efficient clotting process</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Platelet function defects present with a normal platelet count but impaired function , leading to an increased bleeding time , whereas quantitative disorders would show an altered platelet count .</li><li>\u27a4 Platelet function defects</li><li>\u27a4 normal platelet count</li><li>\u27a4 impaired function</li><li>\u27a4 increased bleeding time</li><li>\u27a4 quantitative disorders</li><li>\u27a4 altered platelet count</li><li>\u27a4 Ref : Robbins 10 th / 655</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 655</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b1009c29",
      "audio": ""
    },
    {
      "text": "A 9-year-old boy with no significant past medical history is brought to the pediatrician by his parents who are concerned about his recent onset of spontaneous bruising and a single episode of nose bleeding that took longer than expected to cease. The child has no known allergies, and there is no family history of bleeding disorders. On physical examination, the paediatrician notes several bruises of varying sizes on his legs and arms, as well as petechiae on his ankles. Initial laboratory tests reveal an elevated prothrombin time (PT) and an elevated activated partial thromboplastin time (aPTT), but a normal platelet count and bleeding time (BT). What is the most likely defect in this child's coagulation pathway?",
      "options": [
        {
          "label": "A",
          "text": "Extrinsic pathway",
          "correct": false
        },
        {
          "label": "B",
          "text": "Intrinsic pathway",
          "correct": false
        },
        {
          "label": "C",
          "text": "Platelet function",
          "correct": false
        },
        {
          "label": "D",
          "text": "Common pathway",
          "correct": true
        }
      ],
      "correct_answer": "D. Common pathway",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Common pathway</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Extrinsic pathway: A defect in the extrinsic pathway would typically lead to an isolated elevation of PT , as this pathway is evaluated by the PT test. This does not explain the elevated aPTT observed in the patient.</li><li>\u2022 Option A. Extrinsic pathway:</li><li>\u2022 lead to an isolated elevation of PT</li><li>\u2022 Option B. Intrinsic pathway: A defect in the intrinsic pathway would typically result in an isolated elevation of aPTT , as this pathway is evaluated by the aPTT test. This also does not explain the elevated PT observed in the patient.</li><li>\u2022 Option B. Intrinsic pathway:</li><li>\u2022 result in an isolated elevation of aPTT</li><li>\u2022 Option C. Platelet function: Platelet function defects usually result in a prolonged bleeding time (BT) and normal coagulation tests (PT and aPTT). Since the patient has a normal BT, this is unlikely to be the correct diagnosis.</li><li>\u2022 Option C. Platelet function:</li><li>\u2022 prolonged bleeding time</li><li>\u2022 normal coagulation tests</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Defect in the extrinsic pathway causes elevation of PT Defect in the intrinsic pathway causes elevation of aPTT . Defect in common pathway cause elevation of both PT and aPTT . Platelet function defect causes elevation of BT .</li><li>\u27a4 Defect in the extrinsic pathway causes elevation of PT</li><li>\u27a4 extrinsic pathway</li><li>\u27a4 PT</li><li>\u27a4 Defect in the intrinsic pathway causes elevation of aPTT .</li><li>\u27a4 intrinsic pathway</li><li>\u27a4 aPTT</li><li>\u27a4 Defect in common pathway cause elevation of both PT and aPTT .</li><li>\u27a4 common pathway</li><li>\u27a4 both PT and aPTT</li><li>\u27a4 Platelet function defect causes elevation of BT .</li><li>\u27a4 Platelet function defect</li><li>\u27a4 BT</li><li>\u27a4 Ref : Robbins 10 th / 120</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 120</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ea0223c7",
      "audio": ""
    },
    {
      "text": "A 4-year-old boy is brought to the clinic with a history of recurrent ear infections, easy bruising, and severe eczema. On examination, the child has widespread petechiae and a weeping rash over his arms and legs. Laboratory tests reveal thrombocytopenia with an average platelet volume less than the reference range. The boy's immunoglobulin levels are also noted to be abnormally low. The presence of small sized platelets on the peripheral smear is characteristic of:",
      "options": [
        {
          "label": "A",
          "text": "Idiopathic thrombocytopenia purpura (ITP)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bernard Soulier syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Disseminated intravascular coagulation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Wiskott Aldrich syndrome",
          "correct": true
        }
      ],
      "correct_answer": "D. Wiskott Aldrich syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Wiskott Aldrich syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Idiopathic thrombocytopenic purpura [ITP]: ITP is characterized by autoimmune destruction of platelets , typically leading to thrombocytopenia with normal-sized platelets and no associated eczema or immunodeficiency.</li><li>\u2022 Option A. Idiopathic thrombocytopenic purpura [ITP]:</li><li>\u2022 autoimmune destruction of platelets</li><li>\u2022 thrombocytopenia with normal-sized platelets</li><li>\u2022 Option B. Bernard-Soulier syndrome: Bernard-Soulier syndrome is a platelet function disorder due to a deficiency in glycoprotein Ib, the platelet receptor for von Willebrand factor . Patients may have thrombocytopenia with large platelets and no associated eczema or immunodeficiency.</li><li>\u2022 Option B. Bernard-Soulier syndrome:</li><li>\u2022 platelet function disorder</li><li>\u2022 glycoprotein Ib,</li><li>\u2022 von Willebrand factor</li><li>\u2022 thrombocytopenia</li><li>\u2022 Option C. Disseminated intravascular coagulation [DIC]: DIC is a secondary condition resulting from another underlying disease . It is characterized by widespread activation of coagulation , which can lead to the consumption of platelets and coagulation factors . Platelet size is typically not affected, and it is not associated with eczema or immunodeficiency.</li><li>\u2022 Option C. Disseminated intravascular coagulation [DIC]:</li><li>\u2022 underlying disease</li><li>\u2022 activation of coagulation</li><li>\u2022 consumption of platelets and coagulation factors</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The characteristic features of Wiskott-Aldrich syndrome , include thrombocytopenia with small platelets, eczema, and recurrent infections due to immunodeficiency.</li><li>\u27a4 Wiskott-Aldrich syndrome</li><li>\u27a4 thrombocytopenia with small platelets, eczema, and recurrent infections</li><li>\u27a4 Ref : Robbins 10 th / 243</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 243</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7ab63300",
      "audio": ""
    },
    {
      "text": "A 28-year-old female presents with easy bruising and prolonged bleeding after minor injuries. She has a family history of bleeding disorders. Which of the following is caused by VWF factor deficiency?",
      "options": [
        {
          "label": "A",
          "text": "Reduced platelet function",
          "correct": false
        },
        {
          "label": "B",
          "text": "Reduced factor VIII in plasma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Defective platelet adhesion",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) All of the above</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Reduced Platelet aggregation: True . VWF plays a crucial role in platelet adhesion by binding to platelets and stabilizing the interaction between platelets and the damaged blood vessel wall . Its reduced levels lead to reduced platelet functioning .</li><li>\u2022 Option A. Reduced Platelet aggregation:</li><li>\u2022 True</li><li>\u2022 platelet adhesion by binding to platelets</li><li>\u2022 platelets and the damaged blood vessel wall</li><li>\u2022 reduced levels lead to reduced platelet functioning</li><li>\u2022 Option B. Reduced factor VIII in plasma: True . VWF serves as a carrier protein for factor VIII , protecting it from rapid clearance and degradation . Therefore, a deficiency in VWF can result in decreased levels of factor VIII in the plasma.</li><li>\u2022 Option B. Reduced factor VIII in plasma:</li><li>\u2022 True</li><li>\u2022 carrier protein for factor VIII</li><li>\u2022 clearance and degradation</li><li>\u2022 decreased levels of factor VIII</li><li>\u2022 Option C. Defective platelet adhesion : True . VWF is essential for the initial adhesion of platelets to the damaged blood vessel wall , facilitating the formation of a stable plug at the site of injury.</li><li>\u2022 Option C. Defective platelet adhesion</li><li>\u2022 True</li><li>\u2022 adhesion of platelets to the damaged blood vessel wall</li><li>\u2022 stable plug at the site of injury.</li><li>\u2022 So, the correct answer is (d) All of the above. Von Willebrand factor deficiency affects both platelet function and factor VIII levels in the plasma .</li><li>\u2022 Von Willebrand factor deficiency</li><li>\u2022 platelet function and factor VIII levels in the plasma</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 VWF deficiency impairs platelet adhesion and aggregation at the site of vascular injury, and reduces the plasma level of factor VIII by decreasing its stability in circulation.</li><li>\u2022 platelet adhesion and aggregation</li><li>\u2022 vascular injury,</li><li>\u2022 reduces the plasma level of factor VIII</li><li>\u2022 decreasing its stability</li><li>\u2022 Ref : Robbins 10 th / 660</li><li>\u2022 Ref</li><li>\u2022 : Robbins 10 th / 660</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "93fd9ad1",
      "audio": ""
    },
    {
      "text": "A 22-year-old male presents with a history of recurrent nosebleeds, easy bruising, and prolonged bleeding after minor injuries. He has a deficiency of glycoprotein IIb-IIIa complex. Glycoprotein IIb-IIIa complex is deficient in which of the following conditions?",
      "options": [
        {
          "label": "A",
          "text": "Bernard Soulier syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glanzmann disease",
          "correct": true
        },
        {
          "label": "C",
          "text": "Von willebrand disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Gray platelet syndrome",
          "correct": false
        }
      ],
      "correct_answer": "B. Glanzmann disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Glanzmann disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Bernard Soulier syndrome is associated with a deficiency of glycoprotein Ib-IX-V complex .</li><li>\u2022 Option A.</li><li>\u2022 Bernard Soulier syndrome</li><li>\u2022 glycoprotein Ib-IX-V complex</li><li>\u2022 Option C. von Willebrand disease is associated with deficiencies or dysfunction of von Willebrand factor , not the glycoprotein IIb-IIIa complex.</li><li>\u2022 Option C.</li><li>\u2022 von Willebrand disease</li><li>\u2022 von Willebrand factor</li><li>\u2022 Option D. Gray platelet syndrome is a rare platelet disorder characterized by grayish platelets and a deficiency of alpha-granules.</li><li>\u2022 Option D.</li><li>\u2022 Gray platelet syndrome</li><li>\u2022 rare platelet disorder</li><li>\u2022 grayish platelets and a deficiency of alpha-granules.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Glycoprotein IIb-IIIa complex is deficient in Glanzmann\u2019s disease .</li><li>\u2022 Glycoprotein IIb-IIIa complex</li><li>\u2022 Glanzmann\u2019s disease</li><li>\u2022 Ref : Robbins 10 th /120</li><li>\u2022 Ref</li><li>\u2022 : Robbins 10 th /120</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0cd83d85",
      "audio": ""
    },
    {
      "text": "A 32-year-old woman with a diagnosis of chronic immune thrombocytopenic purpura (ITP) returns for a follow-up visit. She previously responded well to a course of glucocorticoids but presented again with petechiae and a platelet count of 25,000/\u03bcL. She has no splenomegaly on examination. All the following statements are correct about treatment in chronic immune thrombocytopenic purpura except:",
      "options": [
        {
          "label": "A",
          "text": "Most of the patients respond to immunosuppressive doses of glucocorticoids",
          "correct": false
        },
        {
          "label": "B",
          "text": "Relapse is rare",
          "correct": true
        },
        {
          "label": "C",
          "text": "Splenectomy is the treatment of choice for relapse",
          "correct": false
        },
        {
          "label": "D",
          "text": "Minority have refractory forms of ITP and difficult to treat",
          "correct": false
        }
      ],
      "correct_answer": "B. Relapse is rare",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Relapse is rare</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A . While initial treatment with glucocorticoids can be effective, many patients with chronic ITP may not achieve sustained remission and can experience relapses.</li><li>\u2022 Option A</li><li>\u2022 glucocorticoids</li><li>\u2022 chronic ITP</li><li>\u2022 not</li><li>\u2022 remission and can experience relapses.</li><li>\u2022 Option C. Splenectomy is typically considered after glucocorticoids and other medical therapies have failed , making it not a first-line treatment, but rather a treatment for relapsed or refractory cases .</li><li>\u2022 Option C.</li><li>\u2022 Splenectomy</li><li>\u2022 after glucocorticoids and other medical therapies have failed</li><li>\u2022 relapsed or refractory cases</li><li>\u2022 Option D. Some patients with chronic ITP do not respond to conventional therapies or relapse following initial therapy , which may suggest a refractory form of the disease .</li><li>\u2022 Option D.</li><li>\u2022 chronic ITP</li><li>\u2022 conventional therapies or relapse following initial therapy</li><li>\u2022 refractory form of the disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Direct quote\u2026. \u201cAlmost all patients respond to gluco\u00adcorticoids (which inhibit phagocyte function), but many eventually relapse .\u201d</li><li>\u27a4 respond to gluco\u00adcorticoids</li><li>\u27a4 many eventually relapse</li><li>\u27a4 In individuals with severe thrombocytopenia, sple\u00adnectomy normalizes the platelet counts. Immunomodulatory agents such as intravenous immunoglobulin or anti-CD20 antibody (rituximab) are often effective in patients who relapse after splenectomy or for whom splenectomy is contraindicated.</li><li>\u27a4 In individuals with severe thrombocytopenia, sple\u00adnectomy normalizes the platelet counts.</li><li>\u27a4 severe thrombocytopenia, sple\u00adnectomy normalizes</li><li>\u27a4 platelet counts.</li><li>\u27a4 Immunomodulatory agents such as intravenous immunoglobulin or anti-CD20 antibody (rituximab) are often effective in patients who relapse after splenectomy or for whom splenectomy is contraindicated.</li><li>\u27a4 Immunomodulatory agents</li><li>\u27a4 intravenous immunoglobulin or anti-CD20 antibody (rituximab)</li><li>\u27a4 relapse after splenectomy</li><li>\u27a4 splenectomy is contraindicated.</li><li>\u27a4 Ref : Robbins 10 th / 659</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 659</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9bef974e",
      "audio": ""
    },
    {
      "text": "A 30-year-old male requires a blood transfusion after a severe car accident. He is known to have the Bombay phenotype. Prior to the transfusion, his blood sample is sent to the laboratory for compatibility testing. Based on his blood group, which of the following statements is incorrect?",
      "options": [
        {
          "label": "A",
          "text": "Lack of H, A and B antigen on RBCs",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lack of H, A and B substance in saliva",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lack of antigens of several blood group systems",
          "correct": true
        },
        {
          "label": "D",
          "text": "H, A and B antibody will always be present in se\u00adrum",
          "correct": false
        }
      ],
      "correct_answer": "C. Lack of antigens of several blood group systems",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Lack of antigens of several blood group systems</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. His red blood cells lack H, A, and B antigens: This statement is correct. Individuals with the Bombay blood group do not express A, B, or H antigens on their red blood cells due to a homozygous mutation in the H gene (hh genotype).</li><li>\u2022 Option A. His red blood cells lack H, A, and B antigens:</li><li>\u2022 correct.</li><li>\u2022 do not express A, B, or H antigens on their red blood cells</li><li>\u2022 (hh genotype).</li><li>\u2022 Option B. His saliva does not contain H, A, and B substances: This statement is correct. The lack of H antigen also affects the presence of these antigens in body fluids , including saliva , because the H antigen is a precursor for A and B antigen synthesis.</li><li>\u2022 Option B. His saliva does not contain H, A, and B substances:</li><li>\u2022 correct.</li><li>\u2022 antigens in body fluids</li><li>\u2022 saliva</li><li>\u2022 H antigen is a precursor for A and B antigen synthesis.</li><li>\u2022 Option D. His serum contains antibodies against H, A, and B antigens: This statement is correct . Because individuals with the Bombay phenotype do not express A, B, or H antigens on their red blood cells , they will form antibodies against these antigens if exposed.</li><li>\u2022 Option D. His serum contains antibodies against H, A, and B antigens:</li><li>\u2022 correct</li><li>\u2022 do not express A, B, or H antigens on their red blood cells</li><li>\u2022 antibodies against</li><li>\u2022 exposed.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Individuals with the Bombay phenotype lack A, B, and H antigens on their red blood cells and in their saliva, and their serum contains antibodies against these antigens.</li><li>\u27a4 Ref : Wintrobe\u2019s hematology 12th/635-6</li><li>\u27a4 Ref</li><li>\u27a4 : Wintrobe\u2019s hematology 12th/635-6</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "19d649b8",
      "audio": ""
    },
    {
      "text": "The anticoagulant of choice for anticoagulation testing:",
      "options": [
        {
          "label": "A",
          "text": "Heparin",
          "correct": false
        },
        {
          "label": "B",
          "text": "EDTA",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sodium oxalate",
          "correct": false
        },
        {
          "label": "D",
          "text": "3.2% trisodium citrate",
          "correct": true
        }
      ],
      "correct_answer": "D. 3.2% trisodium citrate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) 3.2% trisodium citrate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Heparin is an anticoagulant that acts by potentiating the activity of antithrombin III, thereby inhibiting thrombin and other coagulation factors. While heparin is commonly used in clinical settings for anticoagulation, it is not the anticoagulant of choice for anticoagulation testing, as it can interfere with clotting assays.</li><li>\u2022 Option A. Heparin</li><li>\u2022 anticoagulant</li><li>\u2022 activity of antithrombin III,</li><li>\u2022 inhibiting thrombin and</li><li>\u2022 other coagulation factors.</li><li>\u2022 used in clinical settings</li><li>\u2022 anticoagulation,</li><li>\u2022 not the anticoagulant of choice for anticoagulation testing,</li><li>\u2022 Option B. EDTA is an anticoagulant that chelates calcium ions , preventing the coagulation process by inhibiting clotting factors that depend on calcium . EDTA is commonly used for collecting blood samples for hematology studies, such as complete blood counts .</li><li>\u2022 Option B. EDTA</li><li>\u2022 anticoagulant</li><li>\u2022 chelates calcium ions</li><li>\u2022 preventing the coagulation</li><li>\u2022 inhibiting clotting factors</li><li>\u2022 calcium</li><li>\u2022 collecting blood samples for hematology studies,</li><li>\u2022 complete blood counts</li><li>\u2022 Option C. Sodium oxalate also chelates calcium ions , similar to EDTA , and is used for collecting blood samples for glucose testing (enolase acting as a glycolysis inhibitor).</li><li>\u2022 Option C. Sodium oxalate</li><li>\u2022 chelates calcium ions</li><li>\u2022 EDTA</li><li>\u2022 glucose testing (enolase acting as a glycolysis inhibitor).</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The anticoagulant of choice for anticoagulation testing is 3.2% trisodium citrate.</li><li>\u2022 anticoagulant of choice for anticoagulation</li><li>\u2022 3.2% trisodium citrate.</li><li>\u2022 Question Id-15404 Unique Key-Q7889064</li><li>\u2022 Question Id-15404 Unique Key-Q7889064</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d84486e3",
      "audio": ""
    },
    {
      "text": "As a primary healthcare worker, you collect blood samples to measure fasting blood glucose levels in a population screening for diabetes. To ensure accurate results, which anticoagulant should be used to prevent glycolysis in the sample during transport to the laboratory ?",
      "options": [
        {
          "label": "A",
          "text": "EDTA",
          "correct": false
        },
        {
          "label": "B",
          "text": "Heparin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Potassium oxalate + sodium fluoride",
          "correct": true
        },
        {
          "label": "D",
          "text": "Tri Sodium citrate",
          "correct": false
        }
      ],
      "correct_answer": "C. Potassium oxalate + sodium fluoride",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Potassium oxalate + sodium fluoride</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. EDTA: Ethylenediaminetetraacetic acid (EDTA) is commonly used as an anticoagulant in hematology for complete blood count testing but not for glucose estimation because it does not prevent glycolysis.</li><li>\u2022 Option A. EDTA:</li><li>\u2022 Ethylenediaminetetraacetic acid</li><li>\u2022 anticoagulant in hematology</li><li>\u2022 complete blood</li><li>\u2022 count testing</li><li>\u2022 Option B. Heparin: Heparin is an anticoagulant that prevents blood clotting by inhibiting thrombin but does not prevent glycolysis, so it is not the best choice for glucose testing.</li><li>\u2022 Option B. Heparin:</li><li>\u2022 anticoagulant</li><li>\u2022 inhibiting thrombin</li><li>\u2022 Option D. Tri Sodium citrate: Trisodium citrate is used mainly for coagulation tests and does not inhibit glycolysis , making it unsuitable for glucose estimation.</li><li>\u2022 Option D. Tri Sodium citrate:</li><li>\u2022 coagulation tests</li><li>\u2022 does not inhibit glycolysis</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Direct quote \u2018 enolase enzyme in the glycolysis is inhibited by fluoride , and when blood samples are taken for measurement of glucose , it is collected in tubes containing fluoride to inhibit glycolysis.\u2019</li><li>\u2022 enolase enzyme in the glycolysis is inhibited by fluoride</li><li>\u2022 blood samples</li><li>\u2022 glucose</li><li>\u2022 collected in tubes</li><li>\u2022 fluoride to inhibit glycolysis.\u2019</li><li>\u2022 Ref : Henry\u2019s 21 st /188, Harper 27th/152</li><li>\u2022 Ref</li><li>\u2022 : Henry\u2019s 21 st /188, Harper 27th/152</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4951d242",
      "audio": ""
    },
    {
      "text": "Most common blood transfusion reaction is:",
      "options": [
        {
          "label": "A",
          "text": "Febrile non-hemolytic transfusion reaction",
          "correct": true
        },
        {
          "label": "B",
          "text": "Hemolysis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Transmission of infections",
          "correct": false
        },
        {
          "label": "D",
          "text": "Electrolyte imbalance",
          "correct": false
        }
      ],
      "correct_answer": "A. Febrile non-hemolytic transfusion reaction",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Febrile non-hemolytic transfusion reaction</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Hemolysis: it is a serious but less common transfusion reaction. It occurs when red blood cells are destroyed, leading to the release of hemoglobin into the bloodstream . Hemolysis can be caused by various factors, including ABO incompatibility, improper storage , or bacterial contamination .</li><li>\u2022 Option B. Hemolysis:</li><li>\u2022 serious but less common</li><li>\u2022 red blood cells are destroyed,</li><li>\u2022 hemoglobin into the bloodstream</li><li>\u2022 various factors,</li><li>\u2022 ABO incompatibility, improper storage</li><li>\u2022 bacterial contamination</li><li>\u2022 Option C. Transmission of Infections: While the transmission of infections is a serious concern in blood transfusions, it is not the most common transfusion reaction. Stringent screening and testing procedures for donated blood have significantly reduced the risk of transmitting infections, making FNHTR more common.</li><li>\u2022 Option C. Transmission of Infections:</li><li>\u2022 serious concern in blood transfusions,</li><li>\u2022 not the most common</li><li>\u2022 Stringent screening and testing procedures for donated blood</li><li>\u2022 reduced</li><li>\u2022 transmitting infections,</li><li>\u2022 Option D. Electrolyte Imbalance: Electrolyte imbalances are not a common transfusion reaction. However, in some cases, transfusions with large volumes of blood or specific blood components can lead to electrolyte disturbances . This is not the primary or most common transfusion reaction.</li><li>\u2022 Option D.</li><li>\u2022 Electrolyte Imbalance:</li><li>\u2022 not</li><li>\u2022 transfusions with large volumes of blood or specific blood components</li><li>\u2022 electrolyte disturbances</li><li>\u2022 not the primary</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Most common blood transfusion reaction is Febrile non-hemolytic transfusion reaction.</li><li>\u2022 blood transfusion</li><li>\u2022 Febrile non-hemolytic transfusion reaction.</li><li>\u2022 Ref: Robbins 10 th 667</li><li>\u2022 Ref:</li><li>\u2022 Robbins 10 th 667</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "28c2c041",
      "audio": ""
    },
    {
      "text": "A 40-year-old male involved in a motor vehicle collision requires a massive transfusion due to severe hemorrhagic shock. He receives 15 units of packed red blood cells within a 24-hour period. Which of the following complications is likely to result after several units of blood have been transferred?",
      "options": [
        {
          "label": "A",
          "text": "Metabolic alkalosis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Metabolic acidosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Respiratory alkalosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Respiratory acidosis",
          "correct": false
        }
      ],
      "correct_answer": "A. Metabolic alkalosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Metabolic alkalosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Metabolic acidosis: While metabolic acidosis can be present initially due to hypoperfusion and lactic acidosis , the administration of several units of blood typically results in the correction of the acidosis, potentially overshooting into alkalosis due to the reasons mentioned above.</li><li>\u2022 Option B. Metabolic acidosis:</li><li>\u2022 due to hypoperfusion and lactic acidosis</li><li>\u2022 potentially overshooting into alkalosis</li><li>\u2022 Option C. Respiratory alkalosis: Respiratory alkalosis typically results from hyperventilation, which may occur in patients in pain or with anxiety , but it is not directly related to the transfusion of blood products.</li><li>\u2022 Option C. Respiratory alkalosis:</li><li>\u2022 hyperventilation,</li><li>\u2022 pain or with anxiety</li><li>\u2022 Option D. Respiratory acidosis: Respiratory acidosis is caused by hypoventilation and the accumulation of carbon dioxide in the blood. It is not a common complication associated with blood transfusion itself, unless there are underlying respiratory issues or transfusion-related complications affecting lung function.</li><li>\u2022 Option D. Respiratory acidosis:</li><li>\u2022 hypoventilation and the accumulation of carbon dioxide</li><li>\u2022 underlying respiratory issues or transfusion-related complications affecting lung function.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Massive Transfusion is defined as the need to transfuse from one to two times the patient\u2019s normal blood vol\u00adume . In a normal adult, this is equivalent to 10-20 units . Most common abnormality is metabolic alkalosis . It re\u00adsults from conversion of citrate (present in stored blood) and lactate (accumulated due to hypoperfusion) to bicar\u00adbonate.</li><li>\u27a4 Massive Transfusion</li><li>\u27a4 one to two times the patient\u2019s normal blood vol\u00adume</li><li>\u27a4 10-20 units</li><li>\u27a4 metabolic alkalosis</li><li>\u27a4 citrate (present in stored blood) and lactate (accumulated due to hypoperfusion) to bicar\u00adbonate.</li><li>\u27a4 Ref: Robbins 10 th / 668</li><li>\u27a4 Ref:</li><li>\u27a4 Robbins 10 th / 668</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b7e6bad6",
      "audio": ""
    },
    {
      "text": "A 58-year-old man with a history of hemophilia A requires a blood product transfusion during a surgical procedure. ABO incompatibility is not seen with:",
      "options": [
        {
          "label": "A",
          "text": "Fresh frozen plasma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Platelet rich plasma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Single donor platelets",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cryoprecipitate",
          "correct": true
        }
      ],
      "correct_answer": "D. Cryoprecipitate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Cryoprecipitate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Fresh frozen plasma: FFP contains all coagulation factors , including soluble ABO antigens . ABO incompatibility can lead to hemolytic reactions ; thus, it should be matched with the recipient's blood group .</li><li>\u2022 Option A. Fresh frozen plasma:</li><li>\u2022 coagulation factors</li><li>\u2022 ABO antigens</li><li>\u2022 ABO incompatibility</li><li>\u2022 hemolytic reactions</li><li>\u2022 matched</li><li>\u2022 recipient's blood group</li><li>\u2022 Option B. Platelet-rich plasma: PRP is derived from whole blood and retains the ABO antigens . Transfusion with incompatible PRP can also lead to hemolytic reactions.</li><li>\u2022 Option B. Platelet-rich plasma:</li><li>\u2022 whole blood and retains the ABO antigens</li><li>\u2022 incompatible PRP</li><li>\u2022 hemolytic reactions.</li><li>\u2022 Option C. Single donor platelets: Single donor platelets carry the donor's ABO antigens , and while the risk is lower compared to red cell transfusion, ABO compatibility is still preferred to minimize the risk of reaction.</li><li>\u2022 Option C. Single donor platelets:</li><li>\u2022 donor's ABO antigens</li><li>\u2022 lower compared to red cell transfusion, ABO compatibility</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 While ABO matching is ideal for all blood components , cryoprecipitate is the least likely to cause an ABO incompatibility reaction due to its low content of plasma and ABO antigens .</li><li>\u27a4 ABO matching</li><li>\u27a4 blood components</li><li>\u27a4 cryoprecipitate</li><li>\u27a4 ABO incompatibility reaction</li><li>\u27a4 low content of plasma</li><li>\u27a4 ABO antigens</li><li>\u27a4 Ref : Wintrobes 12 th /850</li><li>\u27a4 Ref</li><li>\u27a4 : Wintrobes 12 th /850</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "729a2ae9",
      "audio": ""
    },
    {
      "text": "A 55 years old male accident victim in casualty urgently needs blood. The blood bank is unable to determine his ABO group, as his red cell group and plasma group do not match. Emergency transfusion of the patient should be with:",
      "options": [
        {
          "label": "A",
          "text": "RBC corresponding to his red cell group and colloids/ crystalloid",
          "correct": false
        },
        {
          "label": "B",
          "text": "Whole blood corresponding to his plasma group",
          "correct": false
        },
        {
          "label": "C",
          "text": "O positive RBC and colloids/crystalloid",
          "correct": true
        },
        {
          "label": "D",
          "text": "AB negative whole blood",
          "correct": false
        }
      ],
      "correct_answer": "C. O positive RBC and colloids/crystalloid",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) O positive RBC and colloids/crystalloid</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. RBCs corresponding to his red cell group and colloids/crystalloid: While it might seem intuitive to use RBCs corresponding to his red cell group, in cases where there is a discrepancy and the patient's blood group cannot be confirmed, it is safer to use group O RBCs, which are considered universal donors .</li><li>\u2022 Option A. RBCs corresponding to his red cell group and colloids/crystalloid:</li><li>\u2022 discrepancy and the patient's blood group cannot be confirmed,</li><li>\u2022 safer to use group O RBCs,</li><li>\u2022 universal donors</li><li>\u2022 Option B. Whole blood corresponding to his plasma group: When the ABO group cannot be determined, using whole blood of a specific group is not recommended due to the risk of an ABO incompatibility reaction .</li><li>\u2022 Option B. Whole blood corresponding to his plasma group:</li><li>\u2022 not recommended</li><li>\u2022 ABO incompatibility reaction</li><li>\u2022 Option D. AB negative whole blood: AB negative blood is considered the universal plasma donor , not the universal RBC donor . This option could result in an ABO incompatibility reaction if the patient is not AB negative.</li><li>\u2022 Option D. AB negative whole blood:</li><li>\u2022 universal plasma donor</li><li>\u2022 not the universal RBC donor</li><li>\u2022 ABO incompatibility reaction if the patient is not AB negative.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 O positive RBCs can be used in males and non-childbearing potential females, with colloids or crystalloid solutions to manage volume, as this approach minimizes the risk of hemolytic transfusion reactions .</li><li>\u27a4 O positive RBCs</li><li>\u27a4 males and non-childbearing potential females, with colloids or crystalloid solutions</li><li>\u27a4 minimizes</li><li>\u27a4 hemolytic transfusion reactions</li><li>\u27a4 Ref: Wintrobes 12 th 836</li><li>\u27a4 Ref:</li><li>\u27a4 Wintrobes 12 th 836</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b2b1f724",
      "audio": ""
    },
    {
      "text": "Although more than 400 blood groups have been identified, the ABO blood system re-mains the most important in clinical medicine because:",
      "options": [
        {
          "label": "A",
          "text": "It was the first blood group system to be discovered",
          "correct": false
        },
        {
          "label": "B",
          "text": "It has four different blood group A, B, AB, O (H)",
          "correct": false
        },
        {
          "label": "C",
          "text": "ABO (H) antigens are present in most body tissues and fluids",
          "correct": false
        },
        {
          "label": "D",
          "text": "ABO (H) antibodies are invariably present in plasma when persons RBC lack the corresponding antigen",
          "correct": true
        }
      ],
      "correct_answer": "D. ABO (H) antibodies are invariably present in plasma when persons RBC lack the corresponding antigen",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) ABO (H) antibodies are invariably present in plasma when persons RBC lacks the corresponding antigen</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The presence of naturally occurring antibodies in individuals against ABO antigens they do not possess on their red blood cells is the critical factor that can lead to hemolytic reactions if incompatible blood is transfused.</li><li>\u27a4 antibodies</li><li>\u27a4 against ABO antigens</li><li>\u27a4 do not possess on their red blood cells</li><li>\u27a4 lead to hemolytic reactions</li><li>\u27a4 incompatible blood</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "960fcbfd",
      "audio": ""
    },
    {
      "text": "Carbohydrate present in blood group substance is:",
      "options": [
        {
          "label": "A",
          "text": "Fucose",
          "correct": true
        },
        {
          "label": "B",
          "text": "Deoxyribose",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ribulose",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ribose",
          "correct": false
        }
      ],
      "correct_answer": "A. Fucose",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Fucose</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Deoxyribose: Deoxyribose is a sugar found in DNA , not associated with the ABO blood group antigens.</li><li>\u2022 Option B. Deoxyribose:</li><li>\u2022 sugar found in DNA</li><li>\u2022 Option C. Ribulose: Ribulose is a pentose sugar involved in metabolic pathways, like the pentose phosphate pathway, but it is not related to blood group antigen formation.</li><li>\u2022 Option C. Ribulose:</li><li>\u2022 pentose sugar</li><li>\u2022 pentose phosphate pathway,</li><li>\u2022 Option D. Ribose: Ribose is a sugar component of RNA and is not involved in the structure of ABO blood group antigens.</li><li>\u2022 Option D. Ribose:</li><li>\u2022 sugar component of RNA</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Fucose is added to the glycolipid or glycoprotein backbone of red blood cells to form the H antigen.</li><li>\u27a4 Fucose</li><li>\u27a4 glycolipid or glycoprotein backbone</li><li>\u27a4 H antigen.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fc3a1d1f",
      "audio": ""
    },
    {
      "text": "A 23-year-old male presents to the clinic with recurrent, spontaneous joint hemarthroses. Family history is significant for similar symptoms in his maternal uncles. Laboratory evaluation reveals a specific factor deficiency. Which laboratory finding is most consistent with a diagnosis of Hemophilia A?",
      "options": [
        {
          "label": "A",
          "text": "Prolonged PTT",
          "correct": true
        },
        {
          "label": "B",
          "text": "Prolonged PT",
          "correct": false
        },
        {
          "label": "C",
          "text": "Low platelet count",
          "correct": false
        },
        {
          "label": "D",
          "text": "Abnormal BT",
          "correct": false
        }
      ],
      "correct_answer": "A. Prolonged PTT",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Prolonged PTT</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Prolonged PT: The prothrombin time (PT) test evaluates the extrinsic and common pathways .</li><li>\u2022 Option B. Prolonged PT:</li><li>\u2022 extrinsic and common pathways</li><li>\u2022 Option C. Low platelet count: Hemophilia A does not affect the platelet count ; it is a coagulation factor deficiency and does not involve quantitative platelet defects.</li><li>\u2022 Option C. Low platelet count:</li><li>\u2022 does not</li><li>\u2022 platelet count</li><li>\u2022 coagulation factor deficiency</li><li>\u2022 quantitative platelet defects.</li><li>\u2022 Option D. Abnormal BT : Bleeding time tests primary hemostasis , which includes platelet function .</li><li>\u2022 Option D. Abnormal BT</li><li>\u2022 primary hemostasis</li><li>\u2022 platelet function</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hemophilia A , a genetic disorder characterized by factor VIII deficiency leads to impaired function of the intrinsic coagulation pathway . This manifests clinically with a prolonged activated partial thromboplastin time (PTT) and a normal prothrombin time (PT) and bleeding time (BT).</li><li>\u27a4 Hemophilia A</li><li>\u27a4 factor VIII deficiency</li><li>\u27a4 impaired</li><li>\u27a4 intrinsic coagulation pathway</li><li>\u27a4 prolonged activated partial thromboplastin time (PTT) and a normal prothrombin time (PT) and bleeding time (BT).</li><li>\u27a4 Ref : Robbins 10 th 668</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th 668</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d25f29a1",
      "audio": ""
    },
    {
      "text": "A medical student working in a blood bank is tasked with handling stored red blood cells (RBCs) for transfusion purposes. What is the recommended storage temperature for preserving the viability and function of RBCs?",
      "options": [
        {
          "label": "A",
          "text": "2\u20136 \u00b0C",
          "correct": true
        },
        {
          "label": "B",
          "text": "\u20132 to\u20134 \u00b0C",
          "correct": false
        },
        {
          "label": "C",
          "text": "37 \u00b0C",
          "correct": false
        },
        {
          "label": "D",
          "text": "20\u201325\u00b0C",
          "correct": false
        }
      ],
      "correct_answer": "A. 2\u20136 \u00b0C",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture2.jpg"
      ],
      "explanation": "<p><strong>Ans. A) 2\u20136 \u00b0C</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The recommended storage temperature for preserving the viability and function of RBCs is 2-6 degree Celsius .</li><li>\u2022 storage temperature</li><li>\u2022 viability and function of RBCs</li><li>\u2022 2-6 degree Celsius</li><li>\u2022 Ref : Robbins 10 th /; Essentials of Hematology 2nd/500</li><li>\u2022 Ref</li><li>\u2022 : Robbins 10 th /; Essentials of Hematology 2nd/500</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b2266901",
      "audio": ""
    },
    {
      "text": "A 55-year-old male is scheduled for a red blood cell transfusion due to severe anemia. To optimize the transfusion process, which of the following needle sizes is recommended for the administration of red blood cells?",
      "options": [
        {
          "label": "A",
          "text": "With a 16\u201318 G needle",
          "correct": false
        },
        {
          "label": "B",
          "text": "With a 18\u201320 G needle",
          "correct": true
        },
        {
          "label": "C",
          "text": "With a 20\u201322 G needle",
          "correct": false
        },
        {
          "label": "D",
          "text": "With a 22\u201324 G needle",
          "correct": false
        }
      ],
      "correct_answer": "B. With a 18\u201320 G needle",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture3.jpg"
      ],
      "explanation": "<p><strong>Ans. B) With a 18\u201320 G needle</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A needle gauge of 18-20 G is recommended for transfusion to minimize hemolysis and allow for an adequate flow rate .</li><li>\u27a4 18-20 G</li><li>\u27a4 transfusion to minimize hemolysis</li><li>\u27a4 adequate flow rate</li><li>\u27a4 Ref : Essentials of Hematology 2nd/500</li><li>\u27a4 Ref</li><li>\u27a4 : Essentials of Hematology 2nd/500</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "26b7bd86",
      "audio": ""
    },
    {
      "text": "A 30-year-old individual is scheduled to donate blood for a local blood drive. To ensure the safety of the blood supply, the donor's blood will be screened for various infectious diseases. Among the following options, which one is typically NOT included in the routine screening for donated blood?",
      "options": [
        {
          "label": "A",
          "text": "Malaria",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hep B",
          "correct": false
        },
        {
          "label": "C",
          "text": "HIV",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dengue",
          "correct": true
        }
      ],
      "correct_answer": "D. Dengue",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Dengue</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Malaria is routinely screened for in donated blood because it is caused by parasites transmitted through the bite of infected mosquitoes . Screening helps prevent the transmission of malaria through blood transfusions .</li><li>\u2022 Option A.</li><li>\u2022 Malaria</li><li>\u2022 donated blood</li><li>\u2022 parasites transmitted through the bite of infected mosquitoes</li><li>\u2022 Screening helps</li><li>\u2022 malaria</li><li>\u2022 blood transfusions</li><li>\u2022 Option B. Hepatitis B is a viral infection that can be transmitted through blood transfusions. Screening for Hepatitis B surface antigen (HBsAg) is essential to prevent the transmission of the virus to recipients of donated blood .</li><li>\u2022 Option B.</li><li>\u2022 Hepatitis B</li><li>\u2022 viral infection</li><li>\u2022 blood transfusions.</li><li>\u2022 Hepatitis B surface antigen (HBsAg)</li><li>\u2022 virus to recipients of donated blood</li><li>\u2022 Option C. Screening for HIV is crucial in donated blood to prevent the transmission of the virus to recipients . HIV screening typically involves testing for antibodies to HIV-1 and HIV-2 , ensuring the safety of the blood supply .</li><li>\u2022 Option C.</li><li>\u2022 Screening for HIV</li><li>\u2022 donated blood to prevent the transmission of the virus to recipients</li><li>\u2022 antibodies to HIV-1 and HIV-2</li><li>\u2022 safety of the blood supply</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 While diseases such as HIV, Hepatitis B, and Malaria are routinely screened for in donated blood to ensure the safety of the blood supply , Dengue is not typically included in routine screening protocols as it is primarily transmitted by mosquitoes rather than through blood transfusions .</li><li>\u2022 HIV, Hepatitis B, and Malaria</li><li>\u2022 donated blood to ensure the safety of the blood supply</li><li>\u2022 Dengue is not</li><li>\u2022 screening protocols</li><li>\u2022 mosquitoes rather than through blood transfusions</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "82a25666",
      "audio": ""
    },
    {
      "text": "A young boy presented with recurrent episodes of melena. The physician also found presence of dermatitis like rashes and multiple petechiae. His platelet count was low but red cell and white blood cell counts were normal. Which of the following is the diagnostic investigation in this case?",
      "options": [
        {
          "label": "A",
          "text": "Anti-platelet antibodies",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bone marrow examination",
          "correct": false
        },
        {
          "label": "C",
          "text": "WASP gene study",
          "correct": true
        },
        {
          "label": "D",
          "text": "Platelet function analyzer",
          "correct": false
        }
      ],
      "correct_answer": "C. WASP gene study",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture4.jpg"
      ],
      "explanation": "<p><strong>Ans. C) WASP gene study</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Anti-platelet antibodies are antibodies produced by the immune system against platelets, which can result in conditions like immune thrombocytopenic purpura (ITP ). While it could be considered in cases of thrombocytopenia, the clinical presentation described in the question is more indicative of a specific underlying genetic disorder rather than an autoimmune cause.</li><li>\u2022 Option A.</li><li>\u2022 Anti-platelet antibodies</li><li>\u2022 antibodies</li><li>\u2022 against platelets,</li><li>\u2022 immune thrombocytopenic purpura (ITP</li><li>\u2022 more indicative of a specific underlying genetic disorder</li><li>\u2022 Option B. Bone marrow examination is a valuable diagnostic tool in cases of unexplained thrombocytopenia to assess for abnormalities in platelet production or destruction . However, in this case, the clinical presentation and history strongly suggest a specific genetic disorder rather than a primary bone marrow disorder.</li><li>\u2022 Option B.</li><li>\u2022 Bone marrow examination</li><li>\u2022 unexplained thrombocytopenia</li><li>\u2022 abnormalities in platelet production or destruction</li><li>\u2022 specific genetic disorder</li><li>\u2022 Option D . Platelet function analyzers are used to assess platelet function in various bleeding disorders . While they may be useful in certain contexts, the clinical presentation described in the question suggests a genetic disorder rather than a primary platelet dysfunction .</li><li>\u2022 Option D</li><li>\u2022 Platelet function analyzers</li><li>\u2022 platelet function</li><li>\u2022 bleeding disorders</li><li>\u2022 genetic disorder</li><li>\u2022 primary platelet dysfunction</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The clinical presentation described, including thrombocytopenia, recurrent infections, and eczema , is suggestive of Wiskott-Aldrich syndrome , a rare X-linked recessive disorder . Genetic analysis of the WASP gene is the diagnostic investigation of choice to confirm the diagnosis.</li><li>\u2022 clinical presentation</li><li>\u2022 thrombocytopenia, recurrent infections, and eczema</li><li>\u2022 Wiskott-Aldrich syndrome</li><li>\u2022 rare X-linked recessive disorder</li><li>\u2022 WASP gene</li><li>\u2022 diagnostic investigation of choice</li><li>\u2022 diagnosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "61984b00",
      "audio": ""
    },
    {
      "text": "Normal platelet count is found in:",
      "options": [
        {
          "label": "A",
          "text": "Wiskott Aldrich syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Henoch Schonlein purpura",
          "correct": true
        },
        {
          "label": "C",
          "text": "Immune thrombocytopenia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dengue fever",
          "correct": false
        }
      ],
      "correct_answer": "B. Henoch Schonlein purpura",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Henoch Schonlein purpura</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 All other options have decreased platelet count except Henoch Schonlein purpura . Though it has the word pur\u00adpura in its name, but the platelet count in this condition is normal . Th e skin manifestations in HSP are due to small vessel vasculitis .</li><li>\u2022 All other options</li><li>\u2022 decreased platelet count</li><li>\u2022 Henoch Schonlein purpura</li><li>\u2022 platelet count in this condition is normal</li><li>\u2022 e</li><li>\u2022 skin manifestations in HSP</li><li>\u2022 small vessel vasculitis</li><li>\u2022 Ref : Robbins 10 th / 526-527</li><li>\u2022 Ref</li><li>\u2022 : Robbins 10 th / 526-527</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "802fa7e9",
      "audio": ""
    },
    {
      "text": "Which of the following is true about h/h blood group?",
      "options": [
        {
          "label": "A",
          "text": "Lacks H-antigen",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lacks A-antigen",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lacks B antigen",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) All of the above</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "eedff8fd",
      "audio": ""
    },
    {
      "text": "A 45-year-old patient is scheduled for coagulation studies to assess their clotting function. To prevent blood clotting during the tests, which of the following anticoagulants is commonly used in coagulation studies?",
      "options": [
        {
          "label": "A",
          "text": "Calcium citrate",
          "correct": false
        },
        {
          "label": "B",
          "text": "EDTA",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sodium bromide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Trisodium citrate",
          "correct": true
        }
      ],
      "correct_answer": "D. Trisodium citrate",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture5.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Trisodium citrate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Calcium citrate is not commonly used as an a nticoagulant in coagulation studies . In fact, it contains calcium ions , which promote clotting rather than preventing it . Therefore, it is not suitable for use in coagulation tests.</li><li>\u2022 Option A.</li><li>\u2022 Calcium citrate</li><li>\u2022 not</li><li>\u2022 nticoagulant in coagulation studies</li><li>\u2022 calcium ions</li><li>\u2022 promote clotting rather than preventing it</li><li>\u2022 not suitable</li><li>\u2022 coagulation tests.</li><li>\u2022 Option B. EDTA is commonly used as an anticoagulant for blood samples for tests such as complete blood count (CBC). However, it is not typically used in coagulation studies because it can interfere with calcium-dependent coagulation pathways.</li><li>\u2022 Option B.</li><li>\u2022 EDTA</li><li>\u2022 anticoagulant</li><li>\u2022 complete blood count (CBC).</li><li>\u2022 not</li><li>\u2022 coagulation studies</li><li>\u2022 interfere with calcium-dependent coagulation pathways.</li><li>\u2022 Option C. Sodium bromide is not commonly used as an anticoagulant in coagulation studies . It is primarily used in analytical chemistry and not for blood sample collection or coagulation tests .</li><li>\u2022 Option C.</li><li>\u2022 Sodium bromide</li><li>\u2022 not</li><li>\u2022 anticoagulant in coagulation studies</li><li>\u2022 analytical chemistry</li><li>\u2022 not for blood sample collection</li><li>\u2022 coagulation tests</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Trisodium citrate is the correct anticoagulant for coagulation studies.</li><li>\u2022 It chelates calcium ions and is used to prevent blood clotting during tests like prothrombin time (PT) and activated partial thromboplastin time (APTT).</li><li>\u2022 chelates calcium ions</li><li>\u2022 blood clotting</li><li>\u2022 prothrombin time (PT) and activated partial thromboplastin time (APTT).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "801ddd6b",
      "audio": ""
    },
    {
      "text": "A medical student is reviewing the chromosomal locations of blood group antigens. When considering the Rh blood group system, including the Rh antigen, which of the following chromosomes houses the relevant genes?",
      "options": [
        {
          "label": "A",
          "text": "1",
          "correct": true
        },
        {
          "label": "B",
          "text": "9",
          "correct": false
        },
        {
          "label": "C",
          "text": "19",
          "correct": false
        },
        {
          "label": "D",
          "text": "13",
          "correct": false
        }
      ],
      "correct_answer": "A. 1",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) 1</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d193cb7c",
      "audio": ""
    },
    {
      "text": "A laboratory technician is preparing blood samples for various tests requiring the chelation of calcium ions to prevent blood clotting. Which of the following anticoagulants is commonly used?",
      "options": [
        {
          "label": "A",
          "text": "EDTA",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oxalate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sodium citrate",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) All of the above</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. EDTA is an anticoagulant commonly used in laboratory settings for tests such as complete blood count (CBC) . It chelates calcium ions , preventing blood clotting by binding to calcium , which is essential for the coagulation cascade.</li><li>\u2022 Option A.</li><li>\u2022 EDTA</li><li>\u2022 anticoagulant</li><li>\u2022 complete blood count (CBC)</li><li>\u2022 chelates calcium ions</li><li>\u2022 preventing blood clotting by binding to calcium</li><li>\u2022 Option B. Oxalate is another anticoagulant that chelates calcium ions , thus preventing blood clotting . It is commonly used in laboratory settings for tests such as blood glucose measurement .</li><li>\u2022 Option B.</li><li>\u2022 Oxalate</li><li>\u2022 another anticoagulant</li><li>\u2022 calcium ions</li><li>\u2022 blood clotting</li><li>\u2022 blood glucose measurement</li><li>\u2022 Option C. Sodium citrate is a third anticoagulant that chelates calcium ions , effectively preventing blood clotting during various laboratory tests. It is commonly used for coagulation studies such as prothrombin time (PT) and activated partial thromboplastin time (APTT).</li><li>\u2022 Option C.</li><li>\u2022 Sodium citrate</li><li>\u2022 third anticoagulant</li><li>\u2022 calcium ions</li><li>\u2022 preventing blood clotting</li><li>\u2022 prothrombin time (PT) and activated partial thromboplastin time (APTT).</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 EDTA, oxalate, and sodium citrate are all anticoagulants commonly used in laboratory settings. They prevent blood clotting by chelating calcium ions , which are essential for the coagulation cascade . Each anticoagulant has its specific applications in different types of laboratory tests .</li><li>\u2022 EDTA, oxalate, and sodium citrate</li><li>\u2022 anticoagulants</li><li>\u2022 blood clotting by chelating calcium ions</li><li>\u2022 coagulation cascade</li><li>\u2022 specific applications in different types of laboratory tests</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0debded1",
      "audio": ""
    },
    {
      "text": "A young boy came with dyspnea and was found to have a mediastinal mass. Which of the following is known to produce mediastinal lymphadenopathy?",
      "options": [
        {
          "label": "A",
          "text": "Diffuse large B cell Lymphoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "B cell lymphoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mediastinal rich B cell lymphoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "T cell Lymphoblastic ALL",
          "correct": true
        }
      ],
      "correct_answer": "D. T cell Lymphoblastic ALL",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) T cell Lymphoblastic ALL</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Diffuse large B-cell lymphoma (DLBCL) is a type of B-cell lymphoma that typically presents with nodal or extranodal masses , but it is not specifically associated with mediastinal lymphadenopathy.</li><li>\u2022 Option A.</li><li>\u2022 Diffuse large B-cell lymphoma (DLBCL)</li><li>\u2022 B-cell lymphoma</li><li>\u2022 nodal or extranodal masses</li><li>\u2022 not specifically</li><li>\u2022 mediastinal lymphadenopathy.</li><li>\u2022 Option B . B-cell rich T-cell lymphoma is not a well-recognized entity . The common types of lymphomas are generally classified as either B-cell or T-cell lymphomas .</li><li>\u2022 Option B</li><li>\u2022 B-cell rich T-cell lymphoma</li><li>\u2022 not a well-recognized entity</li><li>\u2022 B-cell or T-cell lymphomas</li><li>\u2022 Option C. \" Mediastinal rich B-cell lymphoma\" is not a recognized term , and it doesn't correspond to a specific subtype of lymphoma. However, primary mediastinal large B-cell lymphoma (PMBCL) is a distinct entity that can cause mediastinal masses.</li><li>\u2022 Option C.</li><li>\u2022 Mediastinal rich B-cell lymphoma\"</li><li>\u2022 not a recognized term</li><li>\u2022 subtype of lymphoma.</li><li>\u2022 primary mediastinal large B-cell lymphoma (PMBCL)</li><li>\u2022 mediastinal masses.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 T-cell Lymphoblastic ALL is associated with mediastinal lymphadenopathy , typically presenting with symptoms such as dyspnea due to compression of thoracic structures.</li><li>\u27a4 T-cell Lymphoblastic ALL</li><li>\u27a4 mediastinal lymphadenopathy</li><li>\u27a4 dyspnea due to compression of thoracic structures.</li><li>\u27a4 (Ref: Robbins 10 th / 595)</li><li>\u27a4 (Ref: Robbins 10 th / 595)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f3fa2ea1",
      "audio": ""
    },
    {
      "text": "A 32-year-old male presents with painless enlargement of a cervical lymph node. Excisional biopsy reveals a subtype of Hodgkin\u2019s disease, which is histogenetically distinct from all the other subtypes. Which of the following is the likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Lymphocyte predominant",
          "correct": true
        },
        {
          "label": "B",
          "text": "Nodular sclerosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mixed cellularity",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lymphocyte depleted",
          "correct": false
        }
      ],
      "correct_answer": "A. Lymphocyte predominant",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Lymphocyte predominant</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Nodular Sclerosis : Nodular sclerosis is the most common subtype of Hodgkin's lymphoma in the world. It is characterized by the presence of collagen bands dividing the lymph node architecture into nodules . Reed-Sternberg cells , the hallmark cells of Hodgkin's lymphoma, are found in lacunar spaces. This subtype often affects young adults and typically presents with mediastinal involvement . It has a favorable prognosis.</li><li>\u2022 Option B:</li><li>\u2022 Nodular Sclerosis</li><li>\u2022 most common</li><li>\u2022 Hodgkin's lymphoma in the world.</li><li>\u2022 collagen bands</li><li>\u2022 lymph node architecture into nodules</li><li>\u2022 Reed-Sternberg cells</li><li>\u2022 Hodgkin's lymphoma,</li><li>\u2022 young adults</li><li>\u2022 mediastinal involvement</li><li>\u2022 Option C: Mixed Cellularity: This subtype is characterized by a mixed inflammatory infiltrate , including eosinophils, plasma cells, and histiocytes , along with Reed-Sternberg cells . It is often associated with an advanced stage of the disease and has a less favorable prognosis compared to nodular sclerosis.</li><li>\u2022 Option C:</li><li>\u2022 Mixed Cellularity:</li><li>\u2022 mixed inflammatory infiltrate</li><li>\u2022 eosinophils, plasma cells, and histiocytes</li><li>\u2022 Reed-Sternberg cells</li><li>\u2022 advanced stage of the disease</li><li>\u2022 Option D: Lymphocyte Depleted : This subtype is characterized by a scarcity of lymphocytes and an abundance of Reed-Sternberg cells . It is associated with an advanced stage of the disease and is often seen in immunocompromised individuals . Lymphocyte-depleted Hodgkin's lymphoma has a less favorable prognosis .</li><li>\u2022 Option D:</li><li>\u2022 Lymphocyte Depleted</li><li>\u2022 subtype</li><li>\u2022 scarcity of lymphocytes</li><li>\u2022 an abundance of Reed-Sternberg cells</li><li>\u2022 with</li><li>\u2022 advanced stage of the disease</li><li>\u2022 immunocompromised individuals</li><li>\u2022 less favorable prognosis</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Lymphocyte predominant Hodgkin\u2019s disease is histogenetically distinct from other subtypes, characterized by a nodular pattern with a predominance of lymphocytes and the presence of popcorn cells .</li><li>\u2022 Lymphocyte predominant Hodgkin\u2019s disease</li><li>\u2022 histogenetically distinct</li><li>\u2022 subtypes,</li><li>\u2022 nodular pattern</li><li>\u2022 predominance of lymphocytes</li><li>\u2022 popcorn cells</li><li>\u2022 (Ref: Robbins 10 th 613)</li><li>\u2022 (Ref: Robbins 10 th 613)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8267dcb1",
      "audio": ""
    },
    {
      "text": "Over-expression of BCL-2 proteins occurs in:",
      "options": [
        {
          "label": "A",
          "text": "Burkitt\u2019s lymphoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Follicular lymphoma",
          "correct": true
        },
        {
          "label": "C",
          "text": "Diffuse large B-cell lymphoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Small lymphocytic lymphoma",
          "correct": false
        }
      ],
      "correct_answer": "B. Follicular lymphoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Follicular lymphoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Burkitt's lymphoma is associated with a translocation involving the MYC gene.</li><li>\u2022 Option A:</li><li>\u2022 Burkitt's lymphoma</li><li>\u2022 translocation</li><li>\u2022 MYC gene.</li><li>\u2022 Option C: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of lymphomas and may have various genetic alterations, but it is not primarily associated with BCL-2 over-expression .</li><li>\u2022 Option C:</li><li>\u2022 Diffuse large B-cell lymphoma (DLBCL)</li><li>\u2022 heterogeneous group of lymphomas</li><li>\u2022 genetic alterations,</li><li>\u2022 with BCL-2 over-expression</li><li>\u2022 Option D: Small lymphocytic lymphoma (SLL) is closely related to chronic lymphocytic leukemia (CLL) and is not typically associated with BCL-2 over-expression as a defining characteristic.</li><li>\u2022 Option D:</li><li>\u2022 Small lymphocytic lymphoma (SLL)</li><li>\u2022 closely</li><li>\u2022 chronic lymphocytic leukemia (CLL)</li><li>\u2022 not</li><li>\u2022 BCL-2 over-expression</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Over-expression of BCL-2 proteins is commonly associated with follicular lymphoma due to the t (14;18) chromosomal translocation.</li><li>\u27a4 Over-expression of BCL-2 proteins</li><li>\u27a4 follicular lymphoma</li><li>\u27a4 t (14;18) chromosomal translocation.</li><li>\u27a4 (Ref: Robbins 10 th 600)</li><li>\u27a4 (Ref: Robbins 10 th 600)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2799802f",
      "audio": ""
    },
    {
      "text": "\u2018Starry sky\u2019 appearance is seen in:",
      "options": [
        {
          "label": "A",
          "text": "Burkitt\u2019s lymphoma",
          "correct": true
        },
        {
          "label": "B",
          "text": "Mantle cell lymphoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Extra nodal marginal zone B-cell lymphoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chronic myeloid leukemia",
          "correct": false
        }
      ],
      "correct_answer": "A. Burkitt\u2019s lymphoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Burkitt\u2019s lymphoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Mantle cell lymphoma does not typically exhibit the \" starry sky\" appearance.</li><li>\u2022 Option B:</li><li>\u2022 Mantle cell lymphoma</li><li>\u2022 not</li><li>\u2022 starry sky\"</li><li>\u2022 Option C: Extra nodal marginal zone B-cell lymphoma is not typically associated with the \"starry sky \" appearance.</li><li>\u2022 Option C:</li><li>\u2022 Extra nodal marginal zone B-cell lymphoma is not</li><li>\u2022 \"starry sky</li><li>\u2022 Option D: Chronic myeloid leukemia is a myeloproliferative disorder involving the myeloid lineage , and it does not show the \"starry sky\" appearance.</li><li>\u2022 Option D:</li><li>\u2022 Chronic myeloid leukemia</li><li>\u2022 myeloproliferative disorder</li><li>\u2022 myeloid lineage</li><li>\u2022 does not</li><li>\u2022 \"starry sky\"</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The \"starry sky \" appearance is characteristically seen in Burkitt's lymphoma .</li><li>\u27a4 \"starry sky</li><li>\u27a4 Burkitt's lymphoma</li><li>\u27a4 (Ref: Robbins 10 th 598)</li><li>\u27a4 (Ref: Robbins 10 th 598)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fda14d3d",
      "audio": ""
    },
    {
      "text": "All are B cell lymphomas except:",
      "options": [
        {
          "label": "A",
          "text": "Burkitt\u2019s lymphoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mycosis fungoides",
          "correct": true
        },
        {
          "label": "C",
          "text": "Mantle cell lymphoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Follicular cell lymphoma",
          "correct": false
        }
      ],
      "correct_answer": "B. Mycosis fungoides",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Mycosis fungoides</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Burkitt's lymphoma is indeed a B-cell lymphoma. It is an aggressive form of non-Hodgkin lymphoma that is associated with the Epstein-Barr virus (EBV) and characterized by the translocation involving the MYC gene .</li><li>\u2022 Option A:</li><li>\u2022 Burkitt's lymphoma</li><li>\u2022 B-cell lymphoma.</li><li>\u2022 non-Hodgkin lymphoma</li><li>\u2022 Epstein-Barr virus (EBV)</li><li>\u2022 translocation</li><li>\u2022 MYC gene</li><li>\u2022 Option C: Mantle cell lymphoma is a B-cell lymphoma characterized by the proliferation of malignant B-cells with characteristic involvement of the mantle zone in lymphoid follicles .</li><li>\u2022 Option C:</li><li>\u2022 Mantle cell lymphoma</li><li>\u2022 B-cell lymphoma</li><li>\u2022 proliferation of malignant B-cells</li><li>\u2022 mantle zone in lymphoid follicles</li><li>\u2022 Option D: Follicular lymphoma is a B-cell lymphoma . It is a slow-growing, indolent lymphoma characterized by the proliferation of abnormal B-cells within the lymph nodes.</li><li>\u2022 Option D:</li><li>\u2022 Follicular lymphoma</li><li>\u2022 B-cell lymphoma</li><li>\u2022 slow-growing, indolent lymphoma</li><li>\u2022 abnormal B-cells</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mycosis fungoides is a type of cutaneous T-cell lymphoma and not a B-cell lymphoma.</li><li>\u27a4 Mycosis fungoides</li><li>\u27a4 cutaneous T-cell lymphoma</li><li>\u27a4 (Ref: Robbins 10 th 606)</li><li>\u27a4 (Ref: Robbins 10 th 606)</li><li>\u27a4 (Ref: Robbins 10 th 606)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "caaae648",
      "audio": ""
    },
    {
      "text": "Which one of the following Non-Hodgkin Lymphomas is aggressive?",
      "options": [
        {
          "label": "A",
          "text": "Follicular Lymphoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Burkitt Lymphoma",
          "correct": true
        },
        {
          "label": "C",
          "text": "Small lymphocytic lymphoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lymphoplasmacytic lymphoma",
          "correct": false
        }
      ],
      "correct_answer": "B. Burkitt Lymphoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Burkitt Lymphoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Follicular Lymphoma is an indolent (slow-growing) Non-Hodgkin Lymphoma . It has a more chronic course and tends to be less aggressive compared to Burkitt Lymphoma.</li><li>\u2022 Option A:</li><li>\u2022 Follicular Lymphoma</li><li>\u2022 indolent (slow-growing) Non-Hodgkin Lymphoma</li><li>\u2022 more chronic course</li><li>\u2022 less aggressive</li><li>\u2022 Option C: Small lymphocytic lymphoma is a low-grade, indolent lymphoma that is related to chronic lymphocytic leukemia (CLL). It is characterized by the proliferation of small mature B-cells.</li><li>\u2022 Option C:</li><li>\u2022 Small lymphocytic lymphoma</li><li>\u2022 low-grade, indolent lymphoma</li><li>\u2022 chronic lymphocytic leukemia (CLL).</li><li>\u2022 proliferation of small mature B-cells.</li><li>\u2022 Option D: Lymphoplasmacytic lymphoma is typically an indolent lymphoma characterized by the infiltration of the bone marrow and other tissues by small lymphocytes, plasma cells, and lymphoplasmacytic cells.</li><li>\u2022 Option D:</li><li>\u2022 Lymphoplasmacytic lymphoma</li><li>\u2022 indolent lymphoma</li><li>\u2022 infiltration of the bone marrow</li><li>\u2022 small lymphocytes, plasma cells, and lymphoplasmacytic cells.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Burkitt Lymphoma is an aggressive Non-Hodgkin Lymphoma characterized by a high proliferation rate and MYC gene translocation . \u201c Burkitt lymphoma is believed to be the fastest growing hu\u00adman tumor \u201d \u2026direct line</li><li>\u27a4 Burkitt Lymphoma</li><li>\u27a4 aggressive Non-Hodgkin Lymphoma</li><li>\u27a4 high proliferation rate</li><li>\u27a4 MYC gene translocation</li><li>\u27a4 Burkitt lymphoma</li><li>\u27a4 fastest growing hu\u00adman tumor</li><li>\u27a4 (Ref: Robbin 10 th 598)</li><li>\u27a4 (Ref: Robbin 10 th 598)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8e2f98e5",
      "audio": ""
    },
    {
      "text": "A 50-year-old male presents with persistent skin lesions, including pruritic, erythematous patches and plaques and is diagnosed with mycosis fungoides. Which of the following is true about this condition?",
      "options": [
        {
          "label": "A",
          "text": "Fungal infections of skin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Leukemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Exfoliative erythroderma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cutaneous lymphoma",
          "correct": true
        }
      ],
      "correct_answer": "D. Cutaneous lymphoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Cutaneous lymphoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: (Fungal infections of skin): The term \" mycosis fungoides \" might misleadingly suggest a fungal infection, but the condition is not caused by fungi . It is actually a type of non-Hodgkin lymphoma and has no infectious etiology .</li><li>\u2022 Option A: (Fungal infections of skin):</li><li>\u2022 mycosis fungoides</li><li>\u2022 misleadingly suggest a fungal infection,</li><li>\u2022 not caused by fungi</li><li>\u2022 non-Hodgkin lymphoma</li><li>\u2022 no infectious etiology</li><li>\u2022 Option B: (Leukemia): Leukemia generally refers to c ancers of the blood or bone marrow characterized by an abnormal proliferation of blood cells . Mycosis fungoides can sometimes progress to a leukemic phase known as S\u00e9zary syndrome , but it primarily manifests with skin involvement and is not initially leukemia.</li><li>\u2022 Option B: (Leukemia):</li><li>\u2022 ancers of the blood or bone marrow</li><li>\u2022 abnormal proliferation of blood cells</li><li>\u2022 Mycosis fungoides</li><li>\u2022 progress</li><li>\u2022 leukemic phase</li><li>\u2022 S\u00e9zary syndrome</li><li>\u2022 skin involvement</li><li>\u2022 Option C: (Exfoliative erythroderma): While patients with advanced mycosis fungoides may develop exfoliative erythroderma , which is widespread inflammation and scaling of the skin, this is not the primary or sole manifestation of the disease .</li><li>\u2022 Option C: (Exfoliative erythroderma):</li><li>\u2022 advanced mycosis fungoides</li><li>\u2022 exfoliative erythroderma</li><li>\u2022 widespread inflammation</li><li>\u2022 scaling of the skin,</li><li>\u2022 not the primary</li><li>\u2022 manifestation of the disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mycosis fungoides is a cutaneous T-cell lymphoma that may present with pruritic, erythematous patches and plaques , and is characterized histologically by Sezary Lutzner cells with a cerebriform contour</li><li>\u27a4 Mycosis fungoides</li><li>\u27a4 cutaneous T-cell lymphoma</li><li>\u27a4 pruritic, erythematous patches and plaques</li><li>\u27a4 Sezary Lutzner cells</li><li>\u27a4 cerebriform contour</li><li>\u27a4 (Ref: Robbins 10 th 605)</li><li>\u27a4 (Ref: Robbins 10 th 605)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "59980d8c",
      "audio": ""
    },
    {
      "text": "Myelofibrosis leading to a dry tap on bone marrow aspiration is seen with which of the following conditions?",
      "options": [
        {
          "label": "A",
          "text": "Burkitt\u2019s lymphoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acute erythroblastic leukemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acute megakaryocytic leukemia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Acute undifferentiated leukemia",
          "correct": false
        }
      ],
      "correct_answer": "C. Acute megakaryocytic leukemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Acute megakaryocytic leukemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Burkitt\u2019s lymphoma is a type of non-Hodgkin lymphoma that primarily involves B cells. It typically presents with rapidly growing tumors , often in the jaw or abdomen . Bone marrow involvement in Burkitt's lymphoma is uncommon. While bone marrow examination may reveal lymphoma cells , it is not typically associated with myelofibrosis, and a dry tap is not a characteristic finding.</li><li>\u2022 Option A:</li><li>\u2022 Burkitt\u2019s lymphoma</li><li>\u2022 non-Hodgkin lymphoma</li><li>\u2022 B cells.</li><li>\u2022 rapidly</li><li>\u2022 growing tumors</li><li>\u2022 jaw or abdomen</li><li>\u2022 bone marrow</li><li>\u2022 lymphoma cells</li><li>\u2022 not</li><li>\u2022 myelofibrosis, and a dry tap</li><li>\u2022 Option B: Acute erythroblastic leukemia (erythroleukemia) is a rare subtype of acute myeloid leukemia (AML) characterized by the proliferation of immature erythroid precursors . This condition can infiltrate the bone marrow , leading to a hypercellular marrow with an excess o f erythroid precursors . Myelofibrosis and dry tap are not typical features of acute erythroblastic leukemia.</li><li>\u2022 Option B:</li><li>\u2022 Acute erythroblastic leukemia (erythroleukemia)</li><li>\u2022 subtype of acute myeloid leukemia (AML)</li><li>\u2022 proliferation of immature erythroid precursors</li><li>\u2022 infiltrate the bone marrow</li><li>\u2022 hypercellular marrow</li><li>\u2022 f erythroid precursors</li><li>\u2022 Option D: Acute undifferentiated leukemia refers to a subtype of acute leukemia in which the blasts (immature cells) in the bone marrow lack specific features that would allow classification into myeloid or lymphoid lineages. While acute leukemias can sometimes be associated with bone marrow fibrosis , the dry tap is not typically a defining feature of this subtype.</li><li>\u2022 Option D: Acute undifferentiated leukemia</li><li>\u2022 subtype of acute leukemia</li><li>\u2022 blasts (immature cells)</li><li>\u2022 lack specific features</li><li>\u2022 myeloid or lymphoid lineages.</li><li>\u2022 acute leukemias</li><li>\u2022 bone marrow fibrosis</li><li>\u2022 dry tap is not</li><li>\u2022 subtype.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Acute megakaryocytic leukemia , a subtype of acute myeloid leukemia characterized by the proliferation of megakaryocytic precursors , is associated with the development of myelofibrosis within the bone marrow, which can lead to a ' dry tap' during bone marrow aspiration due to increased fibrous tissue.</li><li>\u27a4 Acute megakaryocytic leukemia</li><li>\u27a4 subtype of acute myeloid leukemia</li><li>\u27a4 proliferation of megakaryocytic</li><li>\u27a4 precursors</li><li>\u27a4 development of myelofibrosis</li><li>\u27a4 dry tap'</li><li>\u27a4 bone</li><li>\u27a4 marrow aspiration due to increased fibrous tissue.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "72ac67ac",
      "audio": ""
    },
    {
      "text": "Adult patient presents with generalized lymphadenop\u00adathy and blood film shows 70% immature looking lym\u00adphocytes. What should be the next best investigation?",
      "options": [
        {
          "label": "A",
          "text": "Genotyping/karyotyping",
          "correct": false
        },
        {
          "label": "B",
          "text": "Immunophenotyping",
          "correct": true
        },
        {
          "label": "C",
          "text": "Bone marrow",
          "correct": false
        },
        {
          "label": "D",
          "text": "Peripheral smear study",
          "correct": false
        }
      ],
      "correct_answer": "B. Immunophenotyping",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Immunophenotyping</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Genotyping/Karyotyping is used to detect chromosomal abnormalities and gene mutations, which can provide information on prognosis and guide treatment , but it is not typically the first step following a blood film analysis showing immature lymphocytes .</li><li>\u2022 Option A:</li><li>\u2022 Genotyping/Karyotyping</li><li>\u2022 chromosomal abnormalities and gene mutations,</li><li>\u2022 prognosis and guide treatment</li><li>\u2022 not typically the first step following a blood film analysis</li><li>\u2022 immature lymphocytes</li><li>\u2022 Option C: Bone Marrow Aspiration/Biopsy is used to examine the morphology of marrow cells and architecture , which can confirm a diagnosis suggested by immunophenotyping , but it's usually not the first follow-up test when a specific leukemia subtype is suspected from a blood smear .</li><li>\u2022 Option C:</li><li>\u2022 Bone Marrow Aspiration/Biopsy</li><li>\u2022 morphology of marrow cells and architecture</li><li>\u2022 suggested by immunophenotyping</li><li>\u2022 not the first follow-up test</li><li>\u2022 specific leukemia subtype</li><li>\u2022 blood smear</li><li>\u2022 Option D: Peripheral Smear Study is an initial investigation that has already been performed, showing immature lymphocytes . This prompts further investigation with more specific tests like immunophenotyping, rather than repeating the same analysis .</li><li>\u2022 Option D:</li><li>\u2022 Peripheral Smear Study</li><li>\u2022 initial investigation</li><li>\u2022 performed, showing immature lymphocytes</li><li>\u2022 investigation</li><li>\u2022 immunophenotyping, rather than repeating the same analysis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The presence of immature lymphocytes in a patient with generalized lymphadenopathy strongly suggests a need for immunophenotyping to identify the specific type of leukemia . It may be chronic lymphocytic leukemia which can be picked up by certain surface markers like CD19, CD20, CD23, and CD5.</li><li>\u27a4 immature lymphocytes</li><li>\u27a4 generalized lymphadenopathy</li><li>\u27a4 immunophenotyping</li><li>\u27a4 leukemia</li><li>\u27a4 chronic lymphocytic leukemia</li><li>\u27a4 surface markers</li><li>\u27a4 CD19, CD20, CD23, and CD5.</li><li>\u27a4 (Ref: Robbins 10 th / 597)</li><li>\u27a4 (Ref: Robbins 10 th / 597)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2a9b5322",
      "audio": ""
    },
    {
      "text": "Origin of CLL/SLL is:",
      "options": [
        {
          "label": "A",
          "text": "Progenitor B cell",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mature B cells",
          "correct": false
        },
        {
          "label": "C",
          "text": "Na\u00efve B cells",
          "correct": true
        },
        {
          "label": "D",
          "text": "Germinal centre",
          "correct": false
        }
      ],
      "correct_answer": "C. Na\u00efve B cells",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Na\u00efve B cells</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Ig genes of some CLL/SLL are somatically hypermutated, whereas others are not, suggesting that the cell of origin may be either a post-germinal center memory B cell or a naive B cell . It is not originating from progenitor B cell or mature B cell.</li><li>\u2022 Ig genes</li><li>\u2022 hypermutated,</li><li>\u2022 cell of origin</li><li>\u2022 post-germinal center memory B cell</li><li>\u2022 naive B cell</li><li>\u2022 not</li><li>\u2022 progenitor B cell or mature B cell.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The cell of origin for CLL/SLL is the naive B cell , which may or may not undergo somatic hypermutation, suggesting that CLL/SLL can arise from a pre-germinal center B cell.</li><li>\u27a4 cell</li><li>\u27a4 CLL/SLL is the naive B cell</li><li>\u27a4 somatic hypermutation,</li><li>\u27a4 CLL/SLL</li><li>\u27a4 pre-germinal center B cell.</li><li>\u27a4 (Ref: Robbins 10th/e p597)</li><li>\u27a4 (Ref: Robbins 10th/e p597)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "524730fe",
      "audio": ""
    },
    {
      "text": "Which of the following is the least likely to be a pre-leukaemic condition?",
      "options": [
        {
          "label": "A",
          "text": "Paroxysmal nocturnal haemoglobinuria",
          "correct": false
        },
        {
          "label": "B",
          "text": "Aplastic anaemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Paroxysmal cold haemoglobinuria",
          "correct": true
        },
        {
          "label": "D",
          "text": "Myelodysplastic syndrome",
          "correct": false
        }
      ],
      "correct_answer": "C. Paroxysmal cold haemoglobinuria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Paroxysmal cold haemoglobinuria</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: \u201cPNH: about 5% to 10% of patients eventually develop acute myeloid leukemia or a my\u00adelodysplastic syndrome , possibly because hematopoietic stem cells have suffered some type of genetic damage \u2019.</li><li>\u2022 Option A: \u201cPNH:</li><li>\u2022 5% to 10%</li><li>\u2022 acute myeloid leukemia or a my\u00adelodysplastic syndrome</li><li>\u2022 hematopoietic stem cells</li><li>\u2022 genetic damage</li><li>\u2022 Option B: Aplastic anemia results from a fundamental stem cell defect supported by the presence of karyotypic aberrations in many cases; the occasional trans\u00adformation of aplasia into myeloid neoplasms , typically myelodysplasia or acute myeloid leukemia; and the asso\u00adciation with abnormally short telomeres .</li><li>\u2022 Option B:</li><li>\u2022 Aplastic anemia</li><li>\u2022 stem cell defect</li><li>\u2022 karyotypic aberrations</li><li>\u2022 aplasia into myeloid neoplasms</li><li>\u2022 myelodysplasia or acute myeloid leukemia;</li><li>\u2022 short telomeres</li><li>\u2022 Option D: The term \u201cmyelodysplastic syndrome\u201d (MDS) refers to a group of clonal stem cell disorders characterized by maturation defects that are associated with ineffective hematopoiesis and a high risk of transformation to AML .</li><li>\u2022 Option D:</li><li>\u2022 \u201cmyelodysplastic syndrome\u201d</li><li>\u2022 clonal stem cell disorders</li><li>\u2022 maturation defects</li><li>\u2022 ineffective hematopoiesis</li><li>\u2022 high risk of transformation to AML</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Paroxysmal Cold Hemoglobinuria (PCH) is primarily an autoimmune hemolytic anemia and not commonly associated with transformation to leukemia , which makes it the least likely condition to be pre-leukemic .</li><li>\u2022 Paroxysmal Cold Hemoglobinuria (PCH)</li><li>\u2022 autoimmune hemolytic anemia</li><li>\u2022 not commonly</li><li>\u2022 transformation to leukemia</li><li>\u2022 least likely condition to be pre-leukemic</li><li>\u2022 (Ref: Robbins 10 th / 545)</li><li>\u2022 (Ref: Robbins 10 th / 545)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0377a018",
      "audio": ""
    },
    {
      "text": "A 6-year-old child presents with pallor that required two blood transfusions previously. He has now developed fever and petechial haemorrhages. His hemoglobin is 9 g/dL, platelet count is 20,000/mm 3 and TLC is 60,000/mm 3 . Flow cytometry reveals the cells to be CD10+ve, MPO+ ve, CD 19 + ve, CD 33 \u2013 ve, CD 117 + ve, and CD3 \u2013 ve. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "ALL",
          "correct": false
        },
        {
          "label": "B",
          "text": "AML",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mixed phenotypic leukaemia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Undifferentiated leukaemia",
          "correct": false
        }
      ],
      "correct_answer": "C. Mixed phenotypic leukaemia",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture6.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Mixed phenotypic leukaemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Acute Lymphoblastic Leukemia (ALL): ALL is a malignancy characterized by the overproduction of immature lymphoid cells , known as lymphoblasts, in the bone marrow. It is the most common type of cancer in children and is characterized by the presence of B or T lymphoid markers , but not typically myeloid markers. The flow cytometry results in the vignette showing CD10 and CD19 positivity suggest a lymphoid origin , which would be consistent with ALL. However, the presence of MPO , which is a myeloid marker, makes pure ALL less likely .</li><li>\u2022 Option A:</li><li>\u2022 Acute Lymphoblastic Leukemia (ALL):</li><li>\u2022 overproduction of immature lymphoid cells</li><li>\u2022 lymphoblasts,</li><li>\u2022 children</li><li>\u2022 B or T lymphoid markers</li><li>\u2022 vignette showing CD10 and CD19 positivity</li><li>\u2022 lymphoid origin</li><li>\u2022 ALL.</li><li>\u2022 MPO</li><li>\u2022 myeloid marker, makes pure ALL less likely</li><li>\u2022 Option B: Acute Myeloid Leukemia (AML): AML is a malignancy of myeloid lineage cells and is associated with the presence of myeloid markers such as CD13, CD33, and myeloperoxidase (MPO). It usually presents with signs of bone marrow failure like anemia, infection, and bleeding due to dysfunctional hematopoiesis . CD117 can also be present in AML . In the given case, the presence of MPO and CD117 supports myeloid involvement, but the additional presence of B-cell markers (CD10, CD19) would be atypical for AML .</li><li>\u2022 Option B:</li><li>\u2022 Acute Myeloid Leukemia (AML):</li><li>\u2022 myeloid lineage cells</li><li>\u2022 CD13, CD33,</li><li>\u2022 myeloperoxidase (MPO).</li><li>\u2022 bone marrow failure like anemia, infection, and bleeding due to dysfunctional hematopoiesis</li><li>\u2022 CD117</li><li>\u2022 AML</li><li>\u2022 MPO and CD117 supports myeloid involvement,</li><li>\u2022 B-cell markers (CD10, CD19) would be atypical for AML</li><li>\u2022 Option D: Undifferentiated Leukemia: Undifferentiated leukemia is a term used when l eukemic cells do not express lineage-specific markers that allow classification as either myeloid or lymphoid . These cells may express non-lineage specific markers like CD34, HLA-DR, and TdT, but lack definitive markers for B-cell, T-cell, or myeloid cell lines. In the vignette, the presence of lineage-specific markers does not support the diagnosis of undifferentiated leukemia.</li><li>\u2022 Option D:</li><li>\u2022 Undifferentiated Leukemia:</li><li>\u2022 Undifferentiated leukemia</li><li>\u2022 eukemic cells</li><li>\u2022 lineage-specific markers</li><li>\u2022 myeloid or lymphoid</li><li>\u2022 non-lineage specific markers like CD34, HLA-DR, and TdT,</li><li>\u2022 lack</li><li>\u2022 B-cell, T-cell, or myeloid cell lines.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 B lymphoid markers: CD10, CD19 and CD79 T lineage markers: CD2, CD3 and CD7 Myeloid markers ; CD13, CD33, CD117 and myeloperoxidase (MPO). Non lineage specific markers of hematopoietic progenitor cells: CD34, HLA-DR and TdT</li><li>\u2022 B lymphoid markers: CD10, CD19 and CD79</li><li>\u2022 B</li><li>\u2022 CD10, CD19 and CD79</li><li>\u2022 T lineage markers: CD2, CD3 and CD7</li><li>\u2022 T</li><li>\u2022 CD2, CD3 and CD7</li><li>\u2022 Myeloid markers ; CD13, CD33, CD117 and myeloperoxidase (MPO).</li><li>\u2022 Myeloid markers</li><li>\u2022 CD13, CD33, CD117 and myeloperoxidase (MPO).</li><li>\u2022 Non lineage specific markers of hematopoietic progenitor cells: CD34, HLA-DR and TdT</li><li>\u2022 Non lineage</li><li>\u2022 CD34, HLA-DR and TdT</li><li>\u2022 (Ref: Wintrobes 12 th /1814-8, Dacie and Lewis hematol\u00adogy 10 th /344-6)</li><li>\u2022 (Ref: Wintrobes 12 th /1814-8, Dacie and Lewis hematol\u00adogy 10 th /344-6)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b82539e2",
      "audio": ""
    },
    {
      "text": "Non-specific esterase is positive in all the categories of AML except:",
      "options": [
        {
          "label": "A",
          "text": "M3",
          "correct": false
        },
        {
          "label": "B",
          "text": "M4",
          "correct": false
        },
        {
          "label": "C",
          "text": "M5",
          "correct": false
        },
        {
          "label": "D",
          "text": "M6",
          "correct": true
        }
      ],
      "correct_answer": "D. M6",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) M6</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: (M3 - Acute Promyelocytic Leukemia, APL): M3 or APL is characterized by a specific chromosomal translocation t(15;17), which leads to the production of the PML-RARA fusion protein. The morphological hallmark of APL is the presence of promyelocytes with heavy granulation and Auer rods . Nonspecific esterase staining may be positive in a minority of APL cases, but this is not the main diagnostic marker. APL is particularly associated with a risk of disseminated intravascular coagulation (DIC) and is treated uniquely with all-trans retinoic acid (ATRA) and arsenic trioxide , which target the PML-RARA fusion protein.</li><li>\u2022 Option A: (M3 - Acute Promyelocytic Leukemia, APL):</li><li>\u2022 specific chromosomal translocation t(15;17),</li><li>\u2022 PML-RARA fusion protein.</li><li>\u2022 APL</li><li>\u2022 promyelocytes with heavy granulation and Auer rods</li><li>\u2022 APL</li><li>\u2022 disseminated intravascular coagulation</li><li>\u2022 all-trans retinoic acid (ATRA) and arsenic trioxide</li><li>\u2022 PML-RARA fusion protein.</li><li>\u2022 Option B: (M4 - Acute Myelomonocytic Leukemia): M4 or acute myelomonocytic leukemia is characterized by the proliferation of both myeloid and monocyte cells . Nonspecific esterase staining is positive because of the monocytic component, distinguishing it from other forms of AML . These cells often show dual esterase staining when stained with both specific and nonspecific esterase, reflecting their mixed lineage.</li><li>\u2022 Option B: (M4 - Acute Myelomonocytic Leukemia):</li><li>\u2022 both myeloid and monocyte cells</li><li>\u2022 Nonspecific esterase</li><li>\u2022 positive</li><li>\u2022 monocytic component,</li><li>\u2022 AML</li><li>\u2022 dual esterase</li><li>\u2022 both specific and nonspecific esterase,</li><li>\u2022 mixed lineage.</li><li>\u2022 Option C: (M5 - Acute Monocytic Leukemia): M5 or acute monocytic leukemia is characterized by an excess of monocytes in the bone marrow and blood . Nonspecific esterase staining is strongly positive in these cells, which reflects the presence of the monocytic component . M5 can be further subdivided into M5a and M5b , based on the maturity of the monocytes.</li><li>\u2022 Option C: (M5 - Acute Monocytic Leukemia):</li><li>\u2022 excess of monocytes</li><li>\u2022 bone marrow and blood</li><li>\u2022 Nonspecific esterase</li><li>\u2022 strongly positive</li><li>\u2022 monocytic component</li><li>\u2022 subdivided into M5a and M5b</li><li>\u2022 maturity of the monocytes.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Non-specific esterase (NSE) staining is characteristic of M4 and M5 subtypes of AML due to their monocytic components and is not a feature of the M6 class , which is marked by a proliferation of erythroid precursors.</li><li>\u27a4 Non-specific esterase (NSE)</li><li>\u27a4 M4 and M5 subtypes of AML</li><li>\u27a4 monocytic components</li><li>\u27a4 M6 class</li><li>\u27a4 proliferation of erythroid precursors.</li><li>\u27a4 (Ref: Robbins 10 th /618)</li><li>\u27a4 (Ref: Robbins 10 th /618)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ba50bf4f",
      "audio": ""
    },
    {
      "text": "Which of the following statements pertaining to leukemia is correct?",
      "options": [
        {
          "label": "A",
          "text": "Blasts of acute myeloid leukemia are typically Su\u00addan black negative",
          "correct": false
        },
        {
          "label": "B",
          "text": "Blasts of acute lymphoblastic leukemia are typically myeloperoxidase positive",
          "correct": false
        },
        {
          "label": "C",
          "text": "Low leucocyte alkaline phosphatase score is charac\u00adteristically seen in blastic phase of chronic myeloid leukemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tartarate resistant acid phosphatase positivity is typically seen in hairy cell leukemia",
          "correct": true
        }
      ],
      "correct_answer": "D. Tartarate resistant acid phosphatase positivity is typically seen in hairy cell leukemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Tartarate resistant acid phosphatase positivity is typically seen in hairy cell leukemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Blasts in acute myeloid leukemia (AML) are often Sudan black positive . This histochemical stain is used to detect the presence of myeloid granules in blasts , which are typically abundant in AML cells .</li><li>\u2022 Option A:</li><li>\u2022 Blasts</li><li>\u2022 acute myeloid leukemia (AML)</li><li>\u2022 Sudan black positive</li><li>\u2022 myeloid granules in blasts</li><li>\u2022 abundant in AML cells</li><li>\u2022 Option B: Blasts of acute lymphoblastic leukemia (ALL) are generally myeloperoxidase (MPO) negative . MPO is an enzyme found predominantly in myeloid cells and is used as a marker to distinguish AML (where blasts are typically MPO positive) from ALL .</li><li>\u2022 Option B:</li><li>\u2022 Blasts of acute lymphoblastic leukemia (ALL)</li><li>\u2022 myeloperoxidase (MPO) negative</li><li>\u2022 myeloid cells</li><li>\u2022 distinguish AML (where blasts are typically MPO positive) from ALL</li><li>\u2022 Option C: A low leukocyte alkaline phosphatase (LAP) score is seen in the chronic phase of chronic myeloid leukemia (CML), reflecting the abundance of immature leukocytes. However, the LAP score often increases when CML progresses to the blast crisis phase , due to the presence of a higher proportion of mature leukocytes.</li><li>\u2022 Option C:</li><li>\u2022 low leukocyte alkaline phosphatase (LAP)</li><li>\u2022 chronic myeloid leukemia (CML),</li><li>\u2022 immature leukocytes.</li><li>\u2022 LAP score</li><li>\u2022 increases</li><li>\u2022 CML progresses to the blast crisis phase</li><li>\u2022 higher</li><li>\u2022 mature leukocytes.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Tartarate resistant acid phosphatase (TRAP) positivity is typically seen in hairy cell leukemia (HCL), which is useful for its diagnosis and differentiation from other hematologic disorders.</li><li>\u27a4 Tartarate resistant acid phosphatase (TRAP) positivity</li><li>\u27a4 hairy cell leukemia (HCL),</li><li>\u27a4 diagnosis and differentiation</li><li>\u27a4 hematologic disorders.</li><li>\u27a4 (Ref: Robbins 10 th / 604)</li><li>\u27a4 (Ref: Robbins 10 th / 604)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d2a422e4",
      "audio": ""
    },
    {
      "text": "Which of the following is having poor prognosis in ALL?",
      "options": [
        {
          "label": "A",
          "text": "TLC 4000-10000",
          "correct": false
        },
        {
          "label": "B",
          "text": "Age < 10 year",
          "correct": false
        },
        {
          "label": "C",
          "text": "Presence of testicular involvement at presentation",
          "correct": true
        },
        {
          "label": "D",
          "text": "Presence of blasts in peripheral smear",
          "correct": false
        }
      ],
      "correct_answer": "C. Presence of testicular involvement at presentation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Presence of testicular involvement at presenta\u00adtion</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: (TLC 4000-10000): Total leukocyte count (TLC) at presentation is an important prognostic factor in ALL . Normal or moderately elevated TLCs are generally associated with a better prognosis . A very high TLC , particularly above 100,000, is typically considered a poor prognostic indicator in ALL , particularly in T-cell ALL .</li><li>\u2022 Option A: (TLC 4000-10000):</li><li>\u2022 prognostic factor in ALL</li><li>\u2022 Normal or moderately elevated TLCs</li><li>\u2022 better prognosis</li><li>\u2022 very high TLC</li><li>\u2022 100,000,</li><li>\u2022 poor prognostic indicator in ALL</li><li>\u2022 T-cell ALL</li><li>\u2022 Option B: (Age < 10 year): Age is a significant prognostic factor in ALL. Children under 1 year of age and adults over 35 years of age have a poorer prognosis compared to children aged 1 to 10 years, who tend to respond better to therapy .</li><li>\u2022 Option B: (Age < 10 year):</li><li>\u2022 under 1 year of age</li><li>\u2022 35 years of age</li><li>\u2022 poorer prognosis</li><li>\u2022 1 to 10 years,</li><li>\u2022 better to therapy</li><li>\u2022 Option D: (Presence of blasts in peripheral smear): The presence of blasts in the peripheral blood smear is characteristic of ALL but on its own is not necessarily a poor prognostic indicator . The percentage and the total number of blasts can provide more specific prognostic information , with a higher burden sometimes indicating more aggressive disease.</li><li>\u2022 Option D: (Presence of blasts in peripheral smear):</li><li>\u2022 blasts</li><li>\u2022 not necessarily a poor prognostic indicator</li><li>\u2022 total number of blasts</li><li>\u2022 more specific prognostic information</li><li>\u2022 higher burden</li><li>\u2022 more aggressive disease.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The presence of testicular involvement at presentation in Acute Lymphoblastic Leukemia (ALL) is associated with a poorer prognosis due to the risk of extramedullary relapse and the need for more aggressive treatment .</li><li>\u27a4 presence of testicular</li><li>\u27a4 Acute Lymphoblastic Leukemia (ALL)</li><li>\u27a4 poorer prognosis</li><li>\u27a4 extramedullary relapse</li><li>\u27a4 more aggressive treatment</li><li>\u27a4 Prognostic factors in ALL</li><li>\u27a4 Prognostic factors in ALL</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3f747bd8",
      "audio": ""
    },
    {
      "text": "A peripheral smear with increased neutrophils, basophils, eosinophils, and platelets is highly suggestive of:",
      "options": [
        {
          "label": "A",
          "text": "Acute myeloid leukemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acute lymphoblastic leukemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chronic myelogenous leukemia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Myelodysplastic syndrome",
          "correct": false
        }
      ],
      "correct_answer": "C. Chronic myelogenous leukemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Chronic myelogenous leukemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Acute Myeloid Leukemia (AML): is characterized by the rapid growth of abnormal myeloid cells in the bone marrow. While AML may show increased myeloid cells in the peripheral smear, it typically presents with blasts and a decrease in mature cells , unlike the broad spectrum of increased cells seen in the question.</li><li>\u2022 Option A:</li><li>\u2022 Acute Myeloid Leukemia (AML):</li><li>\u2022 rapid growth</li><li>\u2022 abnormal myeloid cells</li><li>\u2022 increased myeloid cells</li><li>\u2022 blasts and a decrease in mature cells</li><li>\u2022 Option B: Acute Lymphoblastic Leukemia (ALL): primarily affects lymphoid cells . It is characterized by the presence of lymphoblasts in the peripheral blood. The question describes an increase in myeloid cell lineages (neutrophils, basophils, eosinophils, and platelets), making ALL less likely.</li><li>\u2022 Option B:</li><li>\u2022 Acute Lymphoblastic Leukemia (ALL):</li><li>\u2022 primarily affects lymphoid cells</li><li>\u2022 lymphoblasts</li><li>\u2022 Option D: Myelodysplastic Syndrome (MDS): is a group of disorders characterized by ineffective hematopoiesis . While MDS can present with cytopenias and dysplastic changes in blood cells, the specific pattern described in the question (increased neutrophils, basophils, eosinophils, and platelets) is more indicative of CML.</li><li>\u2022 Option D:</li><li>\u2022 Myelodysplastic Syndrome (MDS):</li><li>\u2022 group of disorders</li><li>\u2022 ineffective hematopoiesis</li><li>\u2022 cytopenias and dysplastic</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Chronic myeloid leukemia is a stem cell disease that is characterized by leukocytosis with granulocytic immaturities, basophilia, splenomegaly and distinct chromosomal abnormality Philadelphia chromosome .</li><li>\u2022 Chronic myeloid leukemia</li><li>\u2022 stem cell disease</li><li>\u2022 leukocytosis with granulocytic immaturities, basophilia, splenomegaly</li><li>\u2022 Philadelphia chromosome</li><li>\u2022 (Ref: Robbins 10 th / 622)</li><li>\u2022 (Ref: Robbins 10 th / 622)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "45efbecf",
      "audio": ""
    },
    {
      "text": "AML with gum infiltration and hepatosplenomegaly is most likely associated with which of the following subtypes of AML?",
      "options": [
        {
          "label": "A",
          "text": "M1",
          "correct": false
        },
        {
          "label": "B",
          "text": "M3",
          "correct": false
        },
        {
          "label": "C",
          "text": "M2",
          "correct": false
        },
        {
          "label": "D",
          "text": "M4",
          "correct": true
        }
      ],
      "correct_answer": "D. M4",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) M4</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: (M1 - Acute Myeloblastic Leukemia without maturation): M1 subtype is characterized by a proliferation of myeloblasts without significant differentiation . While organomegaly can occur , M1 is not typically associated with gum infiltration.</li><li>\u2022 Option A: (M1 - Acute Myeloblastic Leukemia without maturation):</li><li>\u2022 proliferation of myeloblasts without</li><li>\u2022 differentiation</li><li>\u2022 organomegaly can occur</li><li>\u2022 not</li><li>\u2022 gum infiltration.</li><li>\u2022 Option B: (M3 - Acute Promyelocytic Leukemia): M3 subtype is unique due to its association with the t(15;17) translocation and the PML-RARA fusion gene . It can present with disseminated intravascular coagulation (DIC), but gum infiltration is less characteristic of M3 .</li><li>\u2022 Option B: (M3 - Acute Promyelocytic Leukemia):</li><li>\u2022 M3 subtype</li><li>\u2022 t(15;17) translocation</li><li>\u2022 PML-RARA fusion gene</li><li>\u2022 disseminated intravascular coagulation (DIC),</li><li>\u2022 gum infiltration</li><li>\u2022 less</li><li>\u2022 M3</li><li>\u2022 Option C: (M2 - Acute Myeloblastic Leukemia with maturation): M2 subtype shows some degree of myeloid maturation . It can occasionally involve extramedullary sites , but gum infiltration and hepatosplenomegaly are more typical of AML with monocytic differentiation , such as M4 and M5 .</li><li>\u2022 Option C: (M2 - Acute Myeloblastic Leukemia with maturation):</li><li>\u2022 M2</li><li>\u2022 degree of myeloid maturation</li><li>\u2022 extramedullary sites</li><li>\u2022 gum infiltration and hepatosplenomegaly</li><li>\u2022 more typical of AML with monocytic differentiation</li><li>\u2022 M4 and M5</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Acute Myelomonocytic Leukemia (M4) is commonly associated with extramedullary manifestations such as gum infiltration and hepatosplenomegaly due to the infiltrative nature of the monocytic component of the leukemia.</li><li>\u27a4 Acute Myelomonocytic Leukemia (M4)</li><li>\u27a4 gum infiltration and hepatosplenomegaly</li><li>\u27a4 infiltrative nature of the monocytic component</li><li>\u27a4 (Ref: Robbins 10 th / 618)</li><li>\u27a4 (Ref: Robbins 10 th / 618)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "648f56e4",
      "audio": ""
    },
    {
      "text": "A 42-year-old man was referred with a 2 week history of fever weakness and bleeding gum. Peripheral smear showed pancytopenia. The bone marrow examination revealed 26% blasts frequency exhibiting Auer rods and mature myeloid cells. An occasional neutrophil with pseudo Pelger-Huet anomaly was also detected. Which of the following cytochemical stains is most likely to be positive?",
      "options": [
        {
          "label": "A",
          "text": "Acid phosphatase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Non-specific esterase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Myeloperoxidase",
          "correct": true
        },
        {
          "label": "D",
          "text": "Toluidine blue",
          "correct": false
        }
      ],
      "correct_answer": "C. Myeloperoxidase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Myeloperoxidase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: (Acid Phosphatase): Acid phosphatase staining is primarily used to identify cells of the T-lymphoid lineage and is a key diagnostic marker in T-cell acute lymphoblastic leukemia (ALL). It would not typically be positive in myeloid cells or AML .</li><li>\u2022 Option A: (Acid Phosphatase):</li><li>\u2022 T-lymphoid lineage</li><li>\u2022 T-cell acute lymphoblastic leukemia (ALL).</li><li>\u2022 not</li><li>\u2022 positive in myeloid cells or AML</li><li>\u2022 Option B: (Non-Specific Esterase): Non-specific esterase staining is characteristic of monocytes and their malignant counterparts in acute monocytic leukemia (AML M5 subtype). It's not a specific marker for myeloblasts, which are the predominant cells in most AML subtypes.</li><li>\u2022 Option B: (Non-Specific Esterase):</li><li>\u2022 monocytes and their malignant counterparts in acute monocytic leukemia (AML M5 subtype).</li><li>\u2022 Option D: (Toluidine Blue): Toluidine blue staining is used to highlight mast cells and is not typically used in the diagnosis of AML or other types of leukemia .</li><li>\u2022 Option D: (Toluidine Blue):</li><li>\u2022 mast cells</li><li>\u2022 AML or other types of leukemia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In a patient with acute onset of pancytopenia and 26% blasts exhibiting Auer rods in the bone marrow , myeloperoxidase (MPO) staining is most likely to be positive , supporting a diagnosis of Acute Myeloid Leukemia (AML).</li><li>\u27a4 acute onset of pancytopenia and 26% blasts</li><li>\u27a4 Auer rods in the bone marrow</li><li>\u27a4 myeloperoxidase (MPO)</li><li>\u27a4 positive</li><li>\u27a4 Acute Myeloid Leukemia (AML).</li><li>\u27a4 (Ref: Robbins 10 th / 621)</li><li>\u27a4 (Ref: Robbins 10 th / 621)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fc9c6caf",
      "audio": ""
    },
    {
      "text": "\u201cSmudge cells\u201d in the peripheral smear are characteristic of:",
      "options": [
        {
          "label": "A",
          "text": "Chronic myelogenous leukemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chronic lymphocytic leukemia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Acute myelogenous leukemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acute lymphoblastic leukemia",
          "correct": false
        }
      ],
      "correct_answer": "B. Chronic lymphocytic leukemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Chronic lymphocytic leukemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Chronic Myelogenous Leukemia (CML) is characterized by the presence of the Philadelphia chromosome and an increase in myeloid cells , particularly granulocytes . Smudge cells are not a typical feature of CML.</li><li>\u2022 Option A:</li><li>\u2022 Chronic Myelogenous Leukemia (CML)</li><li>\u2022 Philadelphia chromosome</li><li>\u2022 increase in myeloid cells</li><li>\u2022 granulocytes</li><li>\u2022 Option C: Acute Myelogenous Leukemia (AML) is characterized by the rapid proliferation of immature myeloid cells . Smudge cells are not a characteristic feature of AML.</li><li>\u2022 Option C:</li><li>\u2022 Acute Myelogenous Leukemia (AML)</li><li>\u2022 immature myeloid cells</li><li>\u2022 Smudge cells</li><li>\u2022 AML.</li><li>\u2022 Option D: Acute Lymphoblastic Leukemia (ALL) primarily affects lymphoid cells , and it is characterized by the presence of lymphoblasts in the peripheral blood. Smudge cells are not a typical finding in ALL.</li><li>\u2022 Option D:</li><li>\u2022 Acute Lymphoblastic Leukemia (ALL)</li><li>\u2022 lymphoid cells</li><li>\u2022 presence of lymphoblasts</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Smudge cells in the peripheral smear are characteristic of Chronic Lymphocytic Leukemia (CLL), due to the increased fragility of the abnormal lymphocytes encountered in this disease.</li><li>\u2022 Smudge cells</li><li>\u2022 Chronic Lymphocytic Leukemia (CLL), due to the increased fragility of the abnormal lymphocytes encountered in this disease.</li><li>\u2022 (Ref: Robbins 7th/673, 9/e 593)</li><li>\u2022 (Ref: Robbins 7th/673, 9/e 593)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "95eb4929",
      "audio": ""
    },
    {
      "text": "Chromosomal translocation characteristic in acute promyelocytic leukemia is:",
      "options": [
        {
          "label": "A",
          "text": "t (15;17)",
          "correct": true
        },
        {
          "label": "B",
          "text": "t (9;22)",
          "correct": false
        },
        {
          "label": "C",
          "text": "t (17;21)",
          "correct": false
        },
        {
          "label": "D",
          "text": "t (8: 21)",
          "correct": false
        }
      ],
      "correct_answer": "A. t (15;17)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. t (15: 17)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: t (9;22): This translocation is characteristic of Chronic Myelogenous Leukemia (CML) and is known as the Philadelphia chromosome. It involves the fusion of the BCR (breakpoint cluster region) gene on chromosome 22 with the ABL1 (Abelson murine leukemia viral oncogene homolog 1) gene on chromosome 9, resulting in the BCR-ABL1 fusion gene . This fusion gene produces a constitutively active tyrosine kinase , contributing to the pathogenesis of CML.</li><li>\u2022 Option B: t (9;22):</li><li>\u2022 Chronic Myelogenous Leukemia (CML)</li><li>\u2022 Philadelphia chromosome.</li><li>\u2022 BCR (breakpoint cluster region)</li><li>\u2022 chromosome 22 with the ABL1 (Abelson murine</li><li>\u2022 leukemia viral oncogene homolog 1)</li><li>\u2022 chromosome 9,</li><li>\u2022 BCR-ABL1 fusion gene</li><li>\u2022 tyrosine kinase</li><li>\u2022 CML.</li><li>\u2022 Option C: t (17;21): This translocation is not a well-known chromosomal abnormality in leukemia. It doesn't correspond to a recognized leukemia subtype.</li><li>\u2022 Option C: t (17;21):</li><li>\u2022 not a well-known</li><li>\u2022 leukemia.</li><li>\u2022 Option D: t (8;21): This translocation is characteristic of Acute Myeloid Leukemia (AML) with maturation (AML-M2 subtype). It involves the fusion of the AML1 (also known as RUNX1) gene on chromosome 21 with the ETO (Eight-Twenty-One) gene on chromosome 8 , resulting in the AML1-ETO fusion gene . This translocation is associated with a subtype of AML and is used in its classification.</li><li>\u2022 Option D: t (8;21):</li><li>\u2022 Acute Myeloid Leukemia (AML)</li><li>\u2022 (AML-M2 subtype).</li><li>\u2022 AML1 (also known as RUNX1) gene on chromosome 21 with the ETO (Eight-Twenty-One) gene on chromosome 8</li><li>\u2022 AML1-ETO fusion gene</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The chromosomal translocation characteristic of Acute Promyelocytic Leukemia is t(15;17), resulting in the PML-RARA fusion gene .</li><li>\u2022 chromosomal translocation</li><li>\u2022 Acute Promyelocytic Leukemia is t(15;17),</li><li>\u2022 PML-RARA fusion gene</li><li>\u2022 (Ref: Robbins 10 th / 613)</li><li>\u2022 (Ref: Robbins 10 th / 613)</li><li>\u2022 (Ref: Robbins 10 th / 613)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "895fc1b6",
      "audio": ""
    },
    {
      "text": "The difference between leukemia and leukemoid reaction is done by:",
      "options": [
        {
          "label": "A",
          "text": "Elevated total leukocyte count",
          "correct": false
        },
        {
          "label": "B",
          "text": "Leucocyte alkaline phosphatase",
          "correct": true
        },
        {
          "label": "C",
          "text": "Erythrocyte sedimentation rate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Presence of immature cells",
          "correct": false
        }
      ],
      "correct_answer": "B. Leucocyte alkaline phosphatase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Leucocyte alkaline phosphatase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Elevated total leukocyte count: Both leukemia and leukemoid reaction can result in an elevated total leukocyte count. However, the specific characteristics of the white blood cells, along with other parameters, help differentiate between the two.</li><li>\u2022 Option A.</li><li>\u2022 Elevated total leukocyte count:</li><li>\u2022 Both leukemia and leukemoid reaction</li><li>\u2022 elevated total leukocyte count.</li><li>\u2022 Option C. Erythrocyte sedimentation rate (ESR): is a non-specific marker of inflammation and is not commonly used to differentiate between leukemia and leukemoid reaction.</li><li>\u2022 Option C.</li><li>\u2022 Erythrocyte sedimentation rate (ESR):</li><li>\u2022 non-specific marker of inflammation</li><li>\u2022 Option D. Presence of immature cells: The presence of immature or blast cells is not helpful for differentiating between leukemia from a leukemoid reaction. The percentage of immature cells is a crucial factor in distinguishing leukemia from a leukemoid reaction.</li><li>\u2022 Option D.</li><li>\u2022 Presence of immature cells:</li><li>\u2022 immature or blast cells</li><li>\u2022 not helpful</li><li>\u2022 leukemia from a leukemoid reaction.</li><li>\u2022 percentage of immature cells</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Leukocyte alkaline phosphatase (LAP) score helps differentiate between chronic myeloid leukemia (CML), where it is typically low , and a leukemoid reaction, where it is normal or elevated.</li><li>\u2022 Leukocyte alkaline phosphatase (LAP)</li><li>\u2022 chronic myeloid leukemia (CML), where it is typically low</li><li>\u2022 leukemoid reaction, where it is normal or elevated.</li><li>\u2022 (Ref: Robbins 10 th / 584)</li><li>\u2022 (Ref: Robbins 10 th / 584)</li><li>\u2022 (Ref: Robbins 10 th / 584)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ef2486d6",
      "audio": ""
    },
    {
      "text": "In myelodysplastic syndrome, the following statement is incorrect:",
      "options": [
        {
          "label": "A",
          "text": "Platelet counts in the bone marrow are normal or elevated",
          "correct": false
        },
        {
          "label": "B",
          "text": "Leucocyte counts in the marrow are normal or elevated",
          "correct": false
        },
        {
          "label": "C",
          "text": "Always has hypocellular bone marrow",
          "correct": true
        },
        {
          "label": "D",
          "text": "Refractory anemia",
          "correct": false
        }
      ],
      "correct_answer": "C. Always has hypocellular bone marrow",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Platelet counts in the bone marrow are often normal or elevated in myelodysplastic syndrome (MDS). This condition is characterized by ineffective hematopoiesis , and it commonly leads to cytopenias in the peripheral blood . Thrombocytopenia is a common feature in MDS , and it contributes to the increased risk of bleeding in affected individuals.</li><li>\u2022 Option A:</li><li>\u2022 Platelet counts</li><li>\u2022 normal or elevated in myelodysplastic syndrome (MDS).</li><li>\u2022 ineffective hematopoiesis</li><li>\u2022 cytopenias in the peripheral blood</li><li>\u2022 Thrombocytopenia</li><li>\u2022 MDS</li><li>\u2022 increased risk of bleeding</li><li>\u2022 Option B: Leucocyte counts in the bone marrow are normal or elevated: This statement is correct</li><li>\u2022 Option B:</li><li>\u2022 Leucocyte counts in the bone marrow are normal or elevated:</li><li>\u2022 Option D: Refractory anemia: This statement is correct. Refractory anemia is a common subtype of MDS , characterized by ineffective erythropoiesis leading to anemia that does not respond well to conventional treatment.</li><li>\u2022 Option D:</li><li>\u2022 Refractory anemia:</li><li>\u2022 Refractory anemia</li><li>\u2022 subtype of MDS</li><li>\u2022 ineffective erythropoiesis</li><li>\u2022 anemia</li><li>\u2022 does not</li><li>\u2022 conventional treatment.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Myelodysplastic syndrome (MDS) does not always have hypocellular bone marrow ; it is often hypercellular or normocellular.</li><li>\u27a4 Myelodysplastic syndrome (MDS) does not</li><li>\u27a4 hypocellular bone marrow</li><li>\u27a4 hypercellular or normocellular.</li><li>\u27a4 (Ref: Robbins 10 th / 620-1)</li><li>\u27a4 (Ref: Robbins 10 th / 620-1)</li><li>\u27a4 (Ref: Robbins 10 th / 620-1)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8d9d0d4b",
      "audio": ""
    },
    {
      "text": "The presence of the Philadelphia chromosome is associated with a worse prognosis in patients with which of the following diseases?",
      "options": [
        {
          "label": "A",
          "text": "Acute lymphoblastic leukemia",
          "correct": true
        },
        {
          "label": "B",
          "text": "Acute myelogenous leukemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chronic lymphocytic leukemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chronic myelogenous leukemia",
          "correct": false
        }
      ],
      "correct_answer": "A. Acute lymphoblastic leukemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Acute lymphoblastic leukemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: (Acute Myelogenous Leukemia, AML): The Philadelphia chromosome is not commonly associated with AML . AML has other chromosomal abnormalities that are more predictive of prognosis , such as the presence of mutations in genes like FLT3, NPM1, or alterations like t(15;17) in acute promyelocytic leukemia (APL).</li><li>\u2022 Option B: (Acute Myelogenous Leukemia, AML):</li><li>\u2022 Philadelphia chromosome</li><li>\u2022 not</li><li>\u2022 AML</li><li>\u2022 more predictive of prognosis</li><li>\u2022 FLT3, NPM1, or alterations like t(15;17) in acute promyelocytic leukemia (APL).</li><li>\u2022 Option C: (Chronic Lymphocytic Leukemia, CLL): CLL is typically not associated with the Philadelphia chromosome. CLL has its own prognostic markers, such as deletions in chromosome 13q, 11q, and trisomy 12 , or the mutation status of IGHV (immunoglobulin heavy chain variable region genes).</li><li>\u2022 Option C: (Chronic Lymphocytic Leukemia, CLL):</li><li>\u2022 not</li><li>\u2022 Philadelphia chromosome.</li><li>\u2022 deletions in chromosome 13q, 11q, and trisomy 12</li><li>\u2022 IGHV (immunoglobulin heavy chain variable region genes).</li><li>\u2022 Option D: (Chronic Myelogenous Leukemia, CML): The Philadelphia chromosome is the hallmark of CML and is present in the vast majority of cases. The presence of this chromosome is part of the diagnostic criteria for CML and is not considered a worse prognostic factor within this disease context. The treatment for CML includes TKIs , which target the BCR-ABL1 protein resulting from the Philadelphia chromosome translocation.</li><li>\u2022 Option D: (Chronic Myelogenous Leukemia, CML):</li><li>\u2022 Philadelphia chromosome</li><li>\u2022 hallmark of CML</li><li>\u2022 presence of this chromosome</li><li>\u2022 CML</li><li>\u2022 not</li><li>\u2022 worse prognostic factor</li><li>\u2022 TKIs</li><li>\u2022 BCR-ABL1 protein</li><li>\u2022 Philadelphia chromosome translocation.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The presence of the Philadelphia chromosome , a translocation from the long arm of chromosome 22 to chromosome 9 [t(9;22)], is associated with a favorable prognosis in chronic myelogenous leukemia but it associated with an unfavorable outcome in Acute lymphoblastic leukemia .</li><li>\u2022 Philadelphia chromosome</li><li>\u2022 translocation from the long arm of chromosome 22 to chromosome 9 [t(9;22)],</li><li>\u2022 favorable prognosis</li><li>\u2022 chronic myelogenous leukemia but</li><li>\u2022 unfavorable outcome in Acute lymphoblastic leukemia</li><li>\u2022 (Ref: Robbins 10 th / 601)</li><li>\u2022 (Ref: Robbins 10 th / 601)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d84a983e",
      "audio": ""
    },
    {
      "text": "Burkitt\u2019s lymphoma is associated most commonly with of the following translocations?",
      "options": [
        {
          "label": "A",
          "text": "t (8:14)",
          "correct": true
        },
        {
          "label": "B",
          "text": "t (9:22)",
          "correct": false
        },
        {
          "label": "C",
          "text": "t (11:14)",
          "correct": false
        },
        {
          "label": "D",
          "text": "t (8:21)",
          "correct": false
        }
      ],
      "correct_answer": "A. t (8:14)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. t (8:14)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: t (9:22) : is associated with Chronic Myelogenous Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL) but not Burkitt's lymphoma.</li><li>\u2022 Option B: t (9:22)</li><li>\u2022 Chronic Myelogenous Leukemia (CML)</li><li>\u2022 Acute Lymphoblastic Leukemia (ALL)</li><li>\u2022 Option C: t (11;14) : is associated with Mantle Cell Lymphoma but not Burkitt's lymphoma.</li><li>\u2022 Option C: t (11;14)</li><li>\u2022 Mantle Cell Lymphoma</li><li>\u2022 Option D: t (8:21) : is associated with Acute Myeloid Leukemia (AML) with maturation but not Burkitt's lymphoma.</li><li>\u2022 Option D:</li><li>\u2022 t (8:21)</li><li>\u2022 Acute Myeloid Leukemia (AML)</li><li>\u2022 maturation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Burkitt's lymphoma is most commonly associated with the translocation t(8;14) , involving the c-MYC gene on chromosome 8 and the immunoglobulin heavy chain gene on chromosome 14.</li><li>\u27a4 Burkitt's lymphoma</li><li>\u27a4 translocation t(8;14)</li><li>\u27a4 c-MYC gene on chromosome 8 and</li><li>\u27a4 immunoglobulin heavy chain gene on chromosome 14.</li><li>\u27a4 (Ref: Robbins 10 th / 602)</li><li>\u27a4 (Ref: Robbins 10 th / 602)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "eb0caa33",
      "audio": ""
    },
    {
      "text": "Mantle cell lymphomas are positive for all of the following, except:",
      "options": [
        {
          "label": "A",
          "text": "CD 23",
          "correct": true
        },
        {
          "label": "B",
          "text": "CD 20",
          "correct": false
        },
        {
          "label": "C",
          "text": "CD 5",
          "correct": false
        },
        {
          "label": "D",
          "text": "CD 43",
          "correct": false
        }
      ],
      "correct_answer": "A. CD 23",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) CD 23</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Mantle cell lymphomas are positive for CD20 , a B-cell marker .</li><li>\u2022 Option B:</li><li>\u2022 positive for CD20</li><li>\u2022 B-cell marker</li><li>\u2022 Option C: Mantle cell lymphomas are positive for CD5, a T-cell marker. This is a characteristic feature of mantle cell lymphomas and helps distinguish them from other B-cell lymphomas.</li><li>\u2022 Option C:</li><li>\u2022 positive for CD5,</li><li>\u2022 T-cell marker.</li><li>\u2022 mantle cell lymphomas</li><li>\u2022 distinguish them from other B-cell lymphomas.</li><li>\u2022 Option D: Mantle cell lymphomas are positive for CD43, a cell adhesion molecule and marker of T-lymphocytes . It is commonly expressed in mantle cell lymphomas.</li><li>\u2022 Option D:</li><li>\u2022 positive for CD43,</li><li>\u2022 cell adhesion molecule</li><li>\u2022 marker of T-lymphocytes</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mantle cell lymphomas are typically negative for CD23 , helping to distinguish them from other small B-cell lymphomas like CLL and follicular lymphoma.</li><li>\u27a4 Mantle cell lymphomas</li><li>\u27a4 negative for CD23</li><li>\u27a4 small B-cell lymphomas like CLL and</li><li>\u27a4 follicular lymphoma.</li><li>\u27a4 (Ref: Robbins 10 th /602)</li><li>\u27a4 (Ref: Robbins 10 th /602)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "76d30534",
      "audio": ""
    },
    {
      "text": "All of the following statements about hairy cell leukemia are true except:",
      "options": [
        {
          "label": "A",
          "text": "Splenomegaly is conspicuous",
          "correct": false
        },
        {
          "label": "B",
          "text": "Results from an expansion of neoplastic T-lympho\u00adcytes",
          "correct": true
        },
        {
          "label": "C",
          "text": "Cells are positive for Tartarate Resistant Acid phos\u00adphatase",
          "correct": false
        },
        {
          "label": "D",
          "text": "The cells express CD25 consistently",
          "correct": false
        }
      ],
      "correct_answer": "B. Results from an expansion of neoplastic T-lympho\u00adcytes",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Results from an expansion of neoplastic T-lymphocytes</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Splenomegaly is a characteristic feature of hairy cell leukemia.</li><li>\u2022 Option A:</li><li>\u2022 Splenomegaly</li><li>\u2022 Option C: Cells are positive for Tartrate-Resistant Acid Phosphatase (TRAP ) which is a helpful diagnostic marker for HCL.</li><li>\u2022 Option C:</li><li>\u2022 Cells are positive</li><li>\u2022 Tartrate-Resistant Acid Phosphatase (TRAP</li><li>\u2022 Option D: Hairy cells consistently express CD25 (also known as the interleukin-2 receptor alpha chain).</li><li>\u2022 Option D:</li><li>\u2022 Hairy cells</li><li>\u2022 CD25</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Hairy cell leukemia results from an expansion of neoplastic B-lymphocytes, not T-lymphocytes.</li><li>\u2022 Hairy cell leukemia</li><li>\u2022 neoplastic B-lymphocytes,</li><li>\u2022 (Ref: Robbins 10 th 604)</li><li>\u2022 (Ref: Robbins 10 th 604)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d59738f3",
      "audio": ""
    },
    {
      "text": "Post transplant lymphoma occurs due to proliferation of which of the following cells:",
      "options": [
        {
          "label": "A",
          "text": "T-cell",
          "correct": false
        },
        {
          "label": "B",
          "text": "B-cell",
          "correct": true
        },
        {
          "label": "C",
          "text": "NK cell",
          "correct": false
        },
        {
          "label": "D",
          "text": "Monocyte",
          "correct": false
        }
      ],
      "correct_answer": "B. B-cell",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. B-cell</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: (T-cell): T-cell proliferative disorders post-transplant are less common . The immunosuppression used to prevent graft rejection often targets T-cells to a greater extent, which paradoxically may result in a lesser incidence of T-cell lymphomas .</li><li>\u2022 Option A: (T-cell):</li><li>\u2022 post-transplant</li><li>\u2022 less common</li><li>\u2022 prevent graft rejection</li><li>\u2022 T-cells to a greater extent,</li><li>\u2022 lesser incidence of T-cell lymphomas</li><li>\u2022 Option C: (NK cell): Natural Killer (NK) cell neoplasms are rare in the post-transplant setting . NK cells are a part of the innate immune system and are not typically involved in the pathogenesis of PTLDs.</li><li>\u2022 Option C: (NK cell):</li><li>\u2022 neoplasms</li><li>\u2022 post-transplant setting</li><li>\u2022 innate immune system</li><li>\u2022 Option D: (Monocyte): Monocytes are not commonly the source of post-transplant neoplasms . While monocytes and other cells of the myeloid lineage can give rise to cancers, such as acute or chronic myeloid leukemias, they are not the typical cells implicated in PTLDs.</li><li>\u2022 Option D: (Monocyte):</li><li>\u2022 not commonly</li><li>\u2022 post-transplant neoplasms</li><li>\u2022 monocytes</li><li>\u2022 other cells</li><li>\u2022 myeloid lineage</li><li>\u2022 rise to cancers,</li><li>\u2022 acute or chronic myeloid leukemias,</li><li>\u2022 not the typical cells</li><li>\u2022 PTLDs.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Post-transplant lymphoma, or PTLD, occurs most frequently due to the proliferation of B-cells , often as a result of reduced T-cell- mediated immune regulation due to immunosuppressive therapy .</li><li>\u27a4 Post-transplant lymphoma,</li><li>\u27a4 PTLD,</li><li>\u27a4 proliferation of B-cells</li><li>\u27a4 reduced T-cell-</li><li>\u27a4 immunosuppressive therapy</li><li>\u27a4 (Ref: Robbins 10 th 1310)</li><li>\u27a4 (Ref: Robbins 10 th 1310)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "583734f8",
      "audio": ""
    },
    {
      "text": "Histological presence of \u201cHallmark Cells\u201d with horse shoe-like or embryoid like nuclei and voluminous cytoplasm are seen in:",
      "options": [
        {
          "label": "A",
          "text": "Anaplastic large cell lymphoma",
          "correct": true
        },
        {
          "label": "B",
          "text": "Familial Medullary Carcinoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Familial Neuroblastoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lymphocyte predominance type Hodgkin\u2019s lymphoma",
          "correct": false
        }
      ],
      "correct_answer": "A. Anaplastic large cell lymphoma",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture3_gFdbepj.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Anaplastic large cell lymphoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: (Familial Medullary Carcinoma): Familial medullary carcinoma of the thyroid is a calcitonin-producing tumor that arises from parafollicular C cells of the thyroid. It is associated with mutations in the RET proto-oncogene but does not have hallmark cells as described in ALCL.</li><li>\u2022 Option B: (Familial Medullary Carcinoma):</li><li>\u2022 thyroid</li><li>\u2022 parafollicular C cells</li><li>\u2022 RET proto-oncogene</li><li>\u2022 Option C: (Familial Neuroblastoma): Familial neuroblastoma is a rare pediatric malignancy of the sympathetic nervous system . Histologically, it shows small, round, blue cells and is not characterized by hallmark cells with horseshoe-like nuclei.</li><li>\u2022 Option C: (Familial Neuroblastoma):</li><li>\u2022 rare pediatric malignancy</li><li>\u2022 sympathetic nervous system</li><li>\u2022 small, round, blue cells</li><li>\u2022 Option D: (Lymphocyte predominance type Hodgkin\u2019s lymphoma): This type of Hodgkin\u2019s lymphoma is characterized by the presence of popcorn cells (lymphocytic and histiocytic cells) and not by hallmark cells. It's different from the classic Reed-Sternberg cells seen in other subtypes of Hodgkin's lymphoma.</li><li>\u2022 Option D: (Lymphocyte predominance type Hodgkin\u2019s lymphoma):</li><li>\u2022 Hodgkin\u2019s lymphoma</li><li>\u2022 popcorn cells (lymphocytic and histiocytic cells)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The presence of \u201cHallmark Cells \u201d with horseshoe-like nuclei and abundant cytoplasm is characteristic of anaplastic large cell lymphoma.</li><li>\u27a4 \u201cHallmark Cells</li><li>\u27a4 horseshoe-like nuclei</li><li>\u27a4 abundant cytoplasm</li><li>\u27a4 anaplastic large cell lymphoma.</li><li>\u27a4 (Ref: Robbin 10 th 606)</li><li>\u27a4 (Ref: Robbin 10 th 606)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0abc698c",
      "audio": ""
    },
    {
      "text": "The lymphocytic and histiocytic variant of Reed- Sternberg cell is seen in:",
      "options": [
        {
          "label": "A",
          "text": "Follicular center lymphoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lymphocyte depleted Hodgkin\u2019s disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nodular sclerosis Hodgkin\u2019s disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lymphocyte predominant Hodgkin\u2019s disease",
          "correct": true
        }
      ],
      "correct_answer": "D. Lymphocyte predominant Hodgkin\u2019s disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Lymphocyte predominant Hodgkin\u2019s disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Follicular center lymphoma: Reed-Sternberg cells are not typically associated with follicular center lymphoma , which is a subtype of non-Hodgkin's lymphoma .</li><li>\u2022 Option A: Follicular center lymphoma:</li><li>\u2022 Reed-Sternberg cells</li><li>\u2022 not</li><li>\u2022 follicular center lymphoma</li><li>\u2022 non-Hodgkin's lymphoma</li><li>\u2022 Option B: In the lymphocyte-depleted subtype of Hodgkin's disease , the Reed-Sternberg cells are surrounded by a small number of lymphocytes and a significant number o f histiocytes (macrophages). This variant is associated with a poorer prognosis compared to other subtypes of Hodgkin's lymphoma.</li><li>\u2022 Option B:</li><li>\u2022 lymphocyte-depleted subtype of Hodgkin's disease</li><li>\u2022 Reed-Sternberg cells</li><li>\u2022 small number of lymphocytes</li><li>\u2022 f histiocytes (macrophages).</li><li>\u2022 poorer prognosis</li><li>\u2022 Option C: Nodular sclerosis Hodgkin\u2019s disease: The nodular sclerosis subtype of Hodgkin's disease typically features Reed-Sternberg cells with a lacunar (empty) appearance, surrounded by fibrous bands.</li><li>\u2022 Option C: Nodular sclerosis Hodgkin\u2019s disease:</li><li>\u2022 subtype of Hodgkin's disease</li><li>\u2022 Reed-Sternberg cells with a lacunar (empty)</li><li>\u2022 fibrous bands.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The lymphocytic and histiocytic (L&H) variant of Reed-Sternberg cells , often called \"popcorn cells,\" is characteristic of lymphocyte predominant Hodgkin\u2019s disease .</li><li>\u27a4 lymphocytic and histiocytic (L&H)</li><li>\u27a4 Reed-Sternberg cells</li><li>\u27a4 \"popcorn cells,\"</li><li>\u27a4 predominant Hodgkin\u2019s disease</li><li>\u27a4 Ref : Robbins 10 th /613</li><li>\u27a4 Ref : Robbins 10 th /613</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2810dea0",
      "audio": ""
    },
    {
      "text": "A 32-year-old female presents with painless swelling of a supraclavicular lymph node. Excisional biopsy reveals a nodular pattern with a predominance of lymphocytes, and characteristic large, atypical mononuclear or multinucleated cells with a \"popcorn\" appearance. Immunohistochemistry shows positive staining for CD20 and CD45. What subtype of Hodgkin's lymphoma is most likely to be diagnosed in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Lymphocyte dominant Hodgkin's lymphoma",
          "correct": true
        },
        {
          "label": "B",
          "text": "Lymphocyte depleted Hodgkin's lymphoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nodular sclerosis Hodgkin's lymphoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Mixed type Hodgkin's lymphoma",
          "correct": false
        }
      ],
      "correct_answer": "A. Lymphocyte dominant Hodgkin's lymphoma",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture4_6TMNz9L.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Lymphocyte dominant</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: (Lymphocyte depleted Hodgkin's lymphoma): This rare subtype is marked by a lack of lymphocytes and an abundance of classic Reed-Sternberg cells . It often presents in more advanced stages and has a worse prognosis. It does not typically contain popcorn cells.</li><li>\u2022 Option B: (Lymphocyte depleted Hodgkin's lymphoma):</li><li>\u2022 rare subtype</li><li>\u2022 lack of lymphocytes</li><li>\u2022 classic Reed-Sternberg cells</li><li>\u2022 more advanced stages</li><li>\u2022 worse prognosis.</li><li>\u2022 Option C: (Nodular sclerosis Hodgkin's lymphoma): The most common subtype, characterized by the presence of collagen bands dividing the lymph node into nodules and Reed-Sternberg cells within lacunar spaces. This subtype usually affects young adults , and it is not primarily associated with popcorn cells.</li><li>\u2022 Option C: (Nodular sclerosis Hodgkin's lymphoma):</li><li>\u2022 most common subtype,</li><li>\u2022 presence of collagen bands</li><li>\u2022 lymph node into nodules</li><li>\u2022 Reed-Sternberg cells</li><li>\u2022 young adults</li><li>\u2022 Option D: (Mixed type Hodgkin's lymphoma): Also known as mixed cellularity Hodgkin's lymphoma , it is characterized by a mixed infiltrate that includes eosinophils, plasma cells, neutrophils, and Reed-Sternberg cells . It does not have a predominance of lymphocytes nor does it typically show popcorn cells.</li><li>\u2022 Option D: (Mixed type Hodgkin's lymphoma):</li><li>\u2022 mixed cellularity Hodgkin's lymphoma</li><li>\u2022 mixed infiltrate</li><li>\u2022 eosinophils, plasma cells, neutrophils, and Reed-Sternberg cells</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A biopsy showing a nodular pattern with a predominance of lymphocytes and characteristic \" popcorn\" cells that are positive for CD20 and CD45 is diagnostic of Lymphocyte Predominant Hodgkin's Lymphoma.</li><li>\u27a4 nodular pattern with a predominance of lymphocytes</li><li>\u27a4 popcorn\" cells</li><li>\u27a4 CD20 and CD45</li><li>\u27a4 Lymphocyte Predominant Hodgkin's Lymphoma.</li><li>\u27a4 (Ref: Robbins 10 th /613)</li><li>\u27a4 (Ref: Robbins 10 th /613)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "47e08891",
      "audio": ""
    },
    {
      "text": "The CD marker of histiocytosis is:",
      "options": [
        {
          "label": "A",
          "text": "CD 1a",
          "correct": true
        },
        {
          "label": "B",
          "text": "CD 1b",
          "correct": false
        },
        {
          "label": "C",
          "text": "CD 1c",
          "correct": false
        },
        {
          "label": "D",
          "text": "CD 1d",
          "correct": false
        }
      ],
      "correct_answer": "A. CD 1a",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture6_YFhykpf.jpg"
      ],
      "explanation": "<p><strong>Ans. A)\u00a0 CD 1a</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In Langerhans cell histiocytosis, tumor cells typically express the surface marker CD1a and contain intracytoplasmic Birbeck granules .</li><li>\u27a4 In Langerhans cell histiocytosis,</li><li>\u27a4 surface marker CD1a</li><li>\u27a4 intracytoplasmic Birbeck granules</li><li>\u27a4 (Ref: Robbins 10 th 620)</li><li>\u27a4 (Ref: Robbins 10 th 620)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9cb2cd56",
      "audio": ""
    },
    {
      "text": "Q34. A 60-year-old male with a known history of multiple myeloma presents with worsening renal function. A renal biopsy is performed to assess the renal involvement. Which of the following findings would be considered atypical or not commonly associated with renal complications of multiple myeloma?",
      "options": [
        {
          "label": "A",
          "text": "Tubular casts",
          "correct": false
        },
        {
          "label": "B",
          "text": "Amyloidosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Wire loop lesions",
          "correct": true
        },
        {
          "label": "D",
          "text": "Renal tubular necrosis",
          "correct": false
        }
      ],
      "correct_answer": "C. Wire loop lesions",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Wire loop lesions</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Tubular casts: These can result from the precipitation of light chains in the renal tubules , leading to cast formation. This is a common finding in multiple myeloma-associated renal disease.</li><li>\u2022 Option A: Tubular casts:</li><li>\u2022 precipitation of light chains in the renal tubules</li><li>\u2022 cast</li><li>\u2022 multiple myeloma-associated renal disease.</li><li>\u2022 Option B: Amyloidosis: Amyloid deposition in the kidneys is a known complication of multiple myeloma, leading to renal impairment.</li><li>\u2022 Option B: Amyloidosis:</li><li>\u2022 kidneys is a known complication of multiple myeloma,</li><li>\u2022 renal</li><li>\u2022 impairment.</li><li>\u2022 Option D: Renal tubular necrosis: Direct infiltration of myeloma cells into the renal tubules can cause tubular necrosis, contributing to renal dysfunction.</li><li>\u2022 Option D: Renal tubular necrosis:</li><li>\u2022 Direct infiltration of myeloma cells</li><li>\u2022 renal tubules</li><li>\u2022 tubular necrosis,</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Wire loop lesions are not typically associated with multiple myeloma and are characteristic of lupus nephritis.</li><li>\u27a4 Wire loop lesions</li><li>\u27a4 not typically associated with multiple myeloma</li><li>\u27a4 lupus nephritis.</li><li>\u27a4 (Ref: Robbins 10 th / 225)</li><li>\u27a4 (Ref: Robbins 10 th / 225)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "feef7007",
      "audio": ""
    },
    {
      "text": "Which of the following is the least common presentation of multiple myeloma?",
      "options": [
        {
          "label": "A",
          "text": "Anemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hyperviscosity",
          "correct": true
        },
        {
          "label": "C",
          "text": "Bone pains",
          "correct": false
        },
        {
          "label": "D",
          "text": "Infection",
          "correct": false
        }
      ],
      "correct_answer": "B. Hyperviscosity",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Hyperviscosity</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: (Anemia): Anemia is a common finding in multiple myeloma, typically normocytic and normochromic, caused by the replacement of bone marrow with myeloma cells , which impairs normal blood cell production.</li><li>\u2022 Option A: (Anemia):</li><li>\u2022 Anemia is a common</li><li>\u2022 typically normocytic and normochromic,</li><li>\u2022 bone marrow with myeloma cells</li><li>\u2022 Option C: (Bone Pains): Bone pain, particularly in the back or chest , is a very common symptom of multiple myeloma. It results from bone destruction due to the infiltration and activation of osteoclasts by myeloma cells, leading to lytic lesions or fractures.</li><li>\u2022 Option C: (Bone Pains):</li><li>\u2022 Bone pain,</li><li>\u2022 back or chest</li><li>\u2022 very common</li><li>\u2022 bone destruction</li><li>\u2022 infiltration and activation of osteoclasts by myeloma cells,</li><li>\u2022 Option D: (Infection): Patients with multiple myeloma have an increased risk of infections due to an impaired immune response , both from the disease itself and as a consequence of treatment, making infection a common presentation.</li><li>\u2022 Option D: (Infection):</li><li>\u2022 increased risk of infections due to an impaired immune response</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hyperviscosity is the least common presentation of multiple myeloma compared to anemia, bone pains, and infection.</li><li>\u27a4 Hyperviscosity</li><li>\u27a4 least common</li><li>\u27a4 multiple myeloma compared to anemia, bone pains, and infection.</li><li>\u27a4 (Ref: Robbins 10 th / 609)</li><li>\u27a4 (Ref: Robbins 10 th / 609)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "140f872c",
      "audio": ""
    },
    {
      "text": "A 60-year-old male presents with fatigue, weakness, and recurrent infections. Flow cytometry analysis of bone marrow aspirate shows infiltration of small lymphocytes, plasma cells, and lymphoplasmacytoid cells. The patient is diagnosed with lymphoplasmacytoid lymphoma. Which immunoglobulin is most likely to be associated with this lymphoma subtype?",
      "options": [
        {
          "label": "A",
          "text": "IgG",
          "correct": false
        },
        {
          "label": "B",
          "text": "IgA",
          "correct": false
        },
        {
          "label": "C",
          "text": "IgD",
          "correct": false
        },
        {
          "label": "D",
          "text": "IgM",
          "correct": true
        }
      ],
      "correct_answer": "D. IgM",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) IgM</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: (IgG): While IgG is the most common immunoglobulin produced in multiple myeloma , it is not typically associated with lymphoplasmacytoid lymphoma, also known as Waldenstr\u00f6m\u2019s macroglobulinemia.</li><li>\u2022 Option A: (IgG):</li><li>\u2022 IgG</li><li>\u2022 most</li><li>\u2022 immunoglobulin</li><li>\u2022 multiple myeloma</li><li>\u2022 Option B: (IgA): IgA is another immunoglobulin that can be produced in multiple myeloma but is less commonly associated with lymphoplasmacytoid lymphoma.</li><li>\u2022 Option B: (IgA):</li><li>\u2022 IgA</li><li>\u2022 immunoglobulin</li><li>\u2022 multiple myeloma</li><li>\u2022 Option C: (IgD): IgD paraproteinemia is very rare in plasma cell dyscrasias and is not commonly seen in lymphoplasmacytoid lymphoma.</li><li>\u2022 Option C: (IgD):</li><li>\u2022 IgD paraproteinemia</li><li>\u2022 plasma cell dyscrasias</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Lymphoplasmacytoid lymphoma, known as Waldenstr\u00f6m\u2019s macroglobulinemia, is most commonly associated with the overproduction of monoclonal IgM .</li><li>\u27a4 Lymphoplasmacytoid lymphoma,</li><li>\u27a4 Waldenstr\u00f6m\u2019s macroglobulinemia,</li><li>\u27a4 monoclonal IgM</li><li>\u27a4 (Ref: Robbins 10 th / 604)</li><li>\u27a4 (Ref: Robbins 10 th / 604)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4784e555",
      "audio": ""
    },
    {
      "text": "A 55-year-old male who is a diagnosed case of multiple myeloma has come up for follow-up. Elevated levels of which of the following is a poor prognostic factor in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Beta 2 microglobulin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Creatine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Albumin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anemia",
          "correct": false
        }
      ],
      "correct_answer": "A. Beta 2 microglobulin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Beta 2 microglobulin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Elevated creatinine levels can indicate impaired renal function , which is a common complication in multiple myeloma. However, it is not a specific prognostic factor on its own.</li><li>\u2022 Option B:</li><li>\u2022 Elevated creatinine levels</li><li>\u2022 impaired renal function</li><li>\u2022 Option C: Low levels of albumin are associated with poor prognosis in various diseases, including multiple myeloma. However, an increase in albumin is not typically considered a poor prognostic factor in this context.</li><li>\u2022 Option C:</li><li>\u2022 Low levels of albumin</li><li>\u2022 poor prognosis in various diseases,</li><li>\u2022 Option D: Anemia is a common feature of multiple myeloma and is associated with a poorer prognosis. However, the presence of anemia itself may not necessarily indicate a worsening prognosis without considering other factors.</li><li>\u2022 Option D:</li><li>\u2022 Anemia is a common</li><li>\u2022 multiple myeloma</li><li>\u2022 poorer prognosis.</li><li>\u2022 presence of</li><li>\u2022 anemia itself</li><li>\u2022 worsening prognosis</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Elevated serum levels of Beta 2 microglobulin are a powerful prognostic factor in multiple myeloma, reflecting tumor burden and the extent of tumor cell infiltration.</li><li>\u2022 Elevated serum levels of Beta 2 microglobulin</li><li>\u2022 powerful prognostic factor</li><li>\u2022 tumor cell infiltration.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "711d7d5b",
      "audio": ""
    },
    {
      "text": "A patient with lymphoma with CD10 and bcl2 marker is likely to be diagnosed with which of the following?",
      "options": [
        {
          "label": "A",
          "text": "Mycosis fungoides",
          "correct": false
        },
        {
          "label": "B",
          "text": "Follicular lymphoma",
          "correct": true
        },
        {
          "label": "C",
          "text": "Burkitt\u2019s lymphoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hodgkin lymphoma",
          "correct": false
        }
      ],
      "correct_answer": "B. Follicular lymphoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Follicular lymphoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Mycosis fungoides is a type of cutaneous T-cell lymphoma , primarily involving the skin . CD10 and bcl-2 markers are not typically associated with mycosis fungoides.</li><li>\u2022 Option A:</li><li>\u2022 Mycosis fungoides</li><li>\u2022 cutaneous T-cell lymphoma</li><li>\u2022 skin</li><li>\u2022 Option C: Burkitt's lymphoma is an aggressive B-cell lymphoma, often associated with the Epstein-Barr virus. It is characterized by a high proliferation rate and a characteristic translocation involving the c-Myc gene . CD10 can be expressed in Burkitt's lymphoma, but bcl-2 is typically negative.</li><li>\u2022 Option C:</li><li>\u2022 Burkitt's lymphoma</li><li>\u2022 aggressive B-cell lymphoma,</li><li>\u2022 Epstein-Barr virus.</li><li>\u2022 high proliferation</li><li>\u2022 translocation involving the c-Myc gene</li><li>\u2022 CD10</li><li>\u2022 Burkitt's lymphoma,</li><li>\u2022 bcl-2 is typically negative.</li><li>\u2022 Option D: Hodgkin lymphoma is characterized by the presence of Reed-Sternberg cells . CD10 and bcl-2 are not t ypical markers for Hodgkin lymphoma . Classical Hodgkin lymphoma is more commonly associated with CD15 and CD30 expression.</li><li>\u2022 Option D:</li><li>\u2022 Hodgkin lymphoma</li><li>\u2022 presence of Reed-Sternberg cells</li><li>\u2022 CD10 and bcl-2 are not t</li><li>\u2022 Hodgkin lymphoma</li><li>\u2022 CD15 and CD30 expression.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 A lymphoma with positive CD10 and bcl2 markers is likely to be diagnosed as follicular lymphoma.</li><li>\u2022 positive CD10 and bcl2 markers</li><li>\u2022 follicular lymphoma.</li><li>\u2022 (Ref: Robbins 10th/e p468)</li><li>\u2022 (Ref: Robbins 10th/e p468)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "19cdceae",
      "audio": ""
    },
    {
      "text": "An elderly male with dragging sensation in abdomen presents in the OPD. His cell count had elevated total leucocyte count and increased platelet count. His peripheral smear shows metamyelocytes, myelocytes, eosinophilia and basophilia (image given for reference). Which of the following is the likely genetic anomaly present in this individual?",
      "options": [
        {
          "label": "A",
          "text": "t (9; 22)",
          "correct": true
        },
        {
          "label": "B",
          "text": "t (15; 17)",
          "correct": false
        },
        {
          "label": "C",
          "text": "t (8; 14)",
          "correct": false
        },
        {
          "label": "D",
          "text": "t (8; 21)",
          "correct": false
        }
      ],
      "correct_answer": "A. t (9; 22)",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture7_WdmXOwZ.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. t (9; 22)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: t (15;17) : is associated with acute promyelocytic leukemia (APL). It involves the fusion of the PML (promyelocytic leukemia) gene on chromosome 15 with the RARA (retinoic acid receptor alpha) gene on chromosome 17 , resulting in the PML-RARA fusion gene. This fusion gene plays a crucial role in the pathogenesis of APL.</li><li>\u2022 Option B: t (15;17)</li><li>\u2022 acute promyelocytic leukemia (APL).</li><li>\u2022 PML (promyelocytic</li><li>\u2022 leukemia) gene on chromosome 15 with the RARA (retinoic acid receptor alpha) gene on chromosome 17</li><li>\u2022 PML-RARA fusion gene.</li><li>\u2022 Option C: t (8;14) : is associated with Burkitt's lymphoma. It involves the c-MYC gene on chromosome 8 and the immunoglobulin heavy chain gene on chromosome 14 . The dysregulation of c-MYC , a proto-oncogene, contributes to the rapid and uncontrolled proliferation of B cells in Burkitt's lymphoma.</li><li>\u2022 Option C: t (8;14)</li><li>\u2022 Burkitt's lymphoma.</li><li>\u2022 c-MYC gene on chromosome 8</li><li>\u2022 immunoglobulin</li><li>\u2022 heavy chain gene on chromosome 14</li><li>\u2022 c-MYC</li><li>\u2022 rapid and uncontrolled</li><li>\u2022 proliferation of B cells</li><li>\u2022 Option D: t (8;21) : is associated with acute myeloid leukemia (AML) , particularly the subtype known as AML with t(8;21), also called AML-M2. It involves the fusion of the AML1 (acute myeloid leukemia 1) gene on chromosome 21 with the ETO (eight-twenty-one) gene on chromosome 8, resulting in the AML1-ETO fusion gene.</li><li>\u2022 Option D: t (8;21)</li><li>\u2022 acute myeloid leukemia (AML)</li><li>\u2022 AML with t(8;21),</li><li>\u2022 AML-M2.</li><li>\u2022 AML1 (acute myeloid leukemia 1) gene on chromosome 21 with the ETO (eight-twenty-one) gene on chromosome 8,</li><li>\u2022 AML1-ETO fusion gene.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The genetic anomaly likely present in an elderly male with an elevated leukocyte and platelet count , peripheral smear showing metamyelocytes, myelocytes, eosinophilia, and basophilia is t (9;22), which is associated with chronic myeloid leukemia (CML).</li><li>\u27a4 genetic anomaly</li><li>\u27a4 elderly male</li><li>\u27a4 elevated leukocyte and platelet count</li><li>\u27a4 metamyelocytes, myelocytes, eosinophilia, and basophilia is t (9;22),</li><li>\u27a4 chronic myeloid leukemia (CML).</li><li>\u27a4 (Ref: Robbins 10th/e p622)</li><li>\u27a4 (Ref: Robbins 10th/e p622)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "03a8f581",
      "audio": ""
    },
    {
      "text": "A male patient with splenomegaly with myeloid hyperplasia. What\u2019s is the next best investigation to be done?",
      "options": [
        {
          "label": "A",
          "text": "Whole body PET CT",
          "correct": false
        },
        {
          "label": "B",
          "text": "Leucocyte alkaline phosphatase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Immunophenotyping",
          "correct": false
        },
        {
          "label": "D",
          "text": "FISH in the peripheral blood smear",
          "correct": true
        }
      ],
      "correct_answer": "D. FISH in the peripheral blood smear",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. FISH in the peripheral blood smear</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Whole-body PET CT (Positron Emission Tomography with Computed Tomography) is a valuable imaging tool, particularly in the evaluation of lymphomas and solid tumors. However, it may not be the first-line investigation for myeloid hyperplasia or diseases primarily involving the bone marrow.</li><li>\u2022 Option A:</li><li>\u2022 PET CT (Positron Emission Tomography with Computed Tomography)</li><li>\u2022 lymphomas and solid tumors.</li><li>\u2022 not be the first-line investigation for myeloid hyperplasia</li><li>\u2022 primarily</li><li>\u2022 bone marrow.</li><li>\u2022 Option B: Leucocyte alkaline phosphatase (LAP) is an enzyme that can be measured to assess the activity of neutrophils . Low LAP scores may be associated with conditions like chronic myeloid leukemia (CML). However, this test alone might not provide a definitive diagnosis and is often used in conjunction with other tests.</li><li>\u2022 Option B:</li><li>\u2022 Leucocyte alkaline phosphatase (LAP)</li><li>\u2022 enzyme</li><li>\u2022 to assess the activity of neutrophils</li><li>\u2022 Low LAP</li><li>\u2022 chronic myeloid leukemia (CML).</li><li>\u2022 definitive diagnosis</li><li>\u2022 Option C: Immunophenotyping is a crucial investigation in the context of hematological disorders . It involves the analysis of cell surface markers on blood or bone marrow cells but is more useful for other leukemias like ALL, AML or CLL.</li><li>\u2022 Option C:</li><li>\u2022 Immunophenotyping</li><li>\u2022 hematological disorders</li><li>\u2022 cell surface markers</li><li>\u2022 blood or bone marrow cells</li><li>\u2022 ALL, AML or CLL.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For a male patient with splenomegaly and myeloid hyperplasia , the next best investigation is Fluorescence in situ hybridization (FISH) in the peripheral blood smear, particularly to detect chromosomal abnormalities such as the Philadelphia chromosome in chronic myeloid leukemia (CML).</li><li>\u27a4 male</li><li>\u27a4 splenomegaly and myeloid hyperplasia</li><li>\u27a4 Fluorescence in situ hybridization (FISH)</li><li>\u27a4 Philadelphia chromosome</li><li>\u27a4 chronic myeloid leukemia (CML).</li><li>\u27a4 (Ref: Robbins 10th/e p482)</li><li>\u27a4 (Ref: Robbins 10th/e p482)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "043f382b",
      "audio": ""
    },
    {
      "text": "Lacunar cells are seen in which type of Hodgkin\u2019s lymphoma:",
      "options": [
        {
          "label": "A",
          "text": "Lymphocyte predominance",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lyphocyte depletion",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nodular sclerosis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Mixed cellularity",
          "correct": false
        }
      ],
      "correct_answer": "C. Nodular sclerosis",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture5_RDkaQxW.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Nodular sclerosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: (Lymphocyte Predominance): This subtype is characterized by the presence of Reed-Sternberg cell variants called popcorn cells , which are usually CD20 positive , and not by lacunar cells . It has a nodular pattern and an abundance of reactive lymphocytes .</li><li>\u2022 Option A: (Lymphocyte Predominance):</li><li>\u2022 subtype</li><li>\u2022 presence of Reed-Sternberg cell</li><li>\u2022 popcorn cells</li><li>\u2022 CD20 positive</li><li>\u2022 not by lacunar cells</li><li>\u2022 nodular pattern</li><li>\u2022 an abundance of reactive lymphocytes</li><li>\u2022 Option B: (Lymphocyte Depletion): This rare and aggressive subtype contains few lymphocytes and numerous Reed-Sternberg cells , often in a background that may include fibrosis , but not typically lacunar cells .</li><li>\u2022 Option B: (Lymphocyte Depletion):</li><li>\u2022 rare and aggressive</li><li>\u2022 few lymphocytes and numerous Reed-Sternberg cells</li><li>\u2022 fibrosis</li><li>\u2022 not</li><li>\u2022 lacunar cells</li><li>\u2022 Option D: (Mixed Cellularity): Mixed cellularity Hodgkin's lymphoma is noted for a diverse cellular composition that includes numerous classic Reed-Sternberg cells among inflammatory cells , but not specifically lacunar cells.</li><li>\u2022 Option D: (Mixed Cellularity):</li><li>\u2022 diverse cellular composition</li><li>\u2022 Reed-Sternberg cells among inflammatory cells</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Lacunar cells are a characteristic feature of the nodular sclerosis subtype of Hodgkin\u2019s lymphoma .</li><li>\u27a4 Lacunar cells</li><li>\u27a4 nodular sclerosis subtype of Hodgkin\u2019s lymphoma</li><li>\u27a4 (Ref: Robbins 10 th 618)</li><li>\u27a4 (Ref: Robbins 10 th 618)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6d412e23",
      "audio": ""
    },
    {
      "text": "Irradiation of white blood cells prior to transfusion prevents which of the following complications?",
      "options": [
        {
          "label": "A",
          "text": "TRALI",
          "correct": false
        },
        {
          "label": "B",
          "text": "HLA alloimmunisation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Graft versus host disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Immunomodulation",
          "correct": false
        }
      ],
      "correct_answer": "C. Graft versus host disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Graft versus host disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: (TRALI - Transfusion-Related Acute Lung Injury): TRALI is a serious complication characterized by acute respiratory distress following transfusion. It is thought to be caused by donor antibodies against recipient leukocytes . Irradiation does not prevent TRALI.</li><li>\u2022 Option A: (TRALI - Transfusion-Related Acute Lung Injury):</li><li>\u2022 acute respiratory distress</li><li>\u2022 transfusion.</li><li>\u2022 donor antibodies against recipient leukocytes</li><li>\u2022 Option B: (HLA alloimmunization): HLA alloimmunization can occur when a patient develops antibodies against HLA antigens from transfused blood . While leukoreduction can reduce the risk, irradiation of blood products does not prevent HLA alloimmunization.</li><li>\u2022 Option B: (HLA alloimmunization):</li><li>\u2022 patient develops antibodies against HLA antigens from transfused blood</li><li>\u2022 Option D: (Immunomodulation): Immunomodulation refers to the potential immune system changes in transfusion recipients, potentially leading to an increased risk of postoperative infections and malignancy recurrence . Irradiation\u2019s role in preventing immunomodulation is not clearly established.</li><li>\u2022 Option D: (Immunomodulation):</li><li>\u2022 potential immune system</li><li>\u2022 transfusion recipients,</li><li>\u2022 postoperative infections</li><li>\u2022 malignancy recurrence</li><li>\u2022 Irradiation\u2019s</li><li>\u2022 immunomodulation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Irradiation of white and red blood cells prior to transfusion is primarily used to prevent graft versus host disease.</li><li>\u27a4 Irradiation of white</li><li>\u27a4 red blood cells prior</li><li>\u27a4 prevent graft versus host disease.</li><li>\u27a4 (Ref: Robbins 10th/e p671-2)</li><li>\u27a4 (Ref: Robbins 10th/e p671-2)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a67ef890",
      "audio": ""
    }
  ]
}